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Chapter 1 
INTRODUCTION 
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by a broad 
spectrum of clinical manifestations. Of these, lupus nephritis is one of the most severe '. The 
glomerular disease manifestations are highly variable in their clinical presentation ranging 
from mild proteinuria to a rapidly progressive course leading to renal insufficiency, within 
relatively short time. Granular deposits of immunoglobulins and complement factors along 
the glomerular capillary wall and in the mesangium point to an immune complex 
pathogenesis 2. For the study of the underlying mechanisms the existence of a number of 
experimental animal models (MRL/lpr and NZB χ W mice) which spontaneously develop a 
syndrome closely resembling the human lupus has been very helpful 3 · 4 . The auto-immune 
nature of the disease was demonstrated by the discovery of the LE cell phenomenon and the 
description of a variety of auto-antibodies. These auto-antibodies are mainly directed against 
several nuclear antigens (dsDNA, ssDNA, RNA, histones, nucleosomes and spliceosomes). 
They can be identified in the circulation and sometimes in the tissue lesions 5'7. Sequencing 
of the V regions of these antibodies and analysis of their immunochemical properties suggest 
that these auto-antibodies are products of an antigen driven response that involves somatic 
mutation, affinity maturation and IgM to IgG class switching "•'. 
Despite several decades of research, the immunopathogenesis of lupus nephritis is not clearly 
defined and remains controversial 10"14. There are currently three major hypotheses for the 
mechanisms responsible for the development of this manifestation of lupus: 
the circulating immune complex hypothesis, in which circulating immune complexes 
bind to or are trapped within the glomerulus21UI5. Although it is still unclear which 
components constitute these immune complexes. 
the planted antigen hypothesis, in which nuclear antigens bind to the glomerulus and 
act as immobilized substrates for subsequent auto-antibody binding 16~". 
the cross-reactive autoantibody hypothesis, in which auto-antibodies directed against 
nuclear antigens cross-react with glomerular epitopes 2 υ 2 3 . 
Despite their differences, these three hypotheses are not mutually exclusive and potentially 
may all contribute to the pathogenesis of nephritis. 
Although there is general agreement that anti-DNA antibodies contribute to the pathogenesis 
of lupus nephritis, multiple lines of evidence suggest that that anti-DNA antibodies are not 
the sole pathogenic mechanism. Recent studies have indicated that nucleosomes play a pivotal 
role in both the initiation and the effector phase of SLE. Nucleosomes are the basic structures 
of chromatin. They consist of an octamenc complex of two H2 A/H2B dimers and one H3/H4 
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tetramer, around which a segment of - 146 bp of DNA is wound in 2 superhelical turns. 
A molecule of histone HI is bound to the short "linker" DNA segment between two 
nucleosomes 2\ Within the nucleosome clustered regions of different charges are present. 
The N terminal regions of the histones are located on the outside of the nucleosome and 
carry many positive charges. The DNA turns display anionic determinants. Nuclear material 
in the circulation of SLE patients is present in the form of oligo-nucleosomes 25. These 
nucleosomes are generated during apoptosis (programmed cell death) by internucleosomal 
cleavage of chromatin. There is now increasing evidence that both in murine and human SLE 
apoptosis is disturbed leading to changes in the release and composition of nucleosomes 26"29. 
Recently, it was discovered that nucleosomes comprise epitopes for pathogenic Τ helper cells 
and that these Τ helper cells not only can stimulate В cells to produce auto-antibodies to 
nucleosomes but also to DNA and histones 30. Furthermore the onset of the autoimmune 
response in SLE is characterized by the early emergence of antibodies that recognize 
conformational epitopes of the nucleosome particle but not its individual components (i.e. 
DNA and histones)31-32. The number of reports that describe nucleosome specific antibodies 
in human 33 3" and murine 3 1 3 2 , 3 7 ' 3 9 SLE increases steadily. These findings indicate that in 
SLE, there is autoimmune response against nucleosomes (being the major immunogen) with 
development of antibodies to various epitopes on nucleosomes (including but not limited to 
DNA). 
Besides serving as an auto-antigenic target nucleosomes appear to be important for the 
binding of anti-nuclear antibodies to the glomerular basement membrane (GBM). Research 
which led to this concept was started several years ago. It was found that certain anti-DNA 
antibodies could bind to heparan sulphate (HS) which was initially explained as cross-
reactivity of anti-DNA to HS 20. HS is an intrinsic constituent of the GBM. Due to its many 
sulphate groups it has a strong negative charge and is responsible for the net negative charge 
of the GBM and for its charge dependent permeability m. However, when these HS cross-
reactive anti-DNA antibodies were purified, the binding to HS was lost while binding could 
be restored with histones and DNA 4 ' . In in vivo renal perfusion studies we found that 
subsequent perfusion of histones, DNA and a non-complexed purified anti-DNA antibody 
resulted in binding to the glomerular capillary wall '*. When purified anti-DNA antibodies 
were perfused, no binding at all occurred, which refutes the concept of cross-reactivity of 
anti-nuclear antibodies with glomerular epitopes. Since the perfusion of histones and DNA 
is rather artificial, since they do not exist as separate entities in vivo, these experiments were 
repeated using anti-nucleosome antibodies complexed to nucleosomes. Again non-complexed 
antibodies did not bind, but with complexed antibodies extensive glomerular binding was 
observed 42. The positively charged histone part of the nucleosome is responsible for binding 
to the negatively charged determinants (mainly HS) in the GBM. 
12 
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Removal of HS from the GBM (by perfusion of the HS degrading enzyme heparitinase) 
decreased the binding of complexed antibodies considerably 42, underlining the importance 
of HS as ligand in this binding. 
Based on these observations a concept was formulated for the mechanism of auto-antibody 
binding to the GBM. This concept is schematically visualized in Fig 1. In this thesis further 
investigations were performed to analyze the contribution of the various players in this 
concept, to the nephritogenicity of nucleosome/auto-antibody complexes. 
Anti-nuclear antibody 
Negative charges present in the GBM 
(HS) and in the nucleosome (DNA) 
Positive charges present in the 
nucleosome (histones) 
Figure 1. Schematic view of the binding of anti-nuclear 
antibodies via nucleosomes to the glomerular basement 
membrane (GBM). 
To evaluate the contribution of the auto-antibodies to this concept 
glomerular eluates of MRL/lpr mice were tested for the presence of the 
various anti-nuclear antibody specificities. In addition the relationship 
between plasma and glomerular antibody reactivity and nephritis was 
studied (chapter 2). In chapter 3, the binding characteristics of 
monoclonal anti-DNA antibodies to native nucleosomes were analyzed. 
If nucleosomes are involved in the evolution of lupus nephritis they 
must be present within glomerular deposits. Therefore kidney biopsies 
of patients with lupus nephritis were analyzed for the presence of 
nucleosomes using nucleosome specific momoclonal auto-antibodies 
(chapter 4) 
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The involvement of HS for the binding of nucleosome/auto-antibody 
complexes to the GBM was evaluated in the MRL/lpr mouse model. 
To this end we evaluated the GBM-HS staining with GBM-HS specific 
monoclonal antibodies developed in our laboratory. This GBM-HS 
staining correlated with the amount of immunoglobulin deposits and 
albuminuria. Furthermore, we analyzed whether nucleosome/auto-
antibody complexes could inhibit the binding of anti-HS antibodies 
to HS (chapter 5). 
The effect of the antigen specificity of the auto-antibody complexed to 
the nucleosome on the nephritogenicity was investigated subsequently. 
This was done by intraperitoneal inoculation of hybridomas secreting 
either anti-histone, anti-dsDNA or anti-nucleosome monoclonal 
antibodies. This procedure leads to the formation of auto-
antibody/nucleosome complexes. In these mice glomerular localization 
was evaluated (chapter 6). 
ñ Based on the results obtained so far showing that nephritogenicity was 
determined by the interaction of cationic histone moieties within the 
nucleosome/auto-antibody complex and the HS associated anionic sites 
in the GBM, attempts were undertaken to inhibit this binding. Because 
of the structural and functional similarities between HS and heparin, 
this latter drug was a logical candidate for these inhibition studies. 
Therefore the effect of heparin/heparinoids on the binding of complexed 
anti-nucleosome auto-antibodies to the GBM and the effects of these 
drugs on nephritis development, both prophylactically as well as 
therapeutically, were assessed (chapter 7). 
The results obtained in these studies are put into perspective in chapter 8, while these studies 
are summarized in chapter 9. 
m 
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Chapter 2 
Significance of anti-nuclear and anti-extracellular matrix autoantibodies for 
albuminuria in murine lupus nephritis; a longitudinal study on plasma and 
glomerular eluates in MRL/1 mice 
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SUMMARY 
The relationship between autoantibody reactivities and nephritis in systemic lupus erythematosus 
(SLE) is unclear We studied M R L I mice which developed a considerable albuminuria (either mice 
with short ( < I week) or heavy and prolonged (3 weeks) albuminuria) and compared them with 
non-albuminunc age-matched controls with young (12 weeks old) non-albuminunc mice and 
with mite which were followed for 36 weeks and did not develop albuminuria In a longitudinal 
prospective study on plasma samples we correlated a variety of anti-nuclear reactivities and 
reactivities against extracellular matrix (ECM) components with the onset of albuminuria We 
found that at the onset of albuminuria anti-DNA was higher while anti nucleosome and anti-
H2A/H2B-DNA subnucleosome reactivities were lower compared with age-matched non-
albummunc mice We also studied glomerular eluates of these mice in ELISA and in indirect 
immunofluorescence (IF) In the eluates we found with IF thai anti-glomerular basement 
membrane (GBM)-tubular basement membrane (TBM) antibodies were already present in 
12-week-old non-albuminunc mice These eluates showed no anti-nuclear antibodies In eluates of 
albuminuric mice more immunoglobulin was deposited, and anti-ECM anti-DNA and anti 
nucleosome reactivities were higher than in eluates of age-matched non-albuminunc mice The 
deposition of anti-nucleosome antibodies preceded the deposition of anti-DNA antibodies since 
they were deposited to a greater extent in mice with a short albuminuria We conclude that anti-
GBM-TBM antibodies are the first autoantibodies that deposit in glomeruli of MRL/l mice at an 
early age The onset of albuminuria is associated with additional deposition of both anti-ECM and 
anti-nuclear (anti-nucleosome and anti DNA) antibodies but the difference with non-albuminunc 
mice seems to be more quantitative than qualitative 
Keywords lupus nucleosome autoantibodies and extracellular matrix 
INTRODUCTION 
Nephntis is one of the most senous manifestations of systemic 
lupus erythematosus (SLE), occurring in about 50% of these 
patients [1] In renal biopsies granular deposits of immunoglo-
bulin and complement are found in the glomeruli, suggesting an 
immune complex pathogenesis [2] The causal relationship 
between autoantibody formation and nephritis has intrigued 
many investigators, and a variety of autoantibody specificities 
have been assigned a pathogenic role in the development of 
lupus nephritis [3] In this respect especially antibodies towards 
nuclear antigens and glomerular basement membrane (GBM) 
Correspondence M С J van Bruggen University Hospital 
Nijmegen Division of Nephrology PO Box 9101 6500 HB Nijmegen 
The Netherlands 
components have been mentioned With regard to anti-nuclear 
antibodies an important role has been assigned to anti-dsDNA 
antibodies [4-6], but also to anti-histone antibodies [7-9] 
More recently, anti-nucleosome reactivity has been identified 
in SLE, apart from anti-DNA and anti-histone reactivities 
Burlmgame et al [10] described how anti-nucleosome, or 
more precisely antibodies against the H2A H2B-DNA sub­
nucleosome complex preceded the formation of anti-histone 
and anti-dsDNA antibodies m the lupus mouse strains 
MRL 1 and BXSB Lately it was found that the prevalence 
of anti-nucleosome and anti-H2A H2B-DNA subnucleosome 
reactivity is higher than that of anti-dsDNA and anti-histone 
reactivity [11.12] In addition we [13] and others [14 15] have 
identified MoAbs derived from lupus mice which were reactive 
only with the intact nucleosome and not with its components 
21 
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DNA or h ι st o nes A correlation between both plasma 
anti H2A H2B-DNA subnucleosome and anti-nucleosome 
reacimt> with nephritis has been described [11] and recentlv 
we showed that and nucleosome antibodies complexed to 
nucleosomul antigens are able to bind to the GBM after renal 
perfusion in rats [П] 
Antibodies directed against extracellular matrix (ECM) 
components of the GBM have also been proposed as candi 
dates for the initiation of glomerular disease in lupus In lupus 
sera reactivity against heparan sulphate proteoglycan laminin 
collagen type IV fibronectin and entactin has been described 
[16) In another experimental model for lupus nephritis 
the chronic grafl-untn-host (GVH) model a role for anli-
basement membrane and anti-tubular brush border antibodies 
has been proposed [17 19] Enrichment of anli-laminin 
reactivity in renal eluates relative to serum has been described 
in MRL I and GVH mice [18 20] Laid) Bernstein a al 
developed an ELISA using the intact glomerulus as substrate 
and used it to show enrichment of anti glomerular reactivity in 
renal eluates [21] in different murine lupus strains 
The aim of the present stud\ was loanalvse the relationship 
between plasma and glomerular anlibodv reactivities and 
nephritis in MRL 1 mice Although the MRL I mouse strain 
is congenie there is a marked variability in onset and course ol 
the disease We exploited this vanabihlv and selected mice 
developing considerable albuminuria within a short period ol 
time (animals were divided into those with albuminuria tor 
either 1 or lor 3 weeks) and compared them with age-matched 
non-albuminuric mice and with mice surviving 6^ weeks with­
out developing albuminuria Until nou mosi studies have 
locused on changes over time irrespective ol clinical signs ol 
nephritis or have only studied animals with overt signs 
of nephritis without comparison with age matched non 
albuminuric mice Bv taking non-albuminuric MRL I mice as 
a control group we argued that we could perhaps identify 
antibody specificities in plasma or in glomerular eluates which 
are positively or negatively associated with albuminuria To 
this end we tested plasma and eluates for anlibodv reactivities 
against various nuclear antigens and ECM components in both 
ELISA and immunofluorescence (IF) To check for non 
spec ι he trapping of immunoglobulin in the glomerulus we 
tested both plasma pools and glomerular eluates for antibody 
reactivity towards a non-relevant antigen dmitrophenol 
(DNP) 
MATERIALS AND METHODS 
4mmals 
MRL I (MRL Ipr ipr\ and MRL η (MRL W - ) mice were 
bred in the animal facilities of the University of Nijmegen from 
stock ongmalK obtained via the Scnpps Clinic and Research 
Foundation (La Jolla CA) from the Jackson Laboratory (Bar 
Harbor ME) 
Experimental approach 
Plasma \tud\ Plasma samples were collected at 6 9 12 
16 20 24 28 32 and 36 weeks οΓ age in = 53 36 males and 
17 females at 6 weeks) Blood was collected under ether 
anaesthesia Irom the retro-orbital plexus in EDTA vials 
After centnfugalion plasma was collected and stored at 
-20 С Albuminuria was screened even, week with Albustix 
(Boehnnger Mannheim Mannheim Germany) When albumi 
nuna was more than -+• urine was collected the next day in a 
metabolic cage for 18 h while the animals had free access to 
water Albuminuria was quantified in all urine samples by a 
radial immunodiffusion technique as described [22 23] It was 
found that albuminuria as assessed with Albustix correlated 
verv well with albuminuria determined in the immunodiffusion 
assav Importantly no false-negative and onlv few false 
positive results were obtained (data not shown) Since every 
positive result obtained bv Albustix screening was checked in 
the immunodiffusion assay all false-positive assessments were 
identified 
Of the 53 mice at entry 25 did not develop albuminuria 
(Albustix < +) throughout the study period Of the 25 non-
albuminunc mice 13 died before the age of 36 weeks and 
therefore 12 mice reached the age of 36 weeks In these mice 
urinary albumin excretion was measured at 36 weeks The median 
albuminuria in this group was 60/;g 18 h (range 45-143 fig 
18 h) The plasma samples ol these mice were analysed 
Albuminuria developed in 28 mice The median age of onset 
of albuminuria was 21 weeks (range 12 26 weeks) Of these 28 
mice nine had an albuminuria < 1000 fig 18 h and in 19 mice 
albuminuria was > 1000 fig 18 h (median 2800 /ig 18 h range 
1010 28 500 μ g 18 h) Since we wanted to studv mice which 
developed a considerable (> 1000 /ig 18 h) albuminuria within a 
short period of lime the plasma samples of 17 out of these 19 
mice (iwo mice died in the metabolic cage before the h nal blood 
sample could be taken) were used in this study and the results 
were compared with the non albuminuric mice which reached the 
age of 36 weeks and remained negative on Albustix screening 
Elution stiuh In a different stud) four groups of 
mice (/ι = 10 per group) were selected based on age and 
magnitude of albuminuria and were screened every week 
with Albustix group I 12-week-old mice without albuminuria 
(Albustix $ +) group 2 18 24-week-old mice without 
albuminuria (Albustix $ +) group 3 18 24-week old mice 
with short duration of albuminuria (urine albumin > 
1000 fig 18 h albuminuria period < 7 davs) group 4 18-24-
week-old mice which had albuminuria (urine albumin > 
1000/ig 18 h) on three subsequent occasions (albuminuria 
period at least 14 days but not more than 21 davs) After 
assigning a mouse to one ol the four study groups under 
anaesthesia (50 mg kg sodium pentobarbital Narcovet 
Apharmo Arnhem The Netherlands) kidnevs were flushed 
with PBS perfused with Fe^OatBDH Poole UK) 13 0 mg ml 
and stored at -80 С Perfusion with ¥елО
л
 was done in order 
to isolate glomeruli as described previously [24] Glomerular 
eluates were pooled per group since individual samples did not 
allow analysis of anlibodv reactivity because of the low vield 
For a proper comparison of antibody reactivities from the 
pooled glomerular eluates with plasma plasma samples from 
all mice were collected just belore renal Fe»0.j perfusion and 
also pooled per group 
Elution of antibodies from isolated glomeruli 
Kidnevs perfused with Fe^O* were pooled [n = 20 per group) 
homogenized and glomeruli were isolated b\ a magnet as 
described before [24] The material thus obtained consisted of 
> 95% glomeruli Α \0-μ\ sample was taken from the glo­
merular suspension and the number ol glomeruli counted in a 
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haemocytometer Antibodies were eluted from the glomeruli 
by acid elution (0 12 м glycine HC! pH 2 8) In previous 
experiments performed in our laborator) we lound that after 
this elution additional procedures with 0 12 м glycine NaOH 
pH 12 or with 3 M KSCN did not lead to further elution of 
immunoglobulin (20] Elution was carried out under continu­
ous shaking for 2 h at room temperature in the presence of 
protease inhibitors (I т ч PMSF 0 05% w\ NaN* 20 т м 
EDTA and 100 Kl units Trasylol) After elution the pH 
was immediately adjusted to 7 4 using 2 м Tris and the eluates 
were dialysed overnight at 4 С against PBS containing the 
above-mentioned protease inhibitors The eluates were then 
concentrated to a final volume of4 ml using an Amicon YM50 
filter and stored at 4 С All analyses on these eluates were 
performed within 48 h after the elution procedure 
Determination of immunoglobulin concentration 
Plasma samples eluates and plasma pools were measured in 
ELISA for immunoglobulin concentration Nunc Maxisorb 
F96 immunoplaies (Life Technologies Ine Gaithersburg 
MD) were coated overnight at 4 С with goat anti-mouse 
immunoglobulin (GM 17 CLB Amsterdam The Netherlands) 
5 /ig ml 100/d well Plaies were washed three times with 
distilled water and three times with PBS containing 0 05% 
(wv) Tween 20 (PBS T) Samples were diluted in PBS Τ 
containing 0 2% gelatin and intubated for I h at 37 С 
100 /il/well Plates were washed again and incubated with 
peroxidase-la be I led goat ant ι mouse immunoglobulin (GM 
17-HRP) diluted 1 1500 for I h at room temperature 100 //1 
well The plates were washed again and developed with 
3 5.3'5'-tetramethylbenzidine (Merck) 100 ¡ig ml in 0 11м 
sodium acetate pH 5 5 containing 0 001° о H-.0-. By adding 
2 M H2S04, 100 μ\ well colour development was stopped after 
15 min and optical densitv (OD) at 450 nm was measured 
Autoantigen readmites of plasma samples plasma pools and 
eluates 
Anti-dsDNA anti-histone anti-nucleosome anti-H2A H2B 
DNA subnucleosome and-laminin anti-collagen IV anti 
entactin and anli-DNP reactivities were assessed in ELISAs 
In addition eluates and plasma pools were tested in indirect IF 
on M R L f l ( M R L + / + ) kidney sections 
Amt-dsDNA ELISA antt-hisfone ELISA anti-nucleosome 
ELISA The anti-dsDNA anti-histone and anti-nucleosome 
ELISAs were performed as described previously [13.25] 
Anti-H2AIH2B-DNA subnucleosome ELISA H2A H2B 
DNA subnucleosome was prepared as described [26] Next 
Nunc immunoplaies were coaled with the H2A'H2B-DNA 
subnucleosome complex 2 5 /ig/ml in 0 15 м NaCI 0 015 м 
tnsodium citrate pH 7 0 for 1 h at room temperature Further 
procedures were identical to the anti-nucleosome ELISA 
Antt-lammm ELISA Mouse EHS Laminin from Engel-
brelh Holm-Swarm (EHS) tumour (Life Technologies) was 
coated onto Greiner plates 1 /ig in 100 μΐ per well overnight at 
room temperature After washing the plates five times with 
PBS-T plates were blocked with 10 т м Tns/HCI pH 7 4 
containing 5% (w v) bovine serum albumin (BSA) 150/d 
well for I h al 37°C Next, samples were diluted in PBS 
containing 1% (w/v) BSA 100 μ\ per well for 1 h at 37CC 
Plates were washed again five times and incubated for 1 h with 
peroxidase-label led ral MoAb anti-mouse immunoglobulin 
(CLB-RM-19 CLB) diluted 1 1000 in PBS 100/d per well 
The plates were washed again and developed with 3 5 3 ^ -
tetramelhylbenzidine (Merck) 100/ig ml in 0 11м sodium 
acetate pH 5 5 containing 0 001% H-.0-. Bv adding 2 м 
HiS0 4 100 /il well colour development was stopped after 
15 min and OD ai 450 nm wai measured 
Ann collagen II ELISA Mouse collagen tvpc IV (Sigma) 
was coated onto Greiner plates 1 /jg in 100 μ\ per well over 
night at room temperature Further procedures were identical 
to the anti-laminin ELISA 
Antt-eniactin ELISA Entattin (Lpstate Biotechnologv 
Ine Waltham MA) was coated onto Greiner plates 1 /ig in 
100 /il per well overnight at room temperature Further 
procedures were identical to the anti-laminin ELISA 
Anti-DNP ELISA DNP coupled lo BSA (Calbiochem La 
Jolla CA) was coaled lo Nunc immunoplaies I /ig in 100 /il per 
well overnight at room temperature After washing the plates 
were blocked with 1% (w v) gelatin in PBS for 1 h at 37 С 
Further procedures were identical to the anti-laminin ELISA 
The titre in each ELISA was denned as the reciprocal of the 
dilution giving an OD of 1 0 
Immunohistoloç\ 
Immunofluorescence was performed on 2-μπ\ crvostai sections 
from all kidnevs to sludv deposition of mouse immunoglobulin 
Sections were incubated with F(abb FITC labelled sheep anti 
mouse IgG (Organon Teknika-Cappel N V Turnhout 
Belgium) The intensitv of staining in the capillarv loops and 
mesangium was scored semiquantitative^ on a 0 4 + scale 
(described previously [23]) 
For indirect immunofluorescence 2-/*m crvostai kidnev 
sections from 6-week-old MRL« mice were incubated with 
the eluates or the plasma pools in two-fold dilution steps lor 
30 min Subsequently ihe sections were incubated with F(abb 
FITC-labelled sheep anti-mouse IgG (Organon Teknika-
Cappel N V ) diluted 1 750 in PBS 1% (w v) BSA lor 1 h at 
37 С The titre was defined as the reciprocal of the highest 
dilution still giving positive staining 
Statistical anah sis 
Plasma reactivities were analysed in two different ways First 
longitudinal plasma antibody reactivities ol albuminuric and 
non-albuminuric mice were compared with a distribution free 
method for curve analysis as described bv Koziol с ι al [27] 
Second the plasma antibody reactivities at (he onset of albu 
minuria were compared with the median of non-albuminunc 
mice at the same age in a sign test Statistical analysis on the 
immunofluorescence score was performed using the Mann 
Whitney t-test Inali tesis Ρ < 0 05 was considered significant 
RESULTS 
Longitudinal plasma stud\ 
When plasma antbody reactivities over lime from mice 
developing albuminuria were compared with those of non 
albuminuric mice there was a marked similarity between the 
two groups (Fig la-d) Antibody reactivities to collagen 
IV laminin and entactin were found from week 15 18 
onwards Immunoglobulin concentration anti-DNA anti-
nucleosome and anti-H2A H2B DNA subnucleosome reac­
tivities rose until week 24 and remained at this level 
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Fig. 1. Autoantigen reactivities in longitudinally obtained plasma samples of albuminuric (0) and non-albuminunc (Δ) mice (means 
and s.e.m. are given), (a) Anli-DNA. (b) anti-nucleosome. Ic) anli-H2A H2B-DNA subnucleosome. (d) immunoglobulin concentra­
tion Autoantibody reactivity at the onset of albuminuria (•) of all albuminuric mice studied, compared with the median at that age in 
non-albuminunc controls (C). (e) Anti-DNA. (0 anti-nucleosome. (g) anti-H2A H2B-DNA subnucleosome. (h) immunoglobulin 
concentration. 
thereafter in the non-albuminur ic mice. Al though the anti-
D N A reactivity was somewhat higher and the immunoglo­
bulin concent ra t ion, ant i-nucleosome and ant i-H2A H2B-
D N A subnucleosome reactivities were slightly lower in 
a lbuminur ic mice, these differences were not statistically 
significant (Koziol test). A different kinetic pat tern was 
seen for anti-histone ant ibody formation. In most mice 
(82%) anti-histone reactivity was very low until week. 24. 
and increased thereafter. 
When autoantibody reactivities at the onset of albuminuria 
were compared with the median at that age in the non-
albuminunc group. anti-DNA reactivity was significantly 
higher in the albuminuric group (P < 0 02. sign test. Fig. 1c). 
In an identical analvsis. anti-nucleosome and anti-H2A H2B-
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Immunoglobulin DNA Laminin Entactin 
Nucleosome Histone Collagen IV 
Нц. 2. Immunoglohi'lin concentration and litres towards the various 
autoantigens in glomerular duales ol the age-matched l IS 24 weeks) 
albuminuric and non-albuminuric \1RL I mice tested (Titres are not 
adjusted tor the quantit) of immunoglobulin ) - Non-albuminuric 
mice (group 2): Ш. short albuminuria 7 days (group Ч): • prolonged 
albuminuria 14 21 da\s(group4) 
D N A stlbnucleosomc titres were signiticantlv lower in the 
albuminuric group (P < 0 05 and Ρ < 0-01. respectively. 
Fig. lf.g). Since anti-DNA antibodies are also measured in the 
anti-nucleosome and the anti-H2A H2B-DNA subnucleosome 
ELISA (because D N A is a pari of both antigens) [13.28]. the 
depression of true anti-nucleosome antibodies in albuminuric 
mice might even be more pronounced 
These differences (higher anii-DNA. lower anti-nucleosome 
and anti-H2A H2B-DNA subnucleosome at the onset of albu­
minuria) are not a mere reflection of the total immunoglobulin 
levels, since these were nol different at the onset of albuminuria 
between the groups (Fig. Ih) For anli-histone antibodies and 
for the antibodies against ECM components, no differences at 
the onset of albuminuria were observed 
Elution study 
The number of glomeruli obtained in the four groups studied was 
about 205 000 glomeruli per group, i.e. a yield of 10 250 glomeruli 
per kidnev The total amount of immunoglobulin eluted ranged 
from 2-4/;g in young (12-week-old) non-albuminunc mice to 
33 //g in albuminuric mice. i.e. 0 12 and I-65 μ% immunoglobulin 
eluted per kidney, respectively. The highest amount of immuno­
globulin was eluted from glomeruli of albuminuric mice (groups 3 
and 4. Fig. 2). This is in line with our previous finding concerning 
glomerular IgG deposition in these mice [23]. With direct IF we 
observed that glomerular deposition of mouse immunoglobulin in 
non-albuminunc mice was predominanti) restricted to the mesan-
gial areas In albuminuric mice immunoglobulin was located both 
in the mesangium and. to a significant extent, along the GBM. The 
degree oï mesangial immunoglobulin (IF score 2-8 ± 0-4» 
and GBM immunoglobulin (IF score 2 6 = 0-4) deposition in 
albuminuric mice was significanti) greater {P < 0 05) than that 
in non-albuminunc mice (mesangial immunoglobulin. IF score 
2 0 ± 0-3: and GBM immunoglobulin. IF score 1 -2 ± 0-6) 
In indirect immunofluorescence, glomerular eluates 
obtained from young non-albuminunc mice (group 1) showed 
binding to the glomerular and tubular basement membranes, 
whereas no nuclear binding was observed (Fig. 3a). Glomeru-
lar eluates of the other groups of older age-matched mice 
(groups 2 4) showed binding to the glomerular and tubular 
basement membranes and. in addition, to nuclei (Fig. 3b). In 
the plasma pools of all groups, nuclear binding at high litre was 
observed, whereas no binding to glomerular and or tubular 
basement membrane was found (data not shown). 
In ELISA. antibod\ reactivities towards all nuclear antigens 
and ECM components were found in eluates of the age-
Fig. 3. Indirect immunofluorescence ot glomerular eluates on MRL η 
kidnev sections Note that with the eluate (1)4 /<g mil of young non-
albuminuric mice. onl> the glomerular basement menbrane (Ci Β Μ l and 
the tubular basement membrane (TBM> stain, whereas the nuclei are 
negative (a) When glomerular eluates (0 4 до ml) of the IX 24-week-
old groups are evaluated nuclei. GBM and TBM are stained (bl 
25 
Autoantibodies and Lupus Nephrins 
Table I Enrichment factors (eluate reactivity per mg immunoglobulin 
plasma reactivity per mg immunoglobulin) lor reactivities towards 
different nuclear antigens and extracellular matrix (ECM) components 
in albuminuric mice (groups 4 and 5) and age matched non albuminu 
ne control;, (group 1) 
Age lueeks) 
A lbuminur ia 
Nucleosome 
D N A 
Н ы о п е 
Laminin 
Collagen IV 
EntaLtm 
G r o u p 3 
1« 24 
•i 
4 
IS 
100 
m 
81 
G r o u p 4 
IK 24 
Short" 
6 
7 
14 
68 
16 
22 
G r o u p s 
Id 24 
Long+ 
-. 
4 
27 
32 
If. 
64 
'Duration ofalbuminuria < 7da\4 
^Duration ol albuminuria 14 21 davs 
matched 18 24-week-old groups (groups 2 4 Fig 2) Eluate 
reactivities in voung mice of 12 weeks ol age (group I) were 
negative or close to background levels in all ELISAs No 
detectable anti D N P reactivity was found in a m eluate 
whereas in the plasma pools ant i-DNP titres were high and 
comparable lo anl i-DNA and anti-nucleosome titres (data not 
shown) These high anl i-DNP utres in pljsnia arc lound in 
many murine lupus strains [29] In albuminuric mice (groups 1 
and 4) approx three times more immunoglobulin was eluted 
compared with age-matched non albuminuric controls (group 
2) and anli-nuclear (except for anti-histone) and anti ECM 
component litres were higher (Fig 2) 
Factors of enrichment for eluates compared with plasma 
(ι e eluate reactivity per mg immunoglobulin plasma reactivity 
per mg immunoglobulin) for alt age matched groups of mice 
were calculated For all parameters tested except for anti 
D N P enrichment in eluates was found (Table 1 ) 
D I S C U S S I O N 
For the studv of the relationship between antibodv specificities 
and lupus nephritis two approaches are possible First plasma 
antibody reactivities can be correlated with the onset of renal 
disease or a renal exacerbation A disadvantage of this 
approach is that antibodies with high affinity for glomerular 
antigens will deposit in the kidney and will not be found in the 
circulation Second antibodies can be eluted from diseased 
glomeruli In this way the nephntogenic antibodies deposited 
in the glomerulus are obtained We adopted both approaches 
and studied the association between albuminuria and the 
reactivities in longitudinal plasma samples and with antibodies 
eluted from isolated glomeruli 
In the longitudinal plasma studv there was a striking similar­
ity between plasma antibody reactivities of mice developing 
albuminuria and mice which did not Onlv when reactivities 
were compared at the moment albuminuria developed were 
higher anti-DNA and lower anti-nucleosome reactivities found 
The hnding that the absolute anti-DNA titre is higher at the onsei 
of albuminuria is in line with many serological studies describing 
a relationship between serum anti D N A levels and nephritis in 
both human and murine lupus [4 6] Lmtil now there have been 
two studies both in humans correlating anti nucleosome and or 
anti-H2A H2B-DNA subnucleosome reactivity to renal disease 
In one studv ihere is a correlation between both parameters and 
renal disease [11] i n t h e o t h e r anti nucleosome reactivity was not 
correlated with this disease manifestation [12] Two features of 
the deposition of anti-nucleosome antibodies are noleworth\ 
First the litre is already high in animals with short-lasting 
albuminuria while the litre ol deposited anti-DNA antibodies 
increases subsiantialK in animals with longer lasting albumi­
nuria This suggests a different time course of deposition between 
the twospecihcilies i e anli nucleosome deposition precedes thai 
of anti D N A Second glomerular deposition of anti-nucleosome 
antibodies in albuminuric mice is associated with lower plasma 
litres than non-albuminunc controls ( Fig 1Γ) This mav be due to 
enhanced glomerular deposition ol these antibodies In contrast 
the higher eluale anti-DNA litre which is most pronounced in 
animals with prolonged albuminuria is found m conjunction 
with higher plasma litres (Fig le) This difference between anti 
DNA and anti nucleosome litres in plasma ιегям eluate suggests 
that from the anti DNA antibodies onlv a subgroup deposits in 
the glomerulus whereas for anli nucleosome antibodies such a 
selective deposuion does not seem to occur A decrease ol plasma 
titres might be due to an enhanced glomerular deposition 
Anti histone antibodies were m a i n h seen later in life in mice 
not developing albuminuria This pattern ol anti-histone 
reactivity is in line with results found by Burhngamc </ al 
[10] These authors also found anli histone reactivity later in 
the disease after the development of anli-chromatin (nucleo­
some) and anti-DNA antibodies In the eluates antibodies to 
histones are not different between albuminuric (groups 1 and 4 
Fig 2) and age-matched non-albuminunc mice (group 2 
Fig 2) It is questionable therefore whether these anti-histone 
antibodies are important for the development of albuminuria 
This observation is in line with ihe clinical experience that in 
drug-induced lupus renal disease is rare despite high serum 
anti-histone reactivity but in the absence of ant i-DNA litres 
Deposition of anti-GBM-tubular basement membrane 
(TBM) antibodies starts at an earlier stage than anti-nuclear 
antibodies for in IF glomerular eluates of young mice show 
exclusively G B M TBM staining i e anu-ECM reactivity with­
out anti-nuclear staining These lindings are in line with results 
found in another mouse lupus model the GVH disease in 
which glomerular eluates 4 weeks alter induction ol the disease 
contain onlv anli ECM reactivity while after 8 weeks anli 
nuclear reactivitv could also be detected [18] Intereslinglv 
when the eluates of the voung non-albuminunc animals in 
our study were tested in ELISA on the ECM components 
laminin collagen IV and entactin these reactivities were 
negative or close to background levels suggesting that other 
antibody specificities at this age are responsible for the G B M 
TBM binding in IF Therelore apparently autoantibodies are 
'ormed with a high affinity for the G B M T B M since ihey are 
not found in (he circulation and arc directed against an as yet 
undefined epitope within the GBM T B M However the 
deposition of these anli-GBM TBM antibodies alone does 
not lead lo albuminuria 
Reactivity to collagen IV and laminin (together with olher 
ECM proteins) has been described in M R L 1 sera later in hie 
from weeks 17 20 onwards [16] We obtained similar results 
since in M R L I plasmas wc found antibody reactivitv to 
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collagen IV laminin and entaclin from weeks 15 18 onwards 
while from ihe age of 18 24 weeks these anlibodv specificities 
could be detected in the eluates 
These reactivities especial К anti-laminin had the highest 
litres in albuminuric mice Anti-laminin reactivit\ has been 
described before in glomerular eluates of albuminuric MRL 1 
mice (20] 
Factors of enrichment for eluates compared with plasma 
(i e eluate reactivity per mg immunoglobulin plasma reacuvit\ 
per mg immunoglobulin) for all age-matched groups of mice 
were calculated Both anti-nuclear and anti-ECM antibodies 
are enriched in glomerular eluates of both albuminuric and 
поп-albuminuric mice Since plasma anti-ECM litres are much 
lower than anti-DNA and anti-nucleosome litres (he enrich 
meni for anti-ECM antibodies is more pronounced than 
enrichment for anti-nuclear specificities Eluate enrichment 
for anti-DNA [20 30) or anli-histone [9] antibodies has been 
described belore in murine lupus 
In this studv we provide evidence thai deposition ol autoanti­
bodies directed against nucleosomes DNA and ECM proteins is 
correlated with the development ol albuminuria in lupus nephritis 
Furthermore anti-GBM-TBM antibodies deposit earl\ in the 
disease (12 weeks) before an\ deposition of anti-nuclear autoanti­
bodies although this deposition is nol sufficient to cause albumi­
nuria Our studv does not permit an\ conclusion about their 
contribution to the development of albuminuria later in life These 
antibodies are directed against an as \et undehned GBM TBM 
epitope Deposition of anti-DNA and anti-nucleosome occurs 
later in the disease Since in the eluate higher tures of anti-DNA 
anti-nucleosome and anii-ECM component reactivitv are seen in 
albuminuric mice in conjunction with a higher amount of immu­
noglobulin deposition these data suggest that the differences 
between albuminuric and non-albuminunt mice are more quanti­
tative than qualitative 
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We have shown previously that four IgG monoclonal 
autoantibodies (mAbs) reacted in ELISA with both dou­
ble-stranded (ds) DNA and peptide 83-100 of histone H3. 
The peptide 83-100 contains a cysteine residue at posi­
tion 96 and readily dimerizes at pH 7-8. We describe 
here that only the 83-100 di mers, and not the 83-100 
monomers, are recognized by the four antibodies and 
inhibit in ELISA the binding of mAbs to dsDNA. The 
equilibrium affinity constants (K
a
) and kinetic rate con­
stants of two of these mAbs were measured in a biosen­
sor system. K
a
 values were significantly higher when 
these mAbs were tested with dsDNA as compared with 
the 83-100 dimer. Further higher K
a
 values were meas­
ured with mononucleosomes containing DNA and his· 
tones. It is proposed that these four mAbs are directed 
against a topographic determinant formed by DNA and 
the region 83-100 of НЭ present as a dimer at the surface 
of nucleosome, and that they react, although signifi­
cantly less well, with DNA and peptide dimer tested 
separately. This study provides a quantitative and ki­
netic basis to interaction between several antibodies 
and distinct antigenic structures and allows us to better 
understand the structural basis of apparent autoanti­
body cross-reactivity. 
Numerous observations have implicated anti-DNA antibod­
ies and nucleosomal ant igens in the pathology of systemic 
lupus ery thematosus (1 2) Antibodies to DNA play a major 
role in lupus nephrit is , their t i ters correlate with disease ac­
tivity, and deposits of anti-DNA containing immune complexes 
are found in the kidneys of lupus pat ients Histories, and ap­
parently also nucleosomes can be detected within glomerular 
deposits (3-5), and anli-DNA, anti-histone as well as anti-
nucleosome antibodies can be eluted from kidneys of (NZB/ 
W)F1 and MRL lpr/lpr lupus mice (6 7) 
The trigger antigen giving rise to anti-DNA antibodies has 
not been strictly identified but a n u m b e r of evidences strongly 
support t h a t nucleosomes (the basic repeat ing unit of chroma­
tin) may represent a potential immunogen (8. 9) Nucleosome-
specific antibodies (ι e antibodies reacting specifically with 
conformational epitopes present a t t h e surface of the nucleo­
some edifice, and not with DNA and histones tested separately 
(10, 11), certainly part icipate in i m m u n e deposition in lupus 
* The costs of publication of this article were defrayed in part by the 
payment of page charges This article must therefore be hereby marked 
"advertisement" in accordance with 18 U S С Section 1734 solely to 
indicate this fact 
t Recipient of a fellowship from Ministère de la Recherche et de la 
Technologie 
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glomerulonephritis The importance of these antibody subsets 
has given rise to many investigations and in part icular to the 
careful study of anti-nuclear monoclonal antibody (mAb)1 char-
acteristics During the course of a fine examination of a series 
of IgG mAbs generated from autoimmune lupus mice and char-
acterized as anti-DNA antibodies 112) we have discovered re-
cently that some of them reacted with a single histone peptide, 
namely peptide 83-100 of H 3 2 This peptide was the only one 
out of 53 overlapping histone peptides Un H I , H2A H2B H3, 
and H4i to be recognized bv mAbs 2 42 53 and 56 These 
antibodies showed no reactivity with the pa ren t histone H3 or 
with an> of the other histones They reacted strongly, however, 
with double-stranded ids) DNA Other mAbs tested in parallel 
reacted only with histone (eg mAb 34 recognized H3 and the 
peptide 18-32 of H 3 ' and bound nucleosomes (13)) and not 
with dsDNA or with dsDNA but with none of the histone 
proteins or histone peptides tested (eg mAbs 36 and 51 J) The 
reactivity of four mAbs 2 42, 53. and 56, with dsDNA and 
peptide 83-100 of H3 was intriguing enough to prompt us to 
further s tudy their fine specificitv and their respective affinity 
for dsDNA and peptide 83-100 which a prion show no obvious 
s t ructura l similarit ies The aim of this work was to examine 
the s t ructural basis of an apparent cross-reaction on a quanti-
tative basis by measur ing kinetic ra te constants for the differ-
ent ant igens and try to bet ter unders tand the fine specificity of 
anti-nucleosome/anti-DNA autoantibodies 
MATERIALS AND METHODS 
Monoclonal Antibodies — The reactivity of several mAbs will be de-
tailed in this study They are mAbs 2 42 53 and 56 which have been 
generated from (NZBWiFl mice that spontaneously develop lupus or 
from grail versus host disease mice that following the injection of alio 
genie Τ cells from a parent strain also develop an autoimmune disease 
very similar to svstemic lupus erythematosus affecting patients The 
production of these mAbs has been described previousl> and designed 
as anti-dsDNA antibodies * 12) Two of them (namely mAbs 42 and 56) 
were strongly positive in the Fair assay indicating their high affiniU 
for dsDNA mAb 34 used in this study as control was initially obtained 
in the same panel of 60 mAbs and its specificity has been recently 
described' 113) mAbs 36 and 51 are control anti-dsDNA antibodies ~ 
mAbs 34 36 42 and 56 are lgG2a and mAbs 2 51, and 53 are IgG2b 
mAbs used in this study were all careful К purified from culture super 
natant as it is known that nucleosomal material DNA and histories 
1
 The abbreviations used are mAb monoclonal antibod\ ELISA 
enzvme linked immunosorbent assay HPLC high pressure liquid Chro­
matograph} RU resonance units PBS phosphate-buffered saline 
RAM rabbit anti-mouse 
1
 К Kramers С Stemmer S Muller M С J \an Bruggen G Ρ M 
Rijke M N Hvlkema W J M Tax R J Τ Smeenk and J Η M 
Berden submitted for publication 
J
 К Kramers С Stemmer M Monestier M С J van Bruggen Τ Ρ 
Μ Rijke Schilder Μ Ν Hylkema, R J Τ Smeenk S Muller and J H 
M Berden submitted for publication 
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can remain bound to antibodies that have not been treated accordingly 
'14-161 Purification of mAbs was performed as described previously 
(Ref 13 procedure 3i Fab fragments 56 were prepared b\ digestion of 
mAb 56 with papain and punned bv protein A Sepharose chromatog 
raphv Their puntv was checked bv HPLC 
\ucleosomes Histories and Historie Peptides -Calf thymus nuclei 
were prepared as described previously (17) Thev were resuspended in 
15 m\i Tris bufTer (pH 7 8) containing 15 mu NaCl 60 т м KCl 5 m\l 
MpCl 1 т м CaCl^ and 0 25 M sucrose and digested at 30 'C with 
micrococcal nuclease The nuclei were lysed at 0 °C for 30 min in 1 т м 
Tris HCl bufTer ipH 7 4) containing 0 2 т м EDTA and 0 1 т м phenyl 
methvlsulfonvl fluoride After centrifugation MO min at 4 000 * g at 
4 Ci 150-200 Aif units of digested chromatin 'supernatant fraction) 
were layered on 5-29*> lu/v) sucrose gradients buffered in 10 т м 
Tris HCl ι pH 7 4) 0 2 m\l EDTA 0 2 т м EGTA and 0 1 m\l phenyl 
methvlsulfonvl fluoride and centnfuged for 21 h at 4 °C in a SW28 
Beekman rotor at 25 000 rpm The gradients were fractionated '0 5 
ml/fiaction) and the absorbance (260 nmi of each fraction was meas 
ured The preparations were then characterized by 2*"" agarose gel 
electrophoresis and fractions containing mononucleosomes were pooled 
and kept at 4 aC for a maximum of 5 days They were never frozen The 
content in histonesof each nucleosome preparation wa^ checked b\ 15^ 
Polyacrylamide electrophoresis 
Histone H3 used in this studv was obtained from calf thymus and 
purified as described '18 Its purity was assessed by 18^ polvacnl 
amide electrophoresis Peptide 83-100 of H3 has been described in 
previous studies (1Θ 19) Peptides partiallv overlapping the sequence 
83-100 namelv peptides encompassing residues 79-92 91-104 and 
98-112 of H3 were also used (Table II Calf thymus sequences were 
used for all syntheses The purity of all peptides was assessed b> 
analytical HPLC on a nucleosil C8 column 5 μπι <3 9 χ 15 mm) using 
a tnethvlammonium phosphate buffer s\stem Peptides were purified 
using a medium pressure chromatography apparatus Amino acid anal 
ysis and electrosprav mass spectra showed that the purified peptides 
had Lhe expected composition Dimers of H3 peptides 83-100 91-104 
and 98-112 were prepared by dissolving peptides in phosphate buff 
ered saline (PBS) 'pH 7 6) containing 2 "v/vi dimethvl sulfoxide as 
oxidizing agent and keeping the solution at air and at room tempera 
ture for 3-4 days before use The presence of dimers was checked bv 
HPLC and the products were analyzed bv fast atom bombardment 
maes spectrometry The dimer solution was stable for at least 2 months 
Enzvme linked Immunosorbent Assov 'ELISAi — The direct ELISA 
procedure used to measure the binding of mAbs was as described 
previously (20) using plates coated with 100 ng/ml H3 in 0 05 \l car 
Donate buffer pH 9 6 or with 2 μΜ of the various peptides dissolved in 
the same buffer For the test of DNA reacting antibodies the plates 
were coated with 100 ng/ml dsDNA (Sigma D4764 ) treated b> nuclease 
SI and dissolved in 0 025 M citrale buffer pH 4 4 Single stranded 'ss) 
DNA was prepared from nucleosomal DNA which ha6 been extracted by 
proteinase К treatment and phenol chloroforme precipitation followed 
by boiling 5 min at 95 °C and cooling on ice to separate DNA strands 
For competition experiments various concentrations of the peptides 
or DNA used as inhibitors were incubated for 1 h at 37 "C and then 
overnight at 4 °C with mAbs diluted in PBS containing 0 050 Tween 
'PBS T> The mixtures were then added to peptide or dsDNA coated 
wells and the test was performed as described (20) 
Kinetic Analysis of mAb Binding— For real time binding expen 
ments a BIAcore™ biosensor svstem (Pharmacia Biosensor AB Upp­
sala Sweden) was used Certain experiments were performed with the 
BIAcore 2000 apparatus Reagents including sensor chips CM5 HBS 
buffer (10 т ч Hepes with 0 15 м NaCl 3 4 mvi EDTA and 0 005Я 
surfactant P20 (pH 7 4)i amine coupling kit containing N hydroxysuc 
amide /velhvliV i3 dimethylaminopropvlkrarbodiimide and ethanol 
amine HCl and rabbit anti mouse Fe (RAM Fe) antibody were from 
Pharmacia Biosensor Immobilization of the free peptides to the sensor 
chip via primary amine groups was performed according to standard 
procedures (211 with a few modifications The carboxylated matrix of 
the CM5 sensor chip was first activated with 50 μΐ of N ethyl N '3 
dimethylaminopropyltcarbodiimide/jV hvdroxvsuccimide mixture (flow 
rate 5 μΐ/min) Dimenzed peptide 83-100 of H3 (20 μΐ) at a concentra 
lion of 500 μρ/ml in 10 т м formate buffer final pH 3 3 was injected at 
a flow of 2 μΐ/min on the sensor chip (the pH used for this step was a 
critical parameter) Approximately 100 pg of peptide were immobilized 
per mm¿ (corresponding to 100 resonance units RL) Successive injec 
tions ofethanolamine (35 μΐι and 0 1м HCl (5 μΙ) were then performed 
at a flow of 5 μΐ/min The protocol used to immobilize dsDNA was 
adapted from the procedure described bv Nilsson et al (22) The sensor 
chip was first treated bv injecting successively 40 μΙ of N ethyl N (3 
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Fie 1 Recognition in competitive ELISA of DNA and 83-100 
dimer by mAb 56 Microliter plates were coated with 10 ng/ml dsDNA 
and allowed to react with mAbs 51 and 56(50 ng/ml) preincubated with 
a large excess of ss and dsDNA (500 ng/ml· or various peptides (100 
μg/mlι as inhibitor Inhibitor peptides were peptides 79-92 83-100 
91-104 and 98-112 used as monomers (Λ/) or dimers (D) 
dimethylaminopropvltearbodnmide/N hydroxys ucci mide mixture 40 μΐ 
of streptavidin (200 Mg/ml Sigma catalog number S4762) in 10 т м 
acetate buffer (pH 4 5) and 35 μΐ ofethanolamine (flow rate 5 μΐ/min) 
In these conditions the chip was coated with approximately 5000 RU 
ΐ e 5 ng of streptavidin/mm ¿ The sensor chip was then treated with five 
pulses of 0 1 M sodium hvdroxide (5 μΐ/pulse at a flow of 5 μΐ/min) Five 
μΐ of biotinylated DNA I Life Technologies Ine catalog number 15616-
014 AX174 DNA Htnñ fragments containing 1 molecule of biotin/mol 
ecule average length 260 bpi at a concentration of 100 μβ/ml in HBS 
buffer containing 0 3м NaCl and without P20 were then injected al a 
(low of 2 μΐ/min on the streptavidin precoated chip This procedure 
allowed about 20 RU (20 pg of DNA/mm^) to be immobilized on the chip 
The surface was then washed with 5 μΐ of HBS containing 0 059Í lv/v) 
SDS To study the binding of mAbs to mononucleosome mAbs were 
immobilized by trapping them on sensor chips containing covalentlv 
bound RAM Fc according to the manufacturers instructions The bind 
ing experiments (pulses with the various analytes used between 1 and 
250 n\l on the specific surfaces) were performed at 25 °C and at a flow 
rate of 5 10 and 40 μΐ/min Antibody concentrations were determined 
according to Karlsson et al (23) Injection times were from 4 to 8 min 
and the postinjection phase duration was 10 min Conditions used were 
established to avoid mass transport effects (24 ι The regeneration step 
was optimalized for each antigen The surfaces were thus regenerated 
during 1 min with 10 т м acetate buffer (pH 6) in the case of the matrix 
with peptide dimer HBS containing 0 05O SDS and P20 in the case of 
the dsDNA matrix and 0 1 м HCl in the case of the RAM Fc matrix 
Both the procedure used to measure the antibody kinetic constants and 
the theory of kinetic measurements using the BIAcore biosensor svstem 
have been reviewed recently (25) 
RESULTS 
In our former study dealing with t h e characterizat ion of t h e 
four mAbs 2 42 53 and 56 l direct ELISA format was used in 
which dsDNA histones and histone peptides were directly 
adsorbed to plastic solid phase In Fig 1 we show t h e resul ts of 
inhibition experiments performed by using dsDNA as coated 
ant igen and several peptides covering the region 79-112 of H 3 
(Table I) as fluid phase competitors These peptides partial ly 
overlap t h e region 83-100 During t h e course of this s tudy we 
found t h a t mainly dimers of peptide 83-100 and not monomers 
of this peptide were significantly able to inhibit t h e reaction of 
mAbs to dsDNA (as exemplified with mAb 56 in Fig 1) Dimers 
of peptide 83-100 were obtained by dimethyl sulfoxide medi 
ated disulfide formation a t 20 °C and pH 7 4 (26) Monomerie 
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TABLE I 
Sequence of H3 peptides tested as monomers and dimers 
The cysteine residue 96 is conserved in human, bovine, and murine 
H3. It is replaced by a senne residue in other species such as birds and 
fishes. 
K D T L R F Q S S A V M A L Q E A C E A Y L V O L F E D T N L C A I 
A. Antigen: dsDNA В Unii;, η peptide 13*100 'dm 
peptides 79-92, 91-104. and 98-112 and dimers of peptides 
91-104 and 98-112 inhibited weakly (S80%) or not at all the 
antibody reaction to dsDNA (Fig. 1). This inhibition was not 
observed with mAbs 36 and 51. which react with dsDNA but 
not with 83-100 dimers (Fig. 1). 
Thus, the 83-100 dimer efficiently competes with DNA for 
t h e binding of mAbs to dsDNA. Reciprocally, we found t h a t the 
binding of mAbs 2. 42. 53, and 56 to 83-100 peptide dimers 
could be very efficiently inhibited by dsDNA (Fig. 2). U p to 
nearly 100% inhibition was reached with about 5-25 ng/ml 
competitor dsDNA (according to mAbs). both when dsDNA was 
used as antigen and competitor I Fig. 2A ) and when dsDNA was 
used to inhibit the binding of antibodies to the 83-100 dimer 
(Fig. 2B). 
These results clearly indicate t h a t four mAbs a re able to 
react with both dsDNA and a unique peptide s t ructure con­
tained in t h e 83-100 dimer. The fact t h a t 91-104 dimers 
showed much weaker activity t h a n 83-100 dimers with mAbs 
supports the conclusion t h a t these mAbs do not only react with 
t h e flanking residues of the disulfide bridge. 
The two mAbs, 42 and 56, were produced in larger amounts , 
extensively purified to remove all bound nuclear material , and 
their capacity to recognize dsDNA and 83-100 dimers was 
further measured in t h e BIAcore using ei ther the peptide co-
valently linked to t h e dextran matr ix through its free N H 2 
t e r m i n u s or biotinylated dsDNA fragments immobilized onto 
t h e biosensor surface covalently precoated with streptavidin. 
We also studied the reactivity of mAbs with calf t h y m u s mono-
nucleosomes. The BIAcore biosensor system based on surface 
plasmon resonance detection permits the quant i ta t ive analysis 
of biomolecular interact ions in real t ime. One of t h e molecular 
p a r t n e r s is immobilized on a dextran matr ix coupled to a th in 
gold film, while the other one is introduced in a continuous flow 
passing over t h e sensor surface. An optical system detects 
changes in refractive index close to the metal surface, which 
allows the concentration of the reactants to be measured. The 
binding signal is continuously monitored and is t rans la ted into 
a sensorgram, expressed in RU over t ime. There are a t least 
three major advantages of using biosensors for molecular in­
teraction m e a s u r e m e n t s : (il molecules don't have to be labeled, 
(ii) each step of the reaction can be directly and ins tanta­
neously visualized, and (iii) accurate affinity and kinetic con­
s t a n t s can be easily measured. As discussed previously (27), 
t h e s t ructure of nucleosomes may be considerably altered if 
they are covalently bound to t h e dextran matr ix on t h e sensor 
chip via amino groups, particularly because histone tails, 
which are very basic, play an important role in t h e stabilization 
of t h e edifice. To overcome this problem, one can either present 
nucleosomes by a first antibody (for example directed against 
one of the constitutive histones) and study the binding of an-
rii.' ml dsDN A inhibitor 
FIG 2. Recognition in competitive ELISA of DNA or 83-100 
dimer by mAbs 42, 53, and 56. Microtiter plates were coated with 10 
ng/ml dsDNA (Α ι or 2 μ.Μ 83-100 dimer (23) and allowed to react with 
mAbs 42 (A). 53 O , and 56 fO) preincubated with increasing concen­
trations of dsDNA. 
tibodies directed against another histone (271 or one can cap­
ture the murine mAb under study with a first antibody directed 
against mouse Ig and then pulse nucleosomes used in this case 
as analytes in the fluid phase. The la t ter procedure was used in 
this study with mAbs 42 and 56. Several concentrat ions (1-250 
пм) of nucleosomes were allowed to react with immobilized 
mAbs (300 RU), and flow rates of 5, 10, and 40 μΐ/min were 
used. FCinetic ra te constants and equilibrium affinity constants 
of mAbs for the 83-100 dimer, dsDNA, and nucleosomes are 
shown in Table II. It appears clearly t h a t in the BIAcore sys­
tem, both mAbs 42 and 56 preferentially bound dsDNA com­
pared with the 83-100 dimer. The equilibrium affinity con­
s tants . K„. of mAbs 42 and 56 were, respectively, 13 and 7 t imes 
higher for dsDNA as compared with the 83-100 dimer. In both 
cases, this was essentially due to a higher association r a t e 
constant, k
a
. Interestingly. mAbs 42 and 56 were found to 
strongly react with nucleosomes. Equil ibrium affinity values 
Kfl of both mAbs 42 and 56 for calf t h y m u s mononucleosomes 
were 2.7 x 1 0 1 0 м " 1 , i.e. 25 and 15 t imes higher t h a n K
n
 values 
measured for dsDNA, and 332 and 102 times higher t h a n K
n 
values measured for t h e 83-100 dimer. As compared with bind­
ing to dsDNA, this increase in K
a
 values was mainly due to 
lower k
a
 values. In a control experiment performed with mAb 
56, we found t h a t when presented by RAM Fc. this mAb, as in 
direct ELISA format, did not recognize H3 or H3 dimers used 
as ligands. Reciprocally, mAb 56 used as ligand did not bind H 3 
covalently linked to t h e dextran matrix. 
A few experiments were performed with Fab fragments pre­
pared from mAb 56. We found t h a t t h e respective K
a
 values of 
Fab 56 for the 83-100 dimer and dsDNA were six to seven 
t imes lower (i.e. 37 x 10 6 and 300 x 10 6 M ] ) t h a n t h e K
a 
values (270 x 10 6 and 1870 x 10 6 м l ) of mAb 56 for these 
antigens. Constants kQ were of the same order: the lowered Ka 
values were due to higher kd values as to be expected when 
monovalent binding occurs. In both cases, was t h u s the asso­
ciation of mAb 56 with the 83-100 dimer and dsDNA essen­
tially bivalent, and strictly speaking, it was "avidity" r a t h e r 
t h a n "affinity" of antibody t h a t was measured in this study. 
In a further s tudy using the BIAcore system, we confirmed 
t h a t the same antibody population bound dsDNA and 83-100 
dimer. mAb 56 was first allowed to react with t h e 83-100 dimer 
and then recovered by injecting 10 т м acetate buffer (pH 6) 
These antibodies were immediately reinjected on a sensor chip 
presenting dsDNA, and expected RU could be measured. 
We could exclude t h e possibility t h a t Fc domains were in­
volved in the antibody binding as in the three assays described 
(plates with DNA or 83-100 dimer and chips with nucleosome), 
RAM Fc was used to reveal bound mAbs or to capture bound 
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TABLE II 
Kinetic rate constants and equilibrium affinity constants of mAbs 42 
and 56 for the 83-100 dimer dsDNA and mononucleosomes 
Association (A„) and dissociation lkd> rate constants are the mean 
obtained in at least three independent experiments Other mAbs used 
as control show no binding with an\ of these antigens Kinetic data 
were obtained by using mAbs in the flow as analyte over the different 
ligand5 except in the case of nucleosomes where the mAbs were pre 
sen ted bv a first antibody (RAM Fc) immobilized on the dextran and 
mononucleosomes were used as analvte Note that the latter strategy 
was also used with the 83-100 dimer (but not with dsDNA because it 
is not applicable as the number of available epitopes is not known) and 
this gave the same data as those ehown in the table 
AnliRen 
83-100 dimer 
dsDNA 
Mononucleosome 
83-100 dimer 
dsDNA 
Mononucleosome 
A„ 
χ 10 ' 
4 ' 4 ' 
25 z 4 
177 ί 37 
137 ΐ 39 
31 ΐ 5 
335 ΐ 28 
135 î 29 
*„ 
χ 10> , ' 
308 ϊ 11 
164 - 21 
5 : 0 3 
114 ΐ 18 
179 î 27 
5 î 0 3 
К. 
χ 10 s 
m ' 
82 
1080 
27200 
270 
1870 
27600 
mAbs F u r t h e r m o r e , as desenbed above. Fab 56, as mAb 56, 
bound both dsDNA and 63-100 dimer 
DISCUSSION 
DNA antibodies have been shown by several investigators to 
cross-react with diverse nuclear or non-nuclear components In 
some cases, t h e cross-reaction involves s t ructures where the 
similarity can be rationalized, such as cardiolipin which h a s 
two phosphate groupings approximately the s a m e distance 
a p a r t as those on DNA Even in this case, it has been suggested 
t h a t only anti-DNA antibodies of relatively low avidity exten­
sively cross-react with cardiolipin while high-avidily antibod­
ies do not (12) More frequently DNA antibodies reacting with 
cell-surface proteins and also with extracellular matrix pro­
teins have been desenbed (eg Refs 28-30» However, no de­
tailed kinetic affinity studies of any of these cross-reactions 
have been u n d e r t a k e n Moreover, as pointed out previously, 
some of these reactivities may be mainly due to the presence of 
nucleosomal mater ia l complexée to the antibody (1) 
The resul ts described herein further establish our recent 
finding2 t h a t several monoclonal antibodies generated from 
au to immune mice and extensively purified react with both 
dsDNA and peptide 83-100 of H3 present as a dimer involving 
a disulfide bond linking cysteine residues 96 and provide a 
quant i ta t ive support to this appa ren t cross-reaction Several 
explanat ions for our observations can be proposed 
First , one can argue t ha t mAbs 2, 42, 53, and 56 can be 
ranged among the so-called polyspecific antibodies However, 
in general , these polyreactive antibodies a re of the IgM isotype, 
have affinities t ha t tend to be low (with Ka values between 103 
and 10' M \ Ref 31), and react with multiple autoant igens 
Second, an a l ternat ive explanation is t ha t the antibodies 
bind with dsDNA and Θ3-100 dimers through different binding 
sites located on t h e antibody variable regions, in a mechanism 
of "multireactivity," as reviewed recently (32) We have re­
ported previously t h a t t h e double reactivity of several rheuma­
toid factors for IgG and histones was related to distinct binding 
sites (33, 34) Topographic mapping of these sites was per­
formed by using t h e whole histones and hi stone peptides in 
inhibition exper iments and reinforced by using m u r i n e mono­
clonal anti-idiotope antibodies reacting with distinct ldiotopes 
on t h e rheumatoid factors 
Third, a n explanation for the specificity of monoclonal anti­
bodies examined in th i s s tudy is t h a t mAbs are directed against 
a topographic d e t e r m i n a n t consti tuted by a segment of DNA 
associated with an epitope normally found in the (H3-H4) 2 
t e t r a m e r region near the surface of the octamer core of the 
nucleosome This hypothesis referring to a mechanism called 
"dual reactivity" (32) is supported by the finding t h a t the an­
tibodies have a very high K
a
 value for nucleosome (around 
2 7 x 1 0 1 0 M M and lower K
a
 values for dsDNA and 83-100 
dimers It is probably because t h e initial affinity particularly 
high with the nucleosome t h a t reaction with par t s of t h e orig­
inal epitope is still detectable both in ELISA and in the 
BIAcore 
In order to reinforce our assumption, we have analyzed our 
results with regards to the crystal s t ructure of the histone 
octamer t h a t has been resolved a t 3 1 À (35-37) A close exam-
ination of the chicken octamer s t ruc ture showed tha t the 8 3 -
100 domain of H3 is only partially surface-oriented 4 Residues 
8 3 - 8 7 define the boundaries of the path of the polypeptide as it 
emerges to and "dives away" from the surface of the octamer 
Residues 88-100 appear to be buried in octamer and not avail-
able for surface-probing by ligand molecules, and the two H3 
residues a t sites 96 are not close to each other In the nucleo-
some model built from x-ray crystallographic data of the 
chicken octamer (35-37), the 8 3 - 8 7 residues a re predicted to 
be located in a DNA binding area and would be under the path 
of the double helix Thus we have difficulty in explaining how 
the mAbs can cross-react with mononucleosomes in view of the 
current nucleosome models We can argue, however, t ha t the 
crystal s t ruc ture was obviously obtained in a chemical environ-
ment very different from the reaction conditions used with 
antibodies and involved the complete octamer and not the 
nucleosome assembly Fur thermore it has to be pointed out 
tha t the crystal s t ruc ture of the histone octamer was solved 
from chicken erythrocyte and not from mammal nuclear mate-
rial In birds and fishes, the cysteine residue 96 (found in 
human , bovine, and murine H3, for example) is replaced by a 
serine residue As we have shown tha t the 83-100 dimer, but 
not the 63-100 monomer, was recognized by the four mAbs 
tested in this work, it might be concluded t ha t in mammal 
octamer, cysteine residue 96 plays an impor tant role and t ha t 
th is region assembles in a slightly different shape compared 
with chicken In this regard, it is interest ing to note t ha t 
cysteine 96 has been reported to be more reactive to sulfhydryl 
reagents , and for this it has been suggested t ha t it might be 
located close to the octamer surface (38, 39) 
Several au thors have recently pointed out the fundamental 
role of anti-nucleosome antibodies in the pathogenesis of lupus 
It is probable t ha t many studies based on the use of p u n n e d 
nuclear proteins or DNA tested separately have obscured an 
impor tant par t of the antibody reactivity underes t imat ing 
specificity for nucleosomes ( 10) It is possible t ha t it is precisely 
because such subsets of antibodies are able to interact with the 
complete nucleosome s t ruc ture and with individual compo-
nents of this s t ruc ture t ha t they have a pathogenic role, in 
part icular in lupus nephn t i s (1) In view of our present knowl-
edge of the nucleosome s t ructure , our results may further sug-
gest t ha t nucleosomes in an abnormal conformation have trig-
gered the production of these cross-reactive antibodies 
This s tudy presents the first detailed kinetic analysis of the 
interactions between several antibodies and apparent ly dis-
t inct antigenic de te rminants A more definitive picture should 
be obtained by combining the present results and informations 
denved from the sequence of vanab le regions of these antibod-
ies (30) All these data allow us to bet ter unders tand the struc-
tural basis of autoantibody reactivity Finally, this analysis 
shows t h a t perhaps a large number of autoantibodies defined 
as anti-dsDNA antibodies on the basis of the Fan* assay (re-
* Ε N Moudnanakis personal communication 
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garded a s t h e golden s t a n d a r d ) can in fact correspond to nu-
cleosome-specific antibodies 
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Abstract 
Background. Recently we showed that antinuclear 
autoantibodies complexed to nucleosomes can bind to 
heparan sulphate (HS) in the glomerular basement 
membrane (GBM ) via the histone part of the nucleo-
some Histones have been identified in glomerular 
deposits in human and murine lupus nephritis. In 
addition, a decreased HS staining in the GBM was 
found, most probably due to masking by deposition 
of antibodies complexed to nucleosomes. 
Methods. In this study we first investigated whether 
histones or nucleosomes could be identified in glomer­
ular deposits in human lupus nephritis, and secondly 
whether the presence of these nuclear components was 
correlated with absence of HS staining. Kidney biopsies 
of SLE patients (11 with diffuse proliferative glom­
erulonephritis (DPGN) and six with membranous 
glomerulonephritis (MGN)) and of non-SLE glomer­
ular diseases were stained for histones, DNA, nucleo­
somes, IgG and HS. 
Results. Using a polyclonal anü-НЗ 1-21 antiserum, 
histones were detected in all patients with DPGN and 
ш two of six patients with SLE-MGN (P<0.01). Using 
a monoclonal antihistone antibody, histones were 
stained in three patients with DPGN, but in none of 
the biopsies with MGN. Using nucleosome specific 
monoclonal antibodies, nucleosomes were detected in 
five patients with DPGN, in two patients with MGN, 
but in none of the biopsies with non-SLE glomerulo­
nephritis. HS staining was nearly absent in DPGN, 
whereas staining was only moderately reduced in 
patients with MGN and controls (P=0 001). 
Conclusion. Using polyclonal and monoclonal antihi­
stone antisera, histones were identified in all patients 
with DPGN and their presence was associated with a 
decrease of HS staming. Nucleosomes were identified 
Corrtspondence and offprint rtqu£3ls Ιο M С 1 van Bruggen, 
Division of Nephrology, University Hospital, St Radboud, Ρ О Box 
9101. 6500 HB Nijmegen, The Netherlands 
in five of 11 patients with DPGN and in two of six 
patients with MGN. This is the first demonstration of 
nucleosomes in glomerular deposits in SLE nephritis 
Key words: DNA; histones; lupus; nucleosomes; SLE 
Introduction 
In systemic lupus erythematosus (SLE) about 50% of 
patients develop renal disease [ 1 ]. Antinuclear antibod­
ies and more specifically anti-dsDNA antibodies are 
regarded as a hallmark of the disease [2]. Since a rise 
in titre of anti-dsDNA antibodies often precedes a 
renal exacerbation [3-5] and renal eluates of patients 
with lupus nephritis are enriched for anti-dsDNA 
antibodies [6,7], these antibodies are thought to play 
a pathogenic role m the initiation of the glomerular 
disease. Some years ago we showed that certain anti-
dsDNA antibodies are able to bind to heparan sulphate 
(HS), an intrinsic constituent of the glomerular base­
ment membrane (GBM). [8]. In subsequent experi­
ments we showed that this HS cross-reactivity was a 
property of antibodies complexed to nucleosomal anti­
gens (i.e. DNA and histones) [9] and that antinucleo-
some antibodies complexed to nucleosomal antigens 
were able to bind to HS in the GBM, whereas pure 
antibodies did not bind [10]. 
In the meantime it was reported that histones are 
present in immune deposits of both human [11] and 
murine [12] lupus nephritis, whereas in murine lupus 
an association between histone deposits and albumin­
uria was found [12]. 
Recently we found that in the majority of patients 
with lupus nephritis HS staining was absent, whereas 
staining for the heparan sulphate proteoglycan 
(HSPG) core protein was intact [13]. In subsequent 
studies in MRL/I mice we found that HS staining 
disappeared in albuminuric mice, and that there was 
С 1997 European Renal Association-European Dialysis and Transplant Associauon 
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an inverse correlation between HS staming and albu­
minuria as well as between HS staining and GBM Ig 
deposits. Since glomerular HS content was not 
decreased in mice in which GBM-HS staining was 
absent, we suggested that HS was masked by nucleo-
some containing immune complexes [14]. Although 
other investigators showed histories [11,12] or D N A 
[IS] in glomerular deposits in lupus nephritis, nucleo­
somes were never identified. 
In the present study we first tested whether nucleo­
somes were present m the glomerular immune deposits 
in human lupus nephritis and secondly whether pres­
ence of histories or nucleosomes correlated with loss 
of GBM-HS staining Since we investigated the inter­
action between immune deposits and HS in the GBM, 
SLE patients with diffuse proliferative ( D P G N ) 
and membranous glomerulonephritis ( M G N ) were 
selected. 
Subjects and methods 
Renal biopsies 
Renal biopsies of 11 SLE patients with DPGN and of six 
SLE patients with MGN were selected (Table I ). All patients 
fulfilled at least four ARA entena for SLE From all renal 
biopsies 2-um cryostat sections were cut. As controls renal 
biopsies of four patients with non-SLE mesangiocapiUary 
glomerulooephntis and of five patients with non-SLE MGN 
were evaluated. 
Immunohistology 
AU sections were stained m direct immunofluorescence (IF) 
for IgG deposits and ш indirect IF for HS, HSPG core 
protein, histones, DNA, and nucleosomes The characteristics 
of the antisera used are given in Table 2. After the staining 
procedure, the sections were embedded ш Aquamount (BDH 
Ltd. Poole, UK) and examined with a Zeiss fluorescence 
microscope 
Human IgG 
Deposits of human IgG were studied by incubating sections 
with FITC-labelled F(ab)2 rabbit anti-human IgG (CLB, 
Amsterdam, the Netherlands) 5 mg/ml diluted 1 400 m PBS 
containing 1% (wt/vol) BSA (PBS/BSA) for 30 mm at room 
temperature 
HS and HSPG core protein 
HS was stained by incubating the sections with a mouse 
anti-rat HS monoclonal antibody (mAb, JM 403) that only 
recognizes HS in basement membranes and cross-reacts with 
human HS [16] (Table 2) HSPG core protem was stained 
by incubating with a mouse monoclonal anti-human HSPG-
core protem (JM-72, [16], Table 2) HS and HSPG-core 
protein were stained simultaneously on the same slide using 
double-staining as described before [16] 
Hislones 
Histones were stained by incubating the sections with a 
polyclonal rabbit antiserum raised against the N-tenmnal 
1-21 peptide of histone H3 [17] and with mAb KM2 against 
histones derived from a lupus prone mouse (Table 2). MAb 
KM2 is directed against H2A and H4. It reacts equally well 
with the N-tennmal pepudes 1-20 of H2A and 1-29 of H4 
which have a large sequence homology. The IF using the 
polyclonal rabbit antiserum was performed as described 
before [11,12]. The IF using the mAb was performed by 
incubating the sections with mAb KM2 (10ug/ml) in 
PBS/BSA for 30 mm at room temperature. Next, sections 
were incubated with FITC labelled F(ab)¡ sheep anti-mouse 
Ig (Cappel, Organon Technika, Turnhout, Belgium) 
10 mg/ml, dduted 1:750 in PBS/BSA for 30 mm at room 
temperature. In addition, sections of all biopsies were incub-
ated with an irrelevant mouse IgG (IgG2a or IgG2b) anti-
body (as a primary antibody control ) and with FITC-labelled 
F(ab)2 sheep anti-mouse Ig without the primary antibodies 
(as a conjugate control). 
DNA and nucleosomes 
DNA and nucleosomes were stamed by incubating the 
sections with mAbs derived from lupus-prone mice. The 
anti-dsDNA mAb (#42) was derived from a panel of 
anti-dsDNA mAbs described previously [18] The anti-
nucleosome mAbs (LG8-1 and LG10-1) (Table 2) only 
recognize the intact nucleosomc and not DNA or histones 
separately as described before [19]. The antinucleosome mAb 
#34 shows strong reactivity with nucleosomes [10] and for 
this mAb the nucleosomal epitope is primarily located on 
( H3-H4)/DNA ( Kramers et al, in press). For IF the sections 
were incubated with mAb #42, mAb #34, mAb LG8-1 
or mAb LG10-1 (10 μg/ml) m PBS/BSA for 30 mm at room 
temperature. Further procedures were identical to the proced­
ure described for mAb KM2. 
We also performed a double Stauung for IgG and nucleo­
somes using FITC-labelled F (ab h rabbit anti-human IgG 
followed by antinucleosome mAb LG 10-1 with TRITC-
labellcd anti-mouse IgG2b as secondary antibody to compare 
the localization of the IgG and nucleosomc deposits. 
Attempts were made to elute Ig from the sections, which 
might improve the detection of nucleosomes, histones and 
DNA. To this end sections were incubated with either pepsin 
(Sigma) lC^g/ml m 0.1M acetate pH4.5, 0.1M glycine or 
2M NaCL for 1 h or overnight at 37°C. These procedures 
failed to remove Ig from the sections and no improvement 
of the detection of nucleosomes, histones, and DNA was 
observed 
Staining of histones using the polyclonal rabbit antiserum 
and HS-staining was scored semiquantitatively on a 0-4 + 
scale on coded sections by two independent investigators 
(regression analysis yielded a good correlation between the 
scores of both investigators, P<0 0001) 
Importantly, all MAbs used were purified to remove bound 
nucleosomal antigens, since this may produce spunous bind­
ing reactions [10]. 
Statistical analysis 
Comparison of the presence of histones in kidney biopsies 
of patients with DPGN or MGN was done with the Fisher 
exact test HS staining (scored semiquantitatively on a 0-4 + 
scale) was compared between kidney biopsies of patients 
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Tabic I. Clinical characteristics of SLb patients 
Age Duration Νυη-renal disease 
manifestations 
K/R' Treatment Creat. Urinary 
(μτηοΐ/l) protein 
(g/24h) 
C3 
(mg/1) 
C4 
(mg/1) 
Diffuse proliferative glomerulonephritis (DPGN) 
1 F 29 8 years Thrombopenia 
2 M 15 < 1 year*1 Leukopenia 
3 F 46 < 1 year Thrombopenia, anaemia 
4 F 18 4 years — 
34 
41 
26 
21 
6 years 
15 years 
8 years 
2 months 
11 years 
10 years 
Pericarditis, pleuritis 
Leukopenia 
Leukopenia, thrombopenia, 
arthralgias, fever 
Arthralgias, fever, 
xerostomia, 
xerophthalmia, butterfly 
rash, leukopenia, anaemia 
Arthritis, anaemia 
Butterfly rash, arthritis, 
pleuritis 
Membranous glomerulonephritis (MGN) 
14 
15 
16 
17 
Prednisone 60 mg 
Prednisone 50 mg 
azathioprine 75 mg 
Chloroquine 250 mg 
Prednisone 60 mg 
Prednisone 15 mg 
Prednisone 30 mg 
H ydroxychloroq uine 
400 mg 
Prednisone 15 mg 
cyclophosphamide 
150mg 
111 
128 
117 
95 
111 
90 
81 
172 
84 
F 
F 
M 
F 
ι· 
F 
29 
29 
51 
37 
29 
54 
< 1 year 
< 1 year 
<1 year 
< 1 year 
9 years 
14 years 
Discoid skin lesions, oral 
ulcers, alopecia, 
thrombopenia 
discoid skinlesions, oral 
ulcers, arthritis, psychosis, 
thrombopenia 
— discoid skinlesions 
thrombopenia, anaemia, 
cerebral infarction 
— 
F 
F 
F 
F 
R 
R 
Prednisone 10 mg 
and chloroquine 
No 
No 
Hydroxychloroquine 
200 mg 
Prednisone 7.5 mg 
No 
60 
57 
85 
94 
279 
54 
98 
4 7 
8 6 
32 
120 
59 
1.3 
0 3 
2 3 
330 
670 
990 
390 
225 
410 
390 
464 
500 
580 
520 
720 
683 
375 
160 
120 
29 
ND 
120 
174 
100 
160 
110 
130 
29 
76 
17 
neg 
2340 
80 
320 
0 
0 
>320 
80 
160 
a, F, first manifestation; R, relapse, b, U/ml or titre; с, titre; d, renal disease at presentation. 
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Tabic 2. Characteristics of the monoclonal and polyclonal antisera used 
Antiserum 
Monoclonal 
L08-1 
LG10-1 
34 
KM2 
42 
JM403 
JM72 
Polyclonal 
Oostende 
Subclass 
IgG2b 
IgG2b 
Ig02a 
Ig02a 
IgG2a 
IgM 
IgGl 
IgG 
Specificity 
a-nucleosome (H2A-H2B/DNA) 
a-nucleosome (H3-H4/DNA) 
ot-nucleosome (H3-H4/DNA) 
a-histone (1-20 H2A.1-29 H4) 
α-dsDNA 
ot-HS-GAG 
a-HSPG core protein 
a-histone(l-21 H3) 
Origin 
MRL/lpr 
MRL.lpr 
NZB/W 
MRL/lpr 
NZB/W 
Rabbit 
Reference 
[19] 
[I»l 
[10] 
This manuscript 
III] 
[It] 
[16] 
[П.12.1Л 
with D P G N and M G N using the Mann-Whitney U test. 
The correlation between HS staining and staining of histones 
with the polyclonal rabbit antiserum was tested by 
Spearman's correlation test. 
Results 
Staining of IgG, histones, nucleosomes and DNA in 
glomerular deposits 
Using the polyclonal anti-H3 (1-21) peptide anti­
serum, histones were detected in all kidney biopsies of 
patients with DPGN and in two of six patients (patient 
no 12 and 17) with SLE-MGN (P<0.01) (Table 3). 
Histone deposits were present in the walls of the 
capillary loops and followed the pattern of IgG depos­
ition (Figure 2a, b). Using the antihistone mAb ÍCM2, 
histones were identified in the immune deposits in three 
kidney biopsies of DPGN patients (patients no. 2, 4 
and 6) and in none of the MGN patients (Table 3). 
Nucleosomes were identified in immune deposits of 
five renal biopsies of patients with DPGN (Figures 1, 
2c) and in two of the biopsies with SLE-MGN 
Table 3. Immunofluorescence findings in renal biopsies of SLE 
patients with either diffuse proliferative glomerulonephritis (DPGN, 
WHO class Г ) or membranous glomerulonephritis (MGN; WHO 
class V) and non-SLE controls with either mesangiocapillary glom­
erulonephritis (MCGN) or idiopathic MGN 
Antibodies 
mAbs· 
Antmucleosome 
Anti-dsDNA 
Antihistone 
Polyclonal* 
Anu-H3(l-21) 
SLE nephritis 
DPGN 
class Г 
5/11· 
0/11 
3/11 
11/11' 
MGN 
class V 
2/6 
0;6 
0/6 
2/6 
Non-SLE nephritis 
MCGN 
0/4 
0/4 
0-4 
1/4 
MGN 
0/5 
0/5 
0/3 
0/5 
a, Stauung of nucleosomes m glomerular deposits using mAbs #34, 
LG8-1 or LG10-I. Staining of histones using mAb KM2; staining 
of DNA using mAb #42. b. Stauung of histones using a polyclonal 
rabbit anü-НЗ 1-21 serum, c. Number of posiüve biopsies/number 
of biopsies tested d, /><001 (Fisher exact test) for SLE-MGN 
compared to DPGN. 
Fig. 1. Immunofluorescence of a kidney biopsy of an SLE patient 
with DPGN stained with a mouse antinucleosome mAb (I.G10 1 ) 
Besides staining of the capillary loops and the mesangmm, prominent 
nuclear staining can be seen (x 300). 
(Table 3). The two positive MGN biopsies (stained 
by mAb #34) were also positive with the polyclonal 
anti-H3 peptide antiserum. MAb LG10-1 stained 
deposits in four renal biopsies of DPGN patients 
(patients no. 2, 5, 6 and 10), mAb LG8-1 in two 
biopsies of DPGN patients (patients no. I and 2) 
and mAb #34 in five biopsies of DPGN patients 
(patients no. 1, 2, 5, 6 and 10). In some biopsies IgG 
deposits were observed without positive staining of 
histones and nucleosomes (Figure 2d-f), indicating 
that the positive staining in the DPGN and SLE-MGN 
biopsies is not due to aspecific binding of the antibodies 
to deposited Ig. In kidneys with nucleosome staining 
we found that nucleosome deposits were present in 
20-80% of the Ig positive glomeruli. The localization 
of the nucleosome deposits was the same as the IgG 
deposition (as assessed by double staining). In the IF 
analysis with the antihistone or antinucleosome mAbs, 
staining in the walls of capillary loops was focal 
and segmental. Furthermore, the antihistone and 
antinucleosome mAbs showed bright nuclear staining. 
Due to this bright staining, the Stauung in the capillary 
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Fig. 2. Immunofluorescence of kidney biopsies of SLE patients Staining for immunoglobulins (with an anti-Ig antiserum (A and D)), 
histones (with a polyclonal rabbit anti-H3 1-21 serum (B and E)), and nucleosomes (with a mouse antinucleosome mAb (LG10-1) (E and 
F)) ш the same glomerulus on consecutive sections Fig 2a-c show positive stajnmg. Ig deposits are located along the glomerular capillary 
walls and in the mesangium Histone and nucleosome deposits are seen in a similar distribution to Ig Fig 2D-F show a glomerulus 
positive for Ig but negative for nucleosomes and histones, ruling out an aspecific binding of the probing antibodies to Ig in the immune 
deposits (x 300). 
43 
Nucleosomes in Glomerular Deposits in SLE 
loops is less prominent (weaker than that obtained 
with the polyclonal antihistone antiserum, which gave 
no nuclear staining). Anti-dsDNA antibodies (mAb 
#42) did not stain deposits in any of the biopsies 
(Table 3) (Figure 3). Also with other anti-dsDNA 
antibodies (mAbs #36 and #56) we were not able to 
detect glomerular DNA deposits (data not shown). 
There was no correlation between the presence of 
nuclear deposits and sex, duration of disease, primary 
manifestation, or flare of glomerulonephritis, serology 
or proteinuria. 
In the control experiments (non-SLE glomerulo­
nephritis) none of the mAbs stained glomerular 
deposits, whereas the polyclonal rabbit anti-H3 (1-21) 
serum stained glomerular immune deposits in one 
patient with non-SLE mesangiocapillary glomerulo­
nephritis (Table 3). 
In all biopsies tested, no staining was observed with 
conjugated secondary antibodies alone or after incu­
bation with non-relevant mouse IgGmAbs and 
conjugate. 
Staining of glomerular HS and HSPG core protein 
Staining of HSPG core protein was normal in all 
kidney biopsies studied (Figure4a,d,g). GBM-HS 
staining was normal (Figure4b) or only moderately 
reduced ( Figure 4e) in renal biopsies of patients with 
SLE-MGN, whereas staining was strongly reduced or 
nearly absent (Figure 4h) in patients with DPGN (P = 
0.001 ). When GBM-HS staining was normal, no stain­
ing for histones was observed (Figure 4c). The appear­
ance of histone deposits ( Figure 4f,i) is paralleled by 
the disappearance of GBM-HS staining. There was a 
significant inverse correlation between HS staining and 
histone deposition as found by the polyclonal rabbit 
A-r*-v;.· ·ί·:\ ·.;·'·%. 
\> rf · щ >·« "-'. 
F- \ , ч » » » »» * 
• .* V i t « * * ^. 
.* ν. « " * . « . < » - · * , 
γ ν·. * 
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- *» * · 
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Fig. 3. Representative example of a kidney biopsy of an SLE patient 
with MGN, stained with a mouse anti-dsDNA mAb (#42). Only 
nuclei stain, and no staining in the walls of the capillary loops or 
the mesangtum is observed ( χ 300). 
anti-H3 1-21 antiserum (r,= -0.77, i»<0.0001, 
Figure 5). 
Discussion 
In recent years evidence has emerged that nucleosomes 
may play an important role in the initiation of lupus 
nephritis [20], by interaction of the histone part of the 
nucleosome with the GBM [21 ]. Histones are positively 
charged (pi = 10) and most probably interact with the 
negatively charged HS in the GBM. We showed that 
after subsequent renal perfusion in the rat of histones, 
DNA and anti-dsDNA mAbs, these antibodies bind 
to the GBM, whereas subsequent perfusion of DNA 
and anti-dsDNA leads to limited mesangial binding of 
antibody, and anti-dsDNA antibodies perfused alone 
do not bind at all [22]. An interaction with HS in the 
GBM was suggested by the finding that anti-dsDNA 
antibodies complexed to DNA and histones were able 
to bind to HS in ELISA [9,10]. Subsequently we 
showed in the same rat kidney perfusion model that 
antinucleosome antibodies complexed to nucleosomes 
are also able to bind to the GBM. When HS was 
removed from the GBM by prior perfusion with the 
HS-degrading enzyme heparinase, the binding of sub­
sequently perfused complexed antinucleosome antibod­
ies was greatly reduced [10]. Taken together, these 
experiments show that HS in the GBM is an important 
ligand for the binding of these nucleosome complexed 
antibodies. It is assumed that histones in these com­
plexes interact with HS, based on charge. 
Although histones have been found in the sera of 
humans [23], it is not very likely that they exist as 
separate molecules devoid of DNA. In the nucleus, 
histones are bound to DNA within the nucleosome. 
These nucleosomes have been found in the circulation 
of lupus patients [24]. It is assumed that they are 
released from apoptotic cells, since apoptoás leads to 
release of oligonucleosomes [25,26]. whereas necrosis 
yields less well-defined histone/DNA complexes. It is 
presently unknown what happens with nuclear material 
after release in the circulation. DNase and proteinases 
are present in plasma [27] so partial degradation of 
the nucleosome particle is possible. 
In the present study we analysed in more detail 
whether nuclear material was present in glomerular 
deposits in human lupus nephritis by staining for 
histones, DNA and nucleosomes. Using the polyclonal 
anti-H3 1-21, antiserum deposits were found in all 
kidney biopsies of patients with DPGN and in two of 
six patients with MGN. This is in accordance with the 
findings of Stôckl et al. who also found glomerular 
staining with this anti-H3 1-21 antiserum in SLE 
patients [II]. However, in Stôckl's study deposits were 
found in 69% of the biopsies with DPGN and in 77% 
of the MGN biopsies, whereas we found deposits in 
100% of the DPGN and in 33% of the MGN patients. 
Using the antihistone mAb KM2, histone deposits were 
found in three renal biopsies of patients with DPGN 
and in none of the patients with MGN. Because of a 
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Fig. 4. Representative examples of double staining of a kidney biopsy of two patients with MGN (Fig. 4A, 4B and 4D, 4E) and of a 
patient with DPGN (Fig 4G. 4H), with the mouse anti-HS mAb JM-403 and with the mouse anti-HSPG core protein mAb JM-72. In 
Fig 4A, 4D and 4G the biopsies are stained with JM-72, showing intact HSPG-stauung. In Fig- 4B, 4E and 4H the same biopsies are 
stained with JM-403. showing normal (4B) or moderately reduced (4E) GBM-HS staining in the MGN patients, and almost absent 
GBM-HS staining in the patient with DPGN (4H). Same glomeruli (successive sections) are stained with polyclonal rabbit anü-НЗ 1-21 
serum I Fie. 4C, 4F and 41). The appearance of histone deposits (Fig. 4F and 41) is paralleled by the disappearance of GBM-HS staining 
(Fig 4E a n d 4 H ) (хЗОО). 
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Fig. 4. (coni.) 
broader reactivity of the polyclonal antibodies reacting 
with different epitopes in the H3 1-21 peptide, this 
polyclonal antiserum has apparantly a greater sensitiv­
ity for the detection of histone deposits. Nucleosomes 
were found m five of eleven kidney biopsies of DPGN 
patients and in two of six patients with MGN. The 
anti-dsDNA antibodies did not stain any deposits. In 
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Fig. 5. Correlation between HS staining and staining of histone 
deposits (as assessed with the polyclonal rabbit anti H3(l-21) 
serum) in the walls of the capillary loops. Staining was scored θα a 
(M scale. DPGN ( ·) , SLE-MGN (A). 
the IF analysis with the anti-dsDNA, antihistone and 
antinucleosome mAbs, nuclear staining was observed 
in all biopsies since the epitopes these mAbs recognize 
are exposed in the nuclei. However, using the poly­
clonal antiserum, no nuclear staining was observed, 
suggesting that the H3 1-21 epitope is not exposed in 
the nucleus in vivo. 
Localization of autoantibodies in the GBM can arise 
along two different mechanisms. First, they can deposit 
from the circulation as complexes. Localization via 
this mechanism leads mainly to subendothelial or 
mesangial deposits, as is found mainly in DPGN. The 
other possibility is an in situ immune complex forma­
tion in which the antibody reacts with an intrinsic 
GBM antigen or an exogenous planted antigen. This 
mechanism takes mainly place in the formation of 
subepithelial deposits as seen in MGN. It is unlikely 
that the nucleosome binds to the GBM in free non-
complexed form and acts as a planted antigen, since 
renal perfusion of intact nucleosomes leads mainly to 
mesangial and not to GBM localization [20,28]. This 
is due to the pi of the native nucleosome which is 
about 7. Furthermore, the negatively charged DNA is 
located on the outside of the nucleosome which reduces 
the possibility that native nucleosomes interact with 
the negatively charged GBM. Such a direct binding 
can only be envisaged if nuclear material is enzym-
atically modified by plasma or tissue DNase and 
proteinases which creates a nuclear particle with less 
DNA and relatively more histones. Such a particle is 
theoretically able to bind to the GBM leading to in 
.viru-immune complex formation. Such a mechanism 
could explain the higher frequency of histone deposits 
that we observed. 
Another, more likely, possibility is that DNA or 
nucleosome-specific epitopes of the nucleosome are 
masked by anti-dsDNA or nucleosome specific autoan­
tibodies. When nucleosomes are released in the circula­
tion of lupus patients they will bind to these antibodies 
and form nucleosome-antibody complexes. Only when 
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these antibodies cover the negatively charged DNA in 
the nucleosome, the complex is able to bind to the 
GBM. In this view the overall pi and thus the nephri-
togenicity of the complex is determined by the antigen 
specificity of the bound antibody. This view is con-
firmed by the fact that glomerular eluates are greatly 
enriched for anti-dsDNA and anti-nucleosome anti-
bodies [6,7,29]. 
In contrast, antihistone antibodies would cover the 
bastone part of the nucleosome, thereby reducing the 
positive charge which prevents it from binding to the 
GBM. Interestingly, in drug induced lupus, in which 
antihistone antibodies are abundantly present and anti-
dsDNA antibodies are absent, nephritis is seldom seen 
[30]. Antihistone Abs are found in glomerular eluates 
of lupus mice [29,31]. However, in our experience, the 
eluates contain only small quantities of antihistone 
antibodies which show no correlation with albuminuria 
[29]. The mechanism of in vivo masking of nucleosome 
and DNA specific epitopes with a relative preservation 
of histone-specific epitopes could explain the lower 
frequency of nucleosome specific staining and the 
higher incidence of histone specific staining that we 
observed. 
Formal proof for this assumption could have come 
from elution studies on kidney sections, which could 
lead to uncovering of these nucleosome specific epi-
topes. However, attempts to achieve this were, for 
technical reasons, unsuccessful as we have described 
previously [14]. 
The second aim of our study was to find out whether 
loss of GBM-HS staining in human lupus nephritis 
was associated with histone or nucleosome deposition. 
In a recent study we found in murine lupus a decrease 
of glomerular HS staining without loss of HS content 
¡n-vitro experiments showed that histones, nucleosomes 
and antinucleosome antibodies complexed to nucleo-
somes were all able to mask HS in ELISA [14]. In the 
present study this m vitro finding was extended since 
the loss of HS staining correlated with histone depos-
ition. Very interestingly, histone deposition was only 
found ш two of six kidney biopsies of SLE-MGN 
patients, and in these patients HS staining was not or 
only moderately reduced. This may be due to quantitat­
ive differences m glomerular IgG deposition between 
DPGN and MGN patients, since in DPGN heavier 
IgG deposits are present. This is in line with our 
observation in murine lupus nephritis, where an inverse 
correlation between IgG deposition and GBM-HS 
staining was found [14] 
In conclusion, we show for the first time that nucleo­
somes can be identified ш immune deposits of patients 
with SLE nephritis This finding underlines the impor­
tance of nucleosomes for the pathogenesis of SLE [20, 
32] Histones are present in all lupus patients with 
DPGN and their presence correlates with a loss of 
GBM-HS staining, which is probably due to masking 
of HS 
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Recently we found in biopsies of human lupus ne­
phritis a nearly complete loss of heparan sulfate 
(HS) staining in the glomerular basement mem­
brane (GBM). To clarify the relationship between 
HS staining and albuminuria in lupus nephritis, 
we studied MRL/lpr mice with short (<7 days) or 
prolonged duration of albuminuria (14-21 days) 
and compared these with mice of different ages 
without albuminuria. Kidney sections were 
stained for mouse immunoglobulin (Ig), HS, 
heparan sulfate proteoglycan (HSPG)-core pro­
tein and laminin in immunofluorescence. In mice 
with prolonged albuminuria HS staining in the 
glomerular capillary loops bad almost completely 
disappeared, whereas staining was unaltered in 
поп-albuminuric mice (V = 0.001). In mice with 
short duration of albuminuria, there was a ten­
dency toward a decrease of HS staining (P = 
0.06). The expression of HSPG-core protein and 
other extra cellular matrix (ECM) components 
was unaltered in all groups. HS staining corre­
lated inversely with albuminuria (i, = -0.55; Ρ < 
0.001) and with staining of Ig deposits in the cap­
illary loops (τ, = -0.74; Ρ < 0.001). Despite the 
nearly complete loss of HS staining in the GBM in 
mice with prolonged albuminuria, there was no 
change in glomerular HS content as assessed by 
agarose electrophoresis and HS inhibition ELISA. 
We conclude that the development of albuminuria 
in MRL/lpr mice is accompanied by a loss of HS 
staining in the GBM, probably due to the masking 
of HS by deposits of Ig. In vitro studies revealed 
that autoantibodies complexed to nucleosomal 
antigens can inhibit the binding of the anti-HS 
monoclonal antibody to HS. Whether this also oc­
curs in vivo remains to be determined (Am J 
Pathol 1995, 146:753-763) 
Systemic lupus erythematosus (SLE) is an autoim­
mune disease characterized by the occurrence of a 
multitude of autoantibodies primarily directed 
against nuclear antigens ' Glomerulonephritis, char­
acterized by albuminuria and deterioration of renal 
function is one of the most serious manifestations of 
this disease 2 The MRL/I (MRL Ipr/lpr) mouse strain is 
a generally accepted animal model lor SLE 3 As in 
human SLE numerous autoantibodies occur and 
most animals develop albuminuria and progressive 
loss of kidney function between 3 and 6 months ol age 
with a 50% mortality rate at 6 months Histologically, 
a diffuse proliferative glomerulonephritis is observed 
and immunofluorescence studies reveal variable 
amounts o( deposits of immunoglobulins (Ig) and 
complement factors in the mesangium and along the 
glomerular capillary walls 3 " 
Deposition of heparan sulfate (HS) reactive autoan­
tibodies has been proposed as an early event in the 
development of lupus nephritis 5~7 HS is the nega­
tively charged glycosaminoglycan side chain of 
heparan sulfate proteoglycan (HSPG) It is an intrinsic 
constituent ol the glomerular basement membrane 
(GBM) and responsible for the maiority of the anionic 
sites in the GBM 8" 1 0 These anionic sites are held re­
sponsible for the charge dependent permeability of 
the GBM n 12 although the relative contribution of 
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other negative charged molecules within the glomer­
ular capillary wall like the sialoprotem podocalyxin is 
still a matter of debate Consequently, loss of these 
anionic sites leads to albuminuria 13~17 Recently, we 
found that staining of HS in the GBM with the anti-HS 
monoclonal antibody (MAb) JM-403 had completely 
disappeared in 12 of 13 renal biopsies of human lu­
pus nephritis whereas staining of the HSPG-core pro­
tein was unaltered , θ 
To clarify the relationship between albuminuria and 
HS staining in SLE we studied MRL/I mice with dif­
ferent stages of renal disease and compared these 
with mice without albuminuria of different ages In 
these groups of mice we studied by immunofluores­
cence the relation of deposited Ig with the staining of 
HS HSPG-core protein and laminm in the glomeruli 
We measured the glomerular HS content in the glo­
meruli of these mice to elucidate whether a potential 
decreased staining of HS was due to decreased HS 
content of the GBM or to blocking of the staining by 
deposited immune complexes Since we have found 
that autoantibodies complexed to nucleosomal anti­
gens can bind to HS in vitro19 2 0 and to GBM-HS in 
vivo,2' 22 we examined in ELISA whether the binding 
of the anti-HS MAb to HS could be inhibited by these 
complexes 
Materials and Methods 
Animals 
MRL/I (MRL Ipr/lpr) mice were bred in the animal fa­
cilities of the University of Nijmegen from stock origi­
nally obtained via the Scripps Clinic and Research 
Foundation (La Jolla CA) from the Jackson Labora­
tory (Bar Harbor, ME) Five groups of mice were se­
lected based on age and magnitude of albuminuria, 
which was screened every week with Albustix (Boeh-
rmger Mannheim Mannheim, Germany) Group 1 
consisted of 12-week-old mice (n = 8) without albu­
minuria (Albustix < 300 pg/ml) Group 2 consisted of 
36-week-old mice (л = 8) without albuminuria (Al­
bustix < 300 мд/rnl) Group 3 consisted of 18- to 24-
week-old mice (n = 8) without albuminuria (Albustix 
<300 мд/rnl) Group 4 consisted of 18- to 24-week-old 
mice (n = 8) with short duration of albuminuria (Al­
bustix > 1000 pg/ml, albuminuria period <7 days) 
Group 5 consisted of 18- to 24-week-old mice ( η = 8) 
which had a positive result on screening (Albustix > 
1000 мд/ті) on three subsequent occasions (albu­
minuria period at least 14 days, but not more than 21 
days) 
After assigning a mouse to one of the five study 
groups, urine was collected the next day for 18 hours 
in a metabolic cage with free access to water Mice 
assigned to groups 1,2,3 and 4 were sacrificed after 
collection of the urine After the kidneys were per­
fused with saline before removal a part was imme­
diately snap frozen in liquid N 2 for immunofluores­
cence and a small piece was immersed in Bouin's 
solution for light microscopy From animals assigned 
to group 5 another urine sample was collected after 
14 days, just before the kidneys were taken for im­
munofluorescence and light microscopy Urinary al­
bumin content was measured by a radial immunod­
iffusion technique as d e s c r i b e d 2 3 Physiological 
albuminuria was determined by measuring albumin­
uria in 50 BALB/c mice The upper level was defined 
as the mean albuminuria plus twice the standard de­
viation 
In a separate experiment animals were divided into 
5 groups in exactly the same way as described above 
( η = 24 per group) The kidneys of these animals were 
flushed with iron oxide (Fe 3 0 4 ) for the isolation of glo­
meruli2" (see below) 
Histology 
For light microscopy tissue fragments fixed in Bouin's 
solution were dehydrated and embedded in para-
plast (Amstelstad B V , Amsterdam. The Nether­
lands) Four-micron sections were stained with peri­
odic acid-Schiff and silver methenamme 2 3 
Immunofluorescence was performed on 2-μ cryo­
stat sections of all kidneys to study deposition of 
mouse Ig and staining of ECM components Depo­
sition of mouse Ig was studied in direct immunofluo­
rescence by incubating the sections with FITC-
labeled F(ab)? sheep anti-mouse Ig (Cappel, 
Organon Technika NV Turnhout Belgium) 10 mg/ml 
diluted 1 750 in PBS containing 1 % (w/v) BSA 
The presence of HS was examined by incubating 
the sections with a biotinylated (1 mg/ml)2 5 mouse 
anti-rat HS MAb that only recognizes HS in basement 
membranes (JM-403,26) The sections were first 
treated with an avidm-biotm blocking kit (Vector Labo­
ratories Ine , Burlingame, CA) before they were incu­
bated with the biotinylated JM-403 MAb in a dilution 
of 1 60 FITC-labeled streptavidm (Extravidin, Sigma, 
St Louis, MO) 1 5 mg/ml diluted 1 400 was used to 
develop the sections The sections were stained in 
indirect immunofluorescence with a goat anti-human 
HSPG-core antiserum prepared in our laboratory,27 
diluted 1 200 FITC-labeled rabbit anti-goat Ig (de 
Beer Med BV, Hilvarenbeek, The Netherlands), 16 
mg/ml diluted 1 500 was used as a secondary anti­
body The sections were also stained with a rabbit 
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anti-EHS laminin antiserum (diluted 1 400, prepared 
in our laboratory) followed by FITC-labeled mouse 
anti-rabbit Ig, which was affinity purified and preab-
sorbed for human mouse, goat and sheep Ig (Jack­
son Laboratories Ine West Grove, PA) 1 mg/ml di­
luted 1 40 as secondary antibody The anti-rat and 
anti-human ECM antibodies used in these studies all 
cross-reacted with mouse constituents in immuno­
fluorescence 
After the staining procedure, the sections were em­
bedded in aquamount (BDH Ltd Poole, UK) and ex­
amined with a Zeiss fluorescence microscope 
Blinded sections were examined by three indepen­
dent investigators The intensity of the staining in the 
capillary loops and the mesangium was scored semi-
quantitatively on a 0 to 4+ scale in at least 30 glo­
meruli per mouse kidney The 0 to 4 scale was defined 
as follows For staining of ECM components in cap­
illary loops no staining at all was scored 0 staining 
of 25% of all capillary loops and/or 75% decrease of 
staining intensity (as compared with a normal BALB/c 
glomerulus) was scored 1, staining of 50% of all cap­
illary loops and/or 50% decrease of staining intensity 
was scored 2, staining of 75% of all capillary loops 
and/or 25% decrease of staining intensity was scored 
3. and normal staining of all capillary loops was 
scored 4 For staining of ECM in the mesangium not 
the intensity but the amount of mesangial staining was 
scored, since staining intensity of ECM components 
in the mesangium in all animals was equal No stain­
ing at all was scored 0, mild staining was scored 1, 
moderate staining was scored 2, strong staining was 
scored 3 and severe staining was scored 4 For stain­
ing of IgG in capillary loops and mesangium, both the 
amount and intensity of staining were scored No 
staining at all was scored 0 mild staining was scored 
1, moderate staining was scored 2, strong staining 
was scored 3, and severe staining was scored 4 
Elution Studies 
Attempts to elute Ig from sections were made To this 
end sections were incubated with pepsin (Sigma) 10 
μg/ml in 0 1 mol/L acetate pH 4 5 2 a , 0 12 mol/L 
glycme-NaOH, pH 122 9. 0 12 mol/L glycme-HCI, pH 
2 β2 9, 0 1 mol/L Tris (hydroxymethyl) ammomethane, 
pH 11 5. heparin (Organon, Oss, The Netherlands) 5 
mg/ml in PBS3 0 and 2 mol/L NaCI for 1 hour at 37 C 3 0 
and 0 1 mol/L glycine, 6 mol/L urea pH 3 5 for 1 hour 
at 4 С 3 ' Next the sections were stained for mouse Ig 
or for HS as described above When this procedure 
failed to remove Ig from the section, the procedure 
was repeated overnight at 37 С To study the effect of 
these different elution procedures on HS also kidney 
sections of young 12-week-old non-albuminunc 
MRL/I mice and Θ- week-old BALB/c mice were 
treated similarly 
Measurement of HS in Glomeruli 
The isolation of glomeruli was performed as de­
scribed before 2 a All steps were carried out in the 
presence of protease inhibitors (1 mmol/L phenylm-
ethylsulfonylfluonde, 0 05% NaN3, 20 mmol/L EDTA, 
and 100 Kl units Trasylol) The obtained material con­
sisted of more than 95% glomeruli The number of 
glomeruli isolated were assessed by counting in trip­
licate in a hemocytometer Next, the glomeruli were 
spun down and treated with 1 mg papain (from pa­
paya latex, Sigma) in 1 ml 0 05 mol/L Na-acetate, 2 
mol/L NaCI. 10 mmol/L cysteme-HCI (pH 5 7) over­
night at 55 С to isolate the glycosaminoglycans 
(GAGs) Protein was precipitated using trichloroace­
tic acid in a final concentration of 5% (w/v), and after 
centnfugation 10% (v/v) 3 mol/L Na-acetate solution 
was added GAGs were precipitated by adding cold 
ethanol (-80 С for 30 minutes), spun down, and dried 
The isolated GAGs were tested by agarose electro­
phoresis on a 1% (w/v) agarose gel with 50 mmol/L 
Ba-acetate, pH 5 0, as electrophoresis bufferЭ 2 A 
mixture of HS (20 ng/ml) dermatan sulfate ( 10 ng/ml), 
and chondroitm sulfate (10 ng/ml) was used as 
marker The GAGs on the gel were stained with 
A g N 0 3 
Furthermore, HS isolated from glomeruli was meas­
ured in an inhibition ELISA (submitted for publication) 
In brief, Nunc-immuno plates (Maxisorp F96, GIBCO 
BRL, Paisley UK) were coated with HS (Seikagagu 
Kogyo Ltd Tokyo, Japan) 50 μg/ml in PBS overnight 
at room temperature Plates were blocked with PBS 
containing 1% (w/v) gelatin, 150 μΙ/well for 2 hours at 
37 С A constant amount of MAb JM-403 giving 50% 
of the maximal ELISA signal, was added to a serially 
diluted sample of the glomerular digest in PBS/1% 
gelatin and incubated for 1 hour at 37 С Thereafter, 
this mixture was added to the HS-coated plates (100 
μΙ/well) and incubated for 1 hour at 37 С After wash­
ing the plates a peroxidase-labeled goat anti-mouse 
IgM antiserum (Southern, Birmingham, AL) was 
added, diluted 1 1000 in PBS containing 0 05% 
Tween 20, 100 μΙ/well The plates were washed again 
and 3,5 3'.5'-tetrarnethylbenzidine (Merck, Darm­
stadt, Germany) 100 мд/ті in 0 11 mol/L sodium ac­
etate (pH 5 5) containing 0 003% H 2 0 2 was added, 
100 μΙ/well The color development was stopped by 
adding 100 μΙ 2 mol/L H 2 S0 4 per well after 15 minutes 
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and the OD al 450 nm was measured in a Titertek 
multiscan Inhibition was calculated according to the 
following formula [1 - (A450 + mhibitor/A450 - in­
hibitor)] χ 100% Then the 50% inhibition point was 
assessed and compared with a standard curve 
Inhibition of Binding of the Anti-HS MAb 
JM-403 to HS in ELISA by Nucleosomes 
and Immune Complexes 
Whether nucleosomes or immune complexes con 
taming nucleosomal antigens were able to inhibit the 
binding of the anti-HS MAb to HS was evaluated in 
ELISA After coating and blocking Nunc plates as de­
scribed above plates were incubated for 1 hour at 
room temperature with a serial dilution of nucleo­
somes purified non-complexed anti-nucleosome 
MAbs and anti-nucleosome MAbs complexed to nu­
cleosomal particles as described 2 2 After washing 
the plates a constant amount of MAb JM-403 giving 
50% of the maximal absorption signal was added for 
1 hour at room temperature Next plates were de­
veloped as described above To control for nonspe 
cific inhibition the same preparations were tested for 
their ability to inhibit an anti-HSPG core MAb (Chemi-
con International Ine Veenendaal The Netherlands) 
to HSPG EHS-HSPG (Collaborative Biomedical Prod­
ucts Bedford MA) was coaled 50 pg/ml ΙΟΟμΙ/well 
in 0 05 mol/L carbonate buffer pH 9 6 to Nunc plates 
overnight at room temperature and the ELISA was 
further carried out as described for the anti-HS ELISA 
Statistical Analysis 
Statistical analysis was performed using the Mann-
Whitney Utest P < 0 05 (two sided) was considered 
to be statistically significant Spearman s correlation 
coefficient was used in linear regression analyses 
Results 
Albuminuria and Renal Histology 
The selection of animals for the different groups was 
based on a screening by Albustix This screening 
proved to be a good selection procedure for the al­
bumin excretion during 18 hours Non-albuminunc 
mice in groups 1 (12 weeks old) 2 (36 weeks old) and 
3 (1Θ-24 weeks old) did show a somewhat variable 
urinary albumin excretion that did not however ex­
ceed the upper level of the normal physiological al­
buminuria in mice (120 pg/18 hours) (Table 1) Mice 
Table 1 Albuminuria in \liceln = Hi 
Age Albuminuria 
Group (Median in Weeks) (Median in мд/18 Hours) 
1 
2 
3 
4 
5 
12 
36 
21 (18-24)' 
23(18-24) 
19(18-24) 
15(3-56)· 
53(27-120) 
52 (20-100) 
1 700(1 200-21 400) 
3 400(1 000-18 200) 
4 800(2 100-23 800)· 
"Range of albuminuria m parentheses 
'Age range m parentheses 
'Second measurement ol albuminuria which took place 2 
weeks after the lirsi 
of group 4 (short duration of albuminuria) and group 
5 (albuminuria for 2 to 3 weeks) did show a marked 
albuminuria that increased over time in group 5 ani­
mals 
Glomerular deposition of mouse Ig in all mice that 
did not show albuminuria (groups 1 2 and 3) was 
predominantly located in the mesangial areas and in­
creased with age In addition to increased mesangial 
Ig deposits mice with albuminuria showed also a sig­
nificant increase in Ig deposition along the glomerular 
capillary loops which was most pronounced in mice 
with prolonged albuminuria (Figures 1 and 2) 
Expansion of mesangial matrix as assessed by 
light microscopy was seen in all groups of mice when 
compared with young (12-week-old) mice This ex­
pansion was most marked in mice with prolonged al­
buminuria although it was also seen in mice with re­
cent onset of albuminuria and to a lesser extent, in 
age-matched non-albuminunc mice Together with 
this mesangial expansion we found an increase in 
mesangial staining for the ECM components HSPG-
core protein (Figure 4) and lammin (not shown) The 
anti-HS MAb JM-403 did not reveal HS in the mesan-
gium but only recognized HS in the GBM When stain­
ing (or ECM components was scored in the capillary 
loops it was found that HSPG-core protein and lami-
nm (Figures 3 and 4) were equally detected in all 
groups In contrast HS staining was markedly de­
creased in the capillary loops of glomeruli of mice with 
prolonged albuminuria (group 5) compared with 
young 12-week-old mice (group 1) and non-
albuminunc age-matched controls (group 3) In mice 
with short duration of albuminuria (group 4) there was 
a tendency toward a decrease in HS staining that, 
however did not reach statistical significance (P = 
0 06) (Figures 3 and 4) 
There was an inverse correlation between HS stain­
ing and albuminuria (rs = - 0 55 Ρ < 0 001) (Figure 
5) and between HS staining and deposits of Ig 
located along the capillary loops (r s = - 0 74 Ρ < 
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Figure 1. Deposition oj Ig in glomerular capillary· loops and mesangium tn glomeruli of mice m the five groups scored semiquantitative^ in im-
munofluorescence on a O lo 4+ scale Deposition of Ig is observed in all groups Ig deposits in glomerular capillary loops were only significantly 
increased tn albuminuric micei groups 4 and 5) Older mice (groups 2-51 show an increase of mesangtal lg deposits üben compared uilb young 
12-ηψ€^οΙά mice Bars represent medians witb interquartile ranges • Group I 12 weeks, no albuminuria Щ Group 2 36 weeks, no albumin 
una О Group 3 18-24 weeks, no albuminuria Ш Group ч 18-24 weeks, recent albuminuria • Group 5 18-24 weeks, prolonged albuminuria 
' = Ρ < 0 05 versus group 1. § = P< 0.05 versus group 2 Ц = Ρ < 0.05 versus group 3 
0.0001 ) (Figure 6) Ig deposits in glomerular capillary 
loops and albuminuria were also correlated {rs = 
0.67. P < 0 001). 
Elution Studies 
Because the above-mentioned data suggested that 
HS was masked by Ig. we tried to elute Ig from the 
sections to restore the HS staining in the GBM. After 
elution using heparin or 2 mol/L NaCI. there was no 
effect or only a slight effect on Ig depositions. After 
elution using glyclne-HCI. pH 2.8. Ig depositions 
were partly removed However, on a normal mouse 
kidney section, HS was partly degraded, leading to 
reduction of HS staining All other elution procedures 
mentioned in Materials and Methods led to complete 
removal of Ig deposits. However, they induced a total 
loss of HS staining on normal kidney sections. Taken 
together, no elution procedure led to total removal of 
Ig, while leaving HS intact. 
Measurement of Glomerular HS Content 
Glomeruli were isolated and pooled for each group 
From an equal amount of glomeruli the GAGs were 
extracted and analyzed on agarose gel electrophore­
sis. Despite the almost complete disappearance of 
HS staining in mice with prolonged albuminuria, we 
found comparable amounts of HS and. although to 
lesser extent, equal amounts of dermatan and chon-
droitin sulfate in glomeruli of mice from all groups (Fig­
ure 7). When HS from the GBM was measured more 
quantitatively in an inhibition ELISA using the antl-HS 
MAb JM-403. the HS content did also not markedly 
differ in any of the groups examined (Table 2) 
In Vitro ELISA Studies 
To elucidate in more detail potential mechanisms for 
the decrease in HS staining in the GBM, we analyzed 
whether nucleosomes, pure non-complexed mono-
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Figure 2 Represenlattiv examples of the immunofluorescence foldings, shotting deposition ofjg iti glomeruli of non-albumtnurtc age-matcbed 
control mlcei group .£ Αι. mice with short duration ofalbuminuria ι цг<>н/> ч B> and тис with prolonged albuminuria ( цптр 5 Ci Vi hik- mia· 
of group и At onh sbou a tnesanglal pattern oj Iti deposition a gradually concomitant increase of deposition of Ig in the glomerular capillar* 
loops и и* demonstrated in the albuminuric groups -t and 5 ι В and С ι most prominent m the group <<f mici' with prolonged albuminuria (A χ 
ЫН1 Β Χ 600. С X 700) 
clonal anti-nuclear antibodies or monoclonal anti-
nuclear antibodies complexed to nucleosomal par­
ticles (described in ref 22) could inhibit the binding 
of JM-403 to HS in ELISA. As shown in Figure 8. im­
mune complexes and nucleosomes were able to In­
hibit dose-dependently this binding, whereas the 
pure, non-complexed monoclonal anti-nuclear anti­
body did not inhibit. In contrast nucleosomes or im­
mune complexes were not able to inhibit the binding 
of an anti-HSPG MAb to HSPG 
Discussion 
Alterations of GBM-HS have been observed in various 
glomerular diseases with albuminuria18 such as dia­
betic nephropathy3 3 3 7 membranous glomerulone­
phritis.3 8 and SLE 1 S 3 9 In SLE it has been suggested 
that the binding to the GBM of HS-reactive antibodies 
or immune complexes initiates renal disease.5 7P0 
and it has been found that anti-HS reactivity is asso­
ciated with renal disease in human SLE.40~4? Re­
cently we reported that in the majority of biopsies of 
patients with lupus nephritis. HS staining in the glo­
merular capillary loops was completely negative, 
whereas staining for the HSPG-core protein was still 
intact 1 8 On the other hand, the relationship between 
albuminuria and HS staining is not unequivocal, since 
in patients with IgA nephropathy and Alports syn­
drome and a marked albuminuria, we found a normal 
staining for GBM-HS.18 
We studied the relationship between HS staining 
and albuminuria in lupus-prone MRL/I mice with dif­
ferent stages of renal disease When we examined 
deposition of Ig in these groups of mice we observed 
that a significant increase of mesangial Ig deposition 
in mice with increasing age. compared with young 
mice 12 weeks of age, was not related to increased 
glomerular permeability for proteins When the Ig de­
posits were located in glomerular capillary loops a 
correlation was found with albuminuria. These find­
ings suggest that deposition of Ig in the glomerular 
capillary loops is causally related to the development 
of albuminuria Linear regression analysis revealed a 
strong correlation between these two parameters 
Both the extent of Ig deposits in the capillary loops 
and the albuminuria were correlated with a decreased 
staining of GBM-HS. while the staining for HSPG-core 
protein and laminiti was not altered in all groups stud­
ied This means that in mice with prolonged albumin­
uria, the expression or the accessibility of the HS side 
chain is diminished, while this is unaltered for its car­
rier protein (HSPG-core protein) These findings are in 
line with a recent report in which administration of 
polyclonal rabbit anti-HSPG antibodies (reactive with 
the core protein, but not with the side chain) in NZB/W 
mice did not competitively inhibit the binding of au­
toantibodies to HS in the GBM. 4 3 The negative cor­
relation between GBM-HS and albuminuria in our 
study suggests that the neutralization of HS related 
anionic sites is related to albuminuria in lupus nephri­
tis. The negative correlation between GBM-HS stain­
ing and capillary loop Ig deposition suggests that the 
blocking of the negative charge in the GBM was 
caused by the deposition of immune complexes in the 
capillary loops Although a correlation does not prove 
a cause and effect, this hypothesis is in line with an 
earlier report which stated that treatment of lupus 
mice with corticosteroids decreased the localization 
of immunoreactants in the GBM 4 4 This treatment pre­
served the presence of anionic sites within the GBM, 
linking, as we found, the status of anionic sites to the 
magnitude of GBM deposition The assumption that 
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Figure 3. Staining of HS, HSPG-core protein, and lamtntn m the capillari ¡чар!, of glomeruli of mice in the different groups scored semlquantita· 
lively in immunofluorescence on a 0 to 4+ scale Staining of US is markedly decreased in mice и ith prolonged albuminuria I group 5) and there 
is a tendency toward a decrease in mice with recent albuminuria ( group 4Ì. whereas staining of HSPG-core protein and lamtntn is unaltered in 
all groups Bars represent medians with interquartile ranges • Croup 1 12 weeks no albuminuria Ш Group 2 ,36 weeks no albuminuria О 
Group Í IH-24 weeks no albuminuria Ш Group ι lH-2-i weeks, recent albuminuria G Group 5 18-24 ueeks. prolonged albuminuria *—P< 
0.05 versus group 1.¡ = P< 0.05 versus group 2 Ц = P< 0 05 versus group .5 # = P< 0 05 versus group 4 
HS associated anionic sites are covered by immu-
noreactants was confirmed by the finding that the 
glomerular content of HS was unchanged in all ex­
perimental groups as assessed by agarose electro­
phoresis and quantitative HS inhibition ELISA. Experi­
ments which attempted to elute the Ig and uncover HS 
failed because no elution procedure was capable of 
eluting all deposited Ig while leaving HS intact. Re­
moval of Ig is only possible by procedures which also 
destroy HS However, we were able to "uncover" HS 
in vitro, since papain digestion of isolated glomeruli 
lead to HS which could be shown in the inhibition 
ELISA and in agarose electrophoresis 
These experiments indicate that HS is still present 
in the GBM but that its accessibility for the anti-HS 
MAb is masked by immune complexes occurring dur­
ing this disease For lupus nephritis, a decrease of the 
net negative charge of the GBM due to the binding of 
cationic proteins or immune complexes has been 
suggested before In this respect, deposition of neu­
trophil4 5 or platelet-derived cationic proteins3 0 has 
been mentioned Also the disappearance of anionic 
sites, as a consequence of immune complex depo­
sition, has been described in lupus nephritis. In 
NZB/W mice it was shown that a decrease in anionic 
sites preceded the deposition of immune complexes 
In the glomerular capillary wall.4 6 In another study in 
NZB/W mice, it has been shown that deposition of 
immune complexes in the GBM is associated with 
loss and/or redistribution of fixed anionic sites in 
areas of increased permeability to anionic protein 3 9 
We also studied albuminuric and non-albuminuric 
NZB/W and GVH mice and found also in these strains 
disappearance of HS staining in albuminuric mice 
(data not shown), showing that this phenomenon oc­
curs also in these models of lupus nephritis Theo­
retically, two mechanisms could explain the relation­
ship between decrease of HS associated anionic 
sites and albuminuria. First, the decrease itself could 
be instrumental in the development of albuminuria. 
Arguments in favor of this explanation are that binding 
of cationic molecules1 3 1 4 or of the anti-HS MAb JM-
403 4 7 to HS can induce albuminuria. Also our obser­
vation that reduction of HS staining was correlated to 
albuminuria in nonimmunological glomerular dis­
eases like diabetic nephropathy40 and adnamycin 
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Figure 4. Representante examples of the im­
munofluorescence findings of staining of 
HSPG-core protein til not ι-albuminurie age 
matched control mice (group .i. A), mice tetlh 
short duration of albuminuria {group -i. C). 
and mice tntb prolonged albuminuria {group 
5 Έ.) and staining of HS in these groups { group 
3 B; group 4. D; and group 5. F) Sole the 
slight increase of HSPG-core protein m the ex· 
f>anded mesutlgium musi abundant!) m mice 
with prolonged albuminuria (group 5 Ε) Λ 
linear staining m the capillar) loops for HSPG-
core is seen in all groups In contrast there Is a 
marked decrease in GB.M-HS staining m mice 
tilth prolonged albuminuria (group 5 Fl 
There is also some decrease in GBM-HS slam 
ing m mice uttb short duration of albuminuria 
I group 4. D) (A X 700. Β Χ 700, С Χ 800. D 
Χ 650. Ε Χ 600 F Χ 600) 
nephropathy4 9 supports this assumption An alterna­
tive explanation could be that the reduction of HS as­
sociated negative charges in the GBM facilitates fur­
ther deposition of immune complexes, which is then 
responsible for the ensuing albuminuria, as sug­
gested by the correlation between GBM Ig deposits 
and albuminuria. One should realize, however, that 
these mechanisms are not mutually exclusive and 
could act in concert 
Previously, we have shown that anti-nuclear anti­
bodies complexed to nucleosomal antigens are able 
to bind to HS in vitro™-22 and to the GBM in vivo2'1 22 
Nucleosomes are built up by histones and DNA and 
are present in nuclei of cells In these HS or GBM 
reactive immune complexes, it is assumed that the 
positively charged histones interact with high affinity 
with the negatively charged HS in the GBM. 5 0 The 
relevance of histones in lupus nephritis with albumin­
uria is further substantiated by the recent detection of 
histones in immune deposits of lupus mice with al­
buminuria, whereas in lupus mice of the same age 
without albuminuria, histones were seldom found 5 1 
Also, in biopsies of patients with lupus nephritis, his­
tones have been identified in the deposits along the 
capillary wall.5 2 In the study described in this paper, 
we show that nucleosomes and MAbs complexed to 
nucleosomal particles are able to inhibit the binding 
of the anti-HS MAb JM-403 to HS in ELISA whereas 
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Group 
albuminuria Ιμς 18 hours' 
Figure 5. Correlation betueen GBM-HS staining and albuminuria 
Figure 6. Correlation between СИМ-HS staining and Ig deposits ¡ 
tbe glomerular capillari' loops 
1 2 3 4 5 6 
Figure 7. Agarose gel electrophoresis of glycosamtnoglycans ex-
tracted from glomeruli of tbe fit e groups of mice studied Lane 1 : 
markers HSÍ20 ng). dermatcin sulfate(DS. 10 ng) and chondroma 
sulfate ICS 10 ug) GAGS isolated from young 12-ueek-old mice 
(lane 2). from 36-iceek-old non-albuminunc mice (lane 3). from 
age-matched non-albtiminunc controls (lane 4). from mice with 
short duration of albuminuria < lane 51 from mice tilth prolonged al-
buminuria (lane 6). 
purified non-complexed MAb did not In previous 
studies we showed that histones are also able to In-
hibit this binding 5 3 This suggests that the histone part 
within the nucleosome interacts with HS. 
In conclusion we found in murine lupus that albu-
minuria is associated with a progressive loss of 
GBM-HS staining The decrease of HS staining is cor-
related with the increase of GBM-lg deposition. Our 
HS (pg/glomerulus) 
124 
171 
152 
140 
112 
0.7 1.5 3 6 12 25 50 100 
concentration Ojqltciïï 
Figure 8. Inhibition of binding of the anti-HS MAbJM-403 to HS and 
of an antl-HSPG MAb to HSPC in ELISA by nucleosomes. purified 
non-complexed anti-nucleosome MAbs, and anti-nucleosome MAbs 
complexed to nucleosomal particles Binding of/M-403 was inhibited 
dose-dependentlr by nucleosomes ( + I and MAbs complexed lo nu-
cleosomal particles ( • I but not b\ purified non-complexed MAbs ( • ) . 
In contrast neither nucleosomes nor immune complexes could inhibit 
the binding of an antt-HSPG MAb to HSPGtO). 
in vitro studies suggest that HS may be masked by 
histone-containing immune deposits 
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ABSTRACT 
Monoclonal anti-nuclear antibodies which are complexed to nucleosomes, are able to bind 
to the glomerular basement membrane (GBM) in vivo, whereas purified antibodies do not 
bind The positively charged histone moieties in the nucleosome are responsible for the 
binding to anionic determinants in the GBM In this study we have tested the hypothesis that 
the specificity of the autoantibodies complexed to the nucleosome influences the glomerular 
binding of the antibody-nucleosome complex It was expected that, by binding to the histone 
part of the nucleosome, anti-histone antibodies would decrease the ability of histones to 
interact with the GBM, whereas anti-dsDNA and anti-nucleosome would increase the GBM 
binding of the complex by binding to anionic determinants within the nucleosome We 
induced the formation of immune complexes in vivo, by intraperitoneal inoculation of 
hybndomas producing monoclonal anti-nuclear antibodies (4 anti-histone, 3 anti-dsDNA and 
3 anti-nucleosome antibodies) into nude BALB/c mice In ascites and plasma from the mice 
inoculated with these hybndomas, nucleosome/autoantibody complexes were detected in 
comparable amounts Immunofluorescence of kidney sections revealed that about 60% of the 
mice inoculated with anti-nucleosome or anti-dsDNA hybndomas had Ig deposits in the 
GBM, whereas only 15% of the mice with anti-histone hybndomas showed these deposits 
(p<0 04) In a Matngel'-ELISA (used as a GBM surrogate) ascites of mice inoculated with 
anti-nucleosome or anti-dsDNA hybndomas displayed significantly higher titers (p <0 002) 
than ascites of mice inoculated with anti-histone hybndomas The in vivo GBM binding 
correlated with the anti-Matngel* reactivity in ascites (R,=0 63, p < 0 0001) while the 
Matngel reactivity in ascites containing anti-dsDNA and anti-nucleosome auto-antibodies 
correlated significantly (Rs=0 51, p=0 005) with the amount of nucleosome/Ig complexes 
in contrast to ascites containing anti-histone autoantibodies In conclusion, nucleosome/Ig 
complexes comprising anti-nucleosome or anti-dsDNA auto-antibodies do bind more 
frequently to the GBM in vivo than nucleosome/Ig complexes containing anti-histone 
antibodies It therefore appears that the specificity of the antibody bound to the nucleosome 
is a critical determinant for the nephntogenic potential of the nucleosome-autoantibody 
complex 
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INTRODUCTION 
Systemic lupus erythematosus (SLE) is a disease characterized by the presence of 
autoantibodies which react with nuclear antigens ' 2 . In recent years it has become clear that 
the nucleosome is an important auto-antigen in SLE 3 4 Recently, nucleosome specific Τ 
helper cells were identified in lupus mice5, which not only induced nucleosome specific auto­
antibodies but also anti-dsDNA and anti-histone antibodies. These findings together with the 
observation that the production of nucleosome specific antibodies precedes the appearance 
of anti-dsDNA and anti-histone antibodies both in murine 6 and human 7 lupus, led to the 
suggestion that loss of tolerance for nucleosomes is an early key event in the evolution of 
lupus 
Nucleosomes are not only important in the induction phase of lupus but also for the evolution 
of tissue lesions, especially glomerulonephritis. Classically, it was thought that glomerular 
lesions in SLE are secondary to the deposition of DNA/anti-dsDNA immune complexes in 
the glomerulus. However, crucial pieces of evidence to support this hypothesis are lacking 
8
 The observation that DNA circulates in SLE patients in the form of oligo-nucleosomes 9 1 0 
and that nucleosome specific antibodies are formed in the majority of SLE patients " 13 
suggested that formation of nucleosome anti-nucleosome complexes might be an alternative 
explanation for the pathogenesis of lupus nephritis. In renal perfusion studies we could indeed 
show that these complexes bind to the GBM via an interaction of canonic histone moieties 
within the nucleosome to anionic heparan sulfate (HS) in the GBM 14 '5 From these renal 
perfusion experiments we also learned that a relative decrease of DNA or a relative increase 
in histone content within the nucleosome could increase the capacity of the 
nucleosome/autoantibody complex to bind to HS in the GBM '5 Apparently, the presence of 
the N-terminal regions of the core histones carrying many positive charges is a critical 
determinant for this binding. These N-terminal regions harbor the epitopes for histone 
specific autoantibodies 1 6 1 7 We reasoned that binding of anti-histone antibodies to these N-
terminal regions would decrease the capacity of the nucleosome-antibody complex to bind 
to the GBM, whereas DNA and nucleosome specific autoantibodies would relatively spare 
these N-terminal regions. 
To test this hypothesis, we compared the glomerular binding of 3 different nucleosome, 4 
histone and 3 dsDNA specific monoclonal antibodies To this end, we inoculated hybndomas 
producing the different monoclonal anti-nuclear antibodies intrapentoneally in nude BALB/c 
mice since this procedure will induce nucleosome/Ig complex formation in vivo 18. In purified 
form, none of these monoclonal antibodies were able to bind to the GBM in vivo after renal 
perfusion 
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METHODS 
Animals 
BALB/c nu/nu and Wistar rats were bred in the animal facilities of the University of 
Nijmegen 
Renal perfusion of purified anti-nuclear antibodies 
Non-complexed anti-histone, anti-dsDNA and anti-nucleosome mAbs were obtained by 
purification under high salt conditions preceded by a DNase treatment as previously described 
15
 For the renal perfusion studies male Wistar rats (130 gram) were used according to a 
perfusion procedure described previously '"1 5 After perfusion, kidneys were taken out for 
direct immunofluorescence and stained for the presence of the perfused mAb using specific 
anti-mouse antibodies (Southern Biotechnology Associates Ine , Birmingham, USA) 
Isoelectric focussing (IEF) of purified anti-nuclear antibodies. 
IEF was carried out in a Phast system separation unit (pH range of the gels 3-9) according 
to the manufacturers instructions (Pharmacia, LKB, Uppsala, Sweden) An IEF calibration 
kit (Pharmacia, LKB, Uppsala, Sweden), range pH 3-10, was used as a marker 
Inoculation of anti-nuclear hybridomas in nude BALB/c mice. 
The anti-nuclear hybridomas that we used are listed in Table I MAbs #2, #32 and #34 are 
anti-nucleosome specific hybridomas 15 MAb #2 was obtained by fusion of spleen cells from 
a GVH mouse and mAbs #32 and #34 from NZB/W mice MAbs #36, #53 and #56 are anti-
dsDNA hybridomas obtained from NZB/W mice " MAbs KM2, LG2-1, LG2-2and MRA 12 
are anti-histone hybridomas obtained from MRL/lpr mice The anti-histone hybridomas KM2, 
LG2-1 and LG2-2 are directed against determinants located in the basic ammo-terminal 
domain of the core histones (16 and Table I) MRA 12 recognizes a conformational 
determinant of the HI molecule requiring both the globular and carboxy-terminal domains 
20
 '' As a control an IgG2a anti-human CD7 antibody (WT1) was used 
Seven week-old BALB/c nu/nu mice received 0 5 ml sterile pnstane (4,6,10 14-
tetramethylpentadecane, Sigma, Poole, Dorset) 10 days prior to intraperitoneal (ι ρ ) injection 
of hybndoma cells Hybridoma cells producing the monoclonal antibodies were harvested 
from midlog phase cultures and resuspended in 0 5 ml PBS to a total cell number of 3xl06 
Five or seven mice were used for each antibody As controls six mice received hybndoma 
cells secreting an IgG2a anti-human CD7 and four mice pnstane alone When mice developed 
visible tumor growth and/or ascites, ascites and plasma were collected for determination of 
antibody levels, anti-nuclear reactivity and the amount of nucleosome/Ig complexes Only 
those animals that developed both visible ascites (and tumors) and anti-nuclear Ab reactivity 
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were subjected to further examination. Although the time required to develop ascites varied, 
mice were always sacrificed three to five days after the onset of visible ascites. The mean 
time between intraperitoneal inoculation and histological analysis is given in Table 2 and was 
not significantly different among the various hybridomas. 
Determination of immunoglobulin concentration in ascites and plasma 
Immunoglobulin (Ig) concentrations were determined in an ELISA for which Nunc-immuno 
plates (maxisorp F96; GIBCO BRL,) were coated overnight with goat anti-mouse Ig (Sigma 
Chemical Co., St. Louis, MO) diluted 1/80 in PBS, ΙΟΟμΙ per well. Plates were washed with 
PBS containing 0.05% (vol/vol) Tween 20 and blocked with PBS containing 1% wt/vol 
gelatin for 2 h at 37°C. Samples were serially diluted in PBS/1% gelatin and incubated for 
1 h. Next, plates were washed again and 100 μΐ of peroxidase conjugated goat anti-mouse 
IgG2a (when plasma/ascites was tested of mice inoculated with hybridomas LG2-1, LG2-2, 
MRA 12, KM2, #36, #56, #32 and #34) or peroxidase conjugated goat anti-mouse IgG2b 
(when plasma/ascites was tested of mice inoculated with hybridomas #53 or #2) (Southern 
Biotechnology Assoc. Inc., Birmingham, AL) diluted 1/750 in PBS/1% gelatin were added 
per well. After 1 hour incubation the plates were washed and developed with 3, 5, 3', 5'-
tetramethylbenzidine (Merck), 100^g/ml in 0.11 M sodium acetate, pH 5.5, containing 
0.003% H,02. By adding 2 M H,S04, ΙΟΟμΙ/well, color development was stopped after 15 
minutes and OD at 450nm was measured. IgG2a and IgG2b myeloma proteins (Cappel, 
Turnhout, Belgium) were used as standards. 
Antibody-reactivities in plasma and ascites. 
Anti-histone, anti-dsDNA and anti-nucleosome reactivities were assessed in ELISA, as 
described previously 15. 
Anti-matrigel® ELISA 
Matrigel®, which is a solubilized basement membrane preparation extracted from the mouse 
Englebreth-Holm-Swarm (EHS) tumor (Beckton and Dickinson, Bedford, MA), was used as 
a "GBM surrogate". It consists of the GBM components laminin, entactin, collagen IV and 
heparan sulphate proteoglycan. Matrigel was first treated with DNase (DNase grade II, 
Boehnnger, Mannheim, Germany) to remove DNA contamination and was coated to Greiner 
plates (Greiner, Frickenhausen, Germany) at 1 μg in 100 μΙ PBS per well overnight at room 
temperature. After washing the plates 5 times with PBS containing 0.1% Tween-20, plates 
were blocked with 10 mM TRIS/HC1 pH 7.4 containing 5% (wt/vol) bovine serum albumin 
(BSA), 150 μΐ/well, for 1 hour at 37°C. Next, samples were diluted in PBS containing 1% 
(wt/vol) BSA, 100 μΐ per well for I hour at 37°C. Plates were washed again 5 times and 
incubated with peroxidase labeled rat mAb anti-mouse Ig (CLB-RM-19, CLB, Amsterdam, 
68 
Chapter 6 
the Netherlands) diluted 1/1000 in PBS 100 μ\ per well. Further procedures were identical 
to the anti-nuclear ELISAs described in 1S. Purified anti-dsDNA, anti-histone and anti-
nucleosome antibodies did not bind to DNase treated Matrigel®, whereas antibodies specific 
for laminin, entactin, collagen IV, HS-glycosaminoglycan (GAG) or HSPG core protein 
showed high reactivity (data not shown). 
Nucleosome/IgG complex assay 
The nucleosome/IgG complex assay was performed as previously described '8. Briefly, 
microtiter plates (NUNC) were coated overnight at 4°C with 50 μΐ of 5 /ig/ml Protein A/G 
(Pharmacia,) in 0.1 M pH 9.6 carbonate buffer. In all subsequent steps, sample volume was 
50 μΐ, washing solution was PBS containing 0.1 % Tween-20 and incubations were performed 
at 30°C. After two washes, plasma samples or ascites samples were diluted (1/20 or 1/250 
resp.) in PBS, containing 0.3 M NaCl and 0.1% bovine serum albumin (Bayer, Germany) 
and incubated in serial dilutions for 30 min. Furthermore, plasma/ascites samples were 
diluted (in a concentration that gave 50% of the maximal absorption) in PBS with varying 
molarity ranging from 0.3 to 2 M NaCl, in order to test differences in binding 
characteristics. After two washes, a nick translation mixture, containing biotinylated 14dATP 
(Gibco-BRL, Life Technology) and cold dCTP/dGTP/dTTP (Boehrmger, Mannheim, 
Germany), was added for an incubation of 1 hour. (When DNA polymerase was absent from 
the nick translation mixture, signals were in the background range). After three washes, 
peroxidase conjugated streptavidin (GIBCO-BRL,) diluted 1/1000 in PBS containing 0.1% 
casein was added for an incubation of 15 min. After 5 washes plates were developed with 
3, 5, 3', 5'-tetramethylbenzidine (Merck), 100μg/ml in 0.11 M sodium acetate, pH 5.5, 
containing 0.003% H202. By adding 2 M H2S04, 50pl/well, color development was stopped 
after 15 minutes and OD at 450nm was measured. 
In addition the nucleosome/IgG complex assay was performed as described above but instead 
of development with DNA specific probes (biotinylated nucleotides), biotinylated anti-histone 
mAb KM2 was used allowing identification of the nucleosome/IgG complexes via their 
histone part. Ascites samples were diluted 1/20 instead of 1/250 since the assay using 
biotinylated anti-histone mAb was less sensitive than the assay using biotinylated nucleotides. 
Characterization of DNA in plasma and ascites 
DNA was extracted from plasma and ascites samples using phenol saturated with 0.1 M Tris 
(pH 8). (2 volumes of the ascites/plasma sample + 1 volume phenol). After centrifugation 
1 μ\ of glycogen (Appligene, Illkirch, France) and 1 ml of cold (- 20CC) absolute ethanol 
(Merck) were added to the supernatant. After centrifugation at 2500 g for 30 min at 4°C 
supernatant was discarded and 1 ml of 75% (v/v) cold (-20°C) ethanol was added. After 
another centrifugation at 2500 g for 20 min the supernatant was discarded again and the 
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remaining ethanol was evaporated for 15 min under centrifugation and vacuum using a Speed 
Vac Concentrator. Precipitated DNA was recovered by adding 15 μ\ of bidistilled water 
previously heated to 56°C. For DNA quantification, a DNA-assay, performed as described 
previously "*•", was used. DNA concentrations were determined by reference to standard 
curves constructed from pBR 322 DNA. Electrophoresis of DNA was carried out in 1.5% 
agarose gels in 40 mM Tris/acetate buffer pH 8 containing 1 mM EDTA. Gels were stained 
with ethidium bromide (l/ig/ml). A 100 bp ladder (Pharmacia, Uppsala, Sweden) was used 
as a size marker. 
Characterization of nucleosome/Ig complexes 
For identification of DNA and histones in the nucleosome/Ig complexes, plasma/ascites 
samples were mixed with Protein A Sepharose beads (Pharmacia, Uppsala, Sweden) for 30 
min. After centrifugation, the beads were washed twice with PBS. DNA was isolated by 
phenol extraction (as described above). 
The presence of histones in the nucleosome/Ig complexes which were bound to the Protein 
A Sepharose beads was determined by SDS-PAGE (12%) analysis followed by double silver 
staining 15. 
Immunohistology 
Cryostat sections of the kidneys of 2μΐη were stained in direct immunofluorescence (IF) for 
IgG deposits. Deposition of mouse IgG2a was studied by incubating sections with FITC 
labeled F(ab)2 goat anti-mouse IgG2a (Southern) lmg/ml diluted 1:80 in PBS containing 1 % 
(w/v) BSA (PBS/BSA) for 30 min at room temperature. Deposits of mouse IgG2b were 
studied by incubating sections with FITC labeled F(ab), goat anti-mouse IgG2b (Southern) 
lmg/ml diluted 1:80 in PBS/BSA. After the staining procedure, the sections were embedded 
in Aquamount (BDH Ltd. Poole, UK) and examined with a Zeiss fluorescence microscope. 
Coded sections of the kidneys were analyzed by two different observers. Both the amount 
and intensity of the staining of IgG2a/2b in capillary loops and mesangium were scored. No 
staining at all was scored as 0; moderate staining was scored as 1; and strong staining was 
scored as 2. 
Statistical analysis 
Statistical analysis was performed using the Fisher exact test and the Mann Whitney U test. 
Ρ < 0.05 was considered to be statistically significant. Spearman's correlation was used in 
linear regression analyses. 
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RESULTS 
Characteristics of the monoclonal anti-nuclear antibodies 
From a panel of hybridomas producing monoclonal anti-nuclear antibodies 4 anti-histone, 3 
anti-dsDNA and 3 anti-nucleosome specific hybridomas were selected. Purified m Abs of 
these hybridomas reacted strongly with histones, dsDNA or nucleosomes respectively. None 
of the purified antibodies bound to the glomerular basement membrane in vivo as assessed 
by renal perfusion studies using the purified non-complexed anti-histone (KM2, MRA12, 
LG2-2 and LG2-1), anti-dsDNA (#36, #53, and #56) or anti-nucleosome (#2, #32 and #34) 
antibodies. The characteristics of the selected hybridomas are listed in Table I. 
Isoelectric points of the purified anti-nuclear antibodies, were assessed by isoelectric 
focusing, pi's of all mAbs ranged from 5.8-7.4, except for mAb #34 which had a pi value 
of 7.0-8.0. 
Table I: Characteristics of anti-nuclear monoclonal antibodies used in this study 
Anti-histone 
Anti-dsDNA 
Anti-nucleosome 
MAb 
LG2-1 
LG2-2 
KM2 
MRA12 
#36 
#53 
#56 
#2 
#32 
#34 
Specificity 
30-45 H3 
1-13 H2B 
1-20 H2A; 1-29 H4 
HI 
dsDNA 
dsDNA 
dsDNA 
H2A-H2B/DNA 
H2A-H2B/DNA 
H3-H4/DNA 
Isotype 
IgG2a 
IgG2a 
IgG2a 
IgG2a 
IgG2a 
IgG2b 
IgG2a 
IgG2b 
IgG2a 
IgG2a 
Pi* 
6.5-6.9 
6.6-7.0 
5.8-6.2 
6.0-6.5 
6.8-7.4 
6.1-6.6 
6.4-6.8 
6.7-7.0 
6.2-6.9 
7.0-8.0 
' pl= isoelectric point 
Ascites development and antibody reactivity 
Thirteen (±3) days after the inoculation of hybridoma cells, the mice developed visible 
ascites with high immunoglobulin levels ( 1610± 1285 ^g/ml). Figure 1 shows the antibody 
reactivity against nuclear antigens in the different ascites samples. In control mice, inoculated 
with an lgG2a anti-CD7 hybridoma, no reactivity against nuclear antigens was found. 
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Figure 1. Reactivity in ELISA towards different nuclear antigens in ascites of mice inoculated with anti-dsDNA (#36, #53 and #56), anti-histone (KM2, LG2-I, LG2-2 
and MRA 12), anti-nucleosome (#2, #32 and #34) or control <anti-CD7) hybridoma. Nuclear antigens tested: histones (Π), DNA (Щ and nucleosomes (Ш). The titer in ELISA 
was defined as the reciprocal of the dilution giving an OD of 1.0 at 450 nm and expressed per mg of Ig. 
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Ascites produced by the anti-histone hybridomas contained high reactivity against histones 
but also against nucleosomes, because histones are present within nucleosomes. Regarding 
the anti-dsDNA hybridomas, anti-dsDNA and anti-nucleosome reactivity was detectable in 
the ascites while anti-nucleosome hybridomas induced predominantly anti-nucleosome 
reactivity. Ig levels and anti-nuclear reactivities in plasma samples were comparable to those 
obtained for ascites (data not shown) indicating that there was transfer to the systemic 
circulation. 
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Figure 2 . Nucleosome/IgG complex assay performed on (A) ascites (diluted 1/250) and (B) plasma (diluted 
1/20) from mice inoculated with anti-dsDNA (#36, #53 and #56), anti-histone (KM2, LG2-1, LG2-2), anti-
nucleosome (#2, #32 and #34) or control hybridomas. Values are given as means+SEM. No statistically 
significant difference was found between the amount of complexes formed for the different anti-nuclear 
antibodies (even when values of the anti-Hl hybridoma, where no complexes were detected, were included). 
Quantification of nucleosome IgG complexes. 
Nucleosome/IgG complexes were found in the plasma and the ascites of all mice inoculated 
with anti-histone (LG2-1, LG 2-2 and KM2), anti-dsDNA (#36,#53 and #36) and anti-
nucleosome (#2, #32 and #34) hybridomas, but not in the plasma and ascites of mice 
inoculated with the control (anti-CD7) hybridoma or the anti-Hl hybridoma MRA 12. 
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The mean amount of complexes formed was not significantly different for the various anti-
nuclear mAbs. (Figure 2A and 2B).The amount of nucleosome/Ig complexes in ascites was 
5 to 20 times higher than the amount in plasma as revealed by ELISA. When ascites (or 
plasma) samples were diluted in PBS with increasing sodium molarity, the amount of 
nucleosome/IgG complexes detected decreased or became negative if molarity exceded 1. 
Representative examples are shown in Figure 3. Overall, the effect was not different for 
nucleosome/anti-nucleosome, nucleosome/anti-dsDNA and nucleosome/anti-histone complexes 
since a 50% decrease was observed at 0.5M for mAbs #53 and LG2-2; at 0.75M for mAbs 
#34, #36 and KM2; at IM for m Ab LG2-1 and at 1-1.5M for mAbs #32 and #56. The 
amount of IgG2a or IgG2b bound to the protein A/G coating did not change, indicating that 
the nucleosome/IgG complexes dissociated during exposure to an increased sodium molarity. 
In the nucleosome/IgG assay in which we used biotinylated anti-histone mAb as probe, we 
found that histones were present to the same amount in the ascites of mice inoculated with 
anti-histone (KM2, LG2-1 and LG2-2), anti-dsDNA (#36, #53 and #56) or anti-nucleosome 
(#2, #32 and #34) hybridomas (Figure 4). Also with this read-out system no complexes were 
detected in ascites of mice inoculated with the anti-HI hybridoma (MRA 12) or the control 
hybridoma (signals in background range). 
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Figure 3. Influence of ionic strength on the nucleosome/IgG complexes in ascites samples. For the three 
different classes of anti-nuclear specificities a representative example is shown: anti-histone (KM2) (Ш), anti-
dsDNA (#36) (A) and anti-nucleosome (#34) ( • ) . The increase in molarity had no effect on the amount of 
IgG2a/2b bound to the protein A/G (dotted lines) as assessed by using anti-mouse IgG-PO in this assay. 
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Figure 4. Nucleosome/IgG complex assay using biotinylated anti-histone mAb performed on ascites (diluted 
1/20) from mice inoculated with anti-dsDNA (#36. #53 and #56), anti-histone (KM2, LG2-1, LG2-2), anti-
nucleosome (#2, #32 and #34) or control hybridomas. 
Values are given as means ± SEM. 
Characterization of the nucleosome/IgG complexes 
In all ascites and plasma samples extracellular DNA was found. On agarose gel 
electrophoresis this DNA appeared as a ladder pattern with a major band of 160-180 bp and 
several bands that were multimeric forms of this band (Figure 5A, lanes 2-5). This pattern 
indicates that the DNA is present as nucleosomal DNA. For the various groups of mice there 
was no difference in the amount of DNA. (DNA concentrations were 292 + 355, 453±727, 
278±347, and 488±630 μg/ml in ascites samples of mice inoculated with anti-histone, anti-
dsDNA, anti-nucleosome or the control hybridoma respectively.) 
In addition, ascites samples were incubated with protein A Sepharose beads. After washing, 
DNA was isolated from the complexes bound to these beads. DNA derived in this way from 
ascites containing anti-nucleosome (#32, #2 and #34), anti-dsDNA (#36, #53 and #56) or 
anti-histone (KM2, LG2-1 and LG2-2) antibodies displayed also a ladder pattern on agarose 
gel electrophoresis (figure 5B, lanes 3-5). No DNA was isolated from beads incubated with 
control ascites (figure 5B,lane 2). SDS-PAGE electrophoresis of the material eluted from the 
protein A Sepharose beads revealed the presence of Ig heavy and light chains and core 
histones (Figure 6). HI was not detectable. Only Ig heavy and light chains were found on 
protein A beads incubated with control ascites or MRA 12 ascites. 
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Figure 5. Representative examples of agarose gel electrophoresis. A: DNA (complexed and non-complexed) 
extracted from ascites of mice bearing anti-CD7 (lane 2), anti-dsDNA (§53) (lane 3), anti-nucleosome (#2) (lane 
4) or anti-histone (KM2) (lane 5) hybridoma. B: DNA (representing only autoantibody complexed DNA) extracted 
from protein A Sepharose beads which were incubated with ascites from mice bearing unti-CD7 (lane 2), anti-
dsDNA (#53) (lane 3), anti-nucleosome (#2) (lane 4) or anti-histone (KM2) (lane 5) hybridoma. Lane I, size 
marker (100 bp ladder). ^ Π Ο Α К 
Ig heavy chain 
—Ig light chain 
HI 
H3 
H2B/H2A1 
H4 
Figure 6. SDS-PAGE of proteins isolated from Protein A Sepharose beads which were incubated with ascites 
from mice bearing anti-dsDNA (056) (lane 3), anti-nucleosome (#2) (lane 4), anti-histone (KM2) (lane 5) or 
control (WT1) (lane 2) hybridoma. Lanes 3-5 show both the Ig heavy and light chains and core histones. Lane 
2 shows only Ig heavy and light chains. Lane I; mixture of histones HI. H2A. H2B, H3 and H4. This 
commercially obtained mixture contains some impurities of other proteins. 
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Glomerular deposition 
The kidneys of the mice with nucleosome/Ig complexes in their ascites/plasma (i.e. all mice 
except those inoculated with the anti-Hl hybridoma MRA 12) and of mice inoculated with the 
control hybridoma were examined by direct IF for Ig deposition. Different staining patterns 
were observed. Deposits along the glomerular capillary wall were observed in 8/13 mice that 
received anti-nucleosome and in 9/15 mice that received anti-dsDNA hybridomas. In 
contrast, only 2/13 mice that received anti-histone hybridomas had GBM-Ig deposits. The 
incidence of GBM deposits in animals inoculated with the anti-dsDNA or anti-nucleosome 
hybridomas compared to that in mice bearing histone specific hybridomas was significantly 
different (p<0.04). In mice that received anti-human CD7 hybridoma no deposits along the 
capillary walls and only scant mesangial deposits of IgG2a were observed (fig 7A). Similar 
mesangial deposits were observed in animals that received pristane alone and did not develop 
ascites. An increased incidence and severity of deposits were observed in the mesangium of 
mice that received anti-nuclear hybridomas compared to the anti-CD7 bearing control (Table 
II). In 9/13 mice injected with the anti-histone hybridomas, nuclear staining was observed 
(Table II, Fig 7C). In kidney sections of mice bearing either anti-dsDNA or anti-nucleosome 
hybridomas this nuclear staining was observed in respectively 10/15 and 12/13 mice. The 
nuclear staining was always observed in mice with positive GBM-Ig deposits (Fig 7D) except 
for mAb #53 (Fig 7B). For this hybridoma, GBM and mesangial deposits were found but 
there was no nuclear staining. 
Table II: Immunofluorescence findings in kidney sections of mice inoculated with the anti-
dsDNA (#56, #36 and #53), anti-histone (KM2, LG2-1 and LG2-2), anti-nucleosome (#32, 
#34 and #2) or control (anti-CD7) hybridomas. Incidence of positive staining (score > 1) 
on immunofluorescence. 
Hybridomas GBM deposits Mesangial deposits Nuclear staining 
Û-CD7 0/6' 3/6 0/6 
a-histone 2/13" 9/13 9/13 
a-dsDNA 9/15 14/15 10/15 
a-nucleosome 8/13 8/13 12/13 
*. number of nuce with positive staining/total number of mice 
**: a-histone vs. a-nucleosome hybridomas (p = 0.04) 
a-histone vs. a-dsDNA hybridomas (p = 0.02) 
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Figure 7. Direct immunofluorescence on kidney sections of mice inoculated with anti-human CD7 (A); anti-
dsDNA mAb #53 (B); anti-histone mAb KM2 (C) and anti-nucleosome mAb #32 (D). 
Binding to extra cellular matrix (Matrigef-ELISA) 
In a Matrigef-ELISA (used as a GBM surrogate), ascites of mice inoculated with anti-
nucleosome or anti-dsDNA hybridomas displayed significantly higher titers (p values 
< 0.002) than ascites of mice inoculated with anti-histone hybridomas (Figure 8). The 
Matrigel* reactivity in ascites of mice inoculated with the different hybridomas correlated 
with the in vivo GBM binding (R
s
=0.63; ρ<0.0001). Furthermore, Matrigel* reactivity in 
ascites containing anti-dsDNA or anti-nucleosome antibodies correlated significantly 
(R,=0.51; ρ =0.005) with the amount of nucleosome/Ig complexes in contrast to the ascites 
containing anti-histone antibodies. 
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Figure 8. Matrigel'1'reactivity in ascites of mice inoculated with the different anti-nuclear hybridomas. Ascites 
of mice inoculated with anti-nucleosome (#2, #32 and #34) and anti-dsDNA (#36, #53 and #56) hybridomas 
displayed significantly higher titers than ascites of mice inoculated with anti-histone hybridomas (KM2, LG2-I 
andLG2-2). *: ρ < 0.002 
DISCUSSION 
Large amounts of nucleosomes are released from cells undergoing apoptosis in hybridoma 
cell cultures 23 and in ascites from mice inoculated intraperitoneally with hybridomas 18. If 
this release occurs in the presence of anti-nuclear antibodies one can envision that this leads 
to the formation of nucleosome-autoantibody complexes. Indeed, Fournie recently showed 
that in ascites of mice inoculated with anti-dsDNA hybridomas these immune complexes are 
formed 18. In the present study we confirmed these observations and found that in plasma and 
ascites of mice inoculated with either anti-dsDNA, anti-histone or anti-nucleosome 
hybridomas, nucleosome/Ig complexes are present. The DNA in these complexes has the 
typical "ladder" pattern with a major band of 160-180 bp, characteristic of nucleosomal DNA 
released by apoptosis 91°. Within the nucleosome/Ig complexes core histones are present, but 
no HI. Similar results with regard to DNA and histones were found in bovine serum 24, 
hybridoma cell cultures " and nucleosome containing immune complexes isolated from 
culture supernatants of hybridomas producing anti-nuclear auto-antibodies 15. The fact that 
H1 is not incorporated in the released nucleosomal material explains why in mice inoculated 
with the anti-Hl hybridoma MRA12, no nucleosome/Ig complexes were detectable. The 
absence of HI is probably due to its exquisite sensitivity to proteolytic degradation. This may 
be of relevance for lupus, since nucleosome core particles lacking HI seem to comprise the 
major auto-antigens recognized by nucleosome specific Τ cells 5, and autoantibodies found 
in the majority of SLE patients I2. 
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The amount of nucleosome/Ig complexes, found in ascites or plasma, was the same in mice 
inoculated with hybridomas producing either anti-histone, anti-dsDNA or anti-nucleosome 
antibodies Therefore, we may conclude that the formation and transfer to the circulation of 
these complexes is not dependent on the specificity of the autoantibody, with the exception 
of anti-Hl as outlined above In control mice inoculated with a hybndoma producing mAbs 
without reactivity to nuclear antigens, the amount of nucleosomes released was identical, but 
no formation of complexes took place, excluding the possibility of non-specific generation 
of complexes Despite the fact that the amount of nucleosome/Ig complexes was not 
significantly different among mice inoculated with the various anti-nuclear specificities, we 
observed clear differences in the glomerular localization of these complexes in the kidneys 
In mice that received anti-nucleosome hybridomas Ig-deposits along the glomerular capillary 
wall were observed in 62% of the animals, while for anti-dsDNA this was 60% In contrast, 
a significantly lower number of mice (15%) that received anti-histone hybridomas had 
immunoglobulin deposits along the GBM There was a correlation between this in vivo GBM 
binding and the in vitro Matngel® (= GBM) reactivity in ascites The Matngel® reactivity 
in ascites of mice inoculated with anti-histone hybridomas was very low (comparable to 
control ascites) whereas the Matngel® reactivity in the ascites of mice inoculated with anti-
nucleosome and anti-dsDNA hybridomas was significantly higher The observed Matngel® 
reactivity and in vivo GBM-binding clearly must be due to complexation to nucleosomes 
since these same antibodies in purified non-complexed form were not able to bind to 
Matngel® nor to the glomerular basement membrane as assessed by renal perfusion 
experiments 
Anionic moieties in the GBM or the Matngel®, such as HS, are important for binding to 
accessible positive histone regions within the nucleosome-autoantibody complexes This can 
be derived from the following observations By using GBM-HS-specific antibodies, we 
observed a strong reduction in GBM-HS staining in immunofluorescence in both human '5 
and murine 26 lupus nephritis Since there was no reduction in the amount of HS, this reduced 
HS staining could be attributed to the binding of nucleosome containing immune complexes 
to HS 1Ь Furthermore, removal of HS from the GBM (by prior perfusion with HS degrading 
enzymes) led to a considerable reduction of the GBM binding of nucleosome complexed 
autoantibodies, but did not completely prevent it '5 Recent findings have indicated that 
collagen IV can also act as a ligand for such nucleosome complexed autoantibodies 11M 
Interestingly, Bernstein et al found that the glomerular binding (which was due to 
nucleosome mediated autoantibody binding) in vitro showed a high correlation with renal 
disease in MRL/lpr mice M and lupus patients3I Furthermore, serum or plasma HS-reactivity 
(which is a measure for nucleosome complexed auto-antibodies) is associated with onset32 33 
or flares M of lupus nephritis 
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The methodologies exploited in this study, have also been used by others to evaluate 
glomerular immune deposit formation of murine 35 " and human 38 anti-dsDNA antibodies. 
In these studies the localization (or pattern) of antibody deposition varied for the different 
antibodies used. Some monoclonal antibodies were reported to produce capillary wall and 
mesangial deposits in a granular pattern as we found for anti-dsDNA mAb #53. For other 
mAbs both nuclear staining and deposits in the mesangium and capillary wall were observed 
(comparable to our anti-dsDNA mAbs #36 and #56). In these studies it was postulated that 
direct binding of anti-dsDNA antibodies to intrinsic glomerular antigens is the major 
mechanism for this immune deposit formation. However, for some of the mAbs described, 
the formation of GBM deposits was only observed after i.p. hybridoma inoculation and not 
after l.v. injection of purified mAbs of these hybridomas 36 3e. These observations suggest that 
in these mice there is no 'direct' binding to intrinsic glomerular antigens but binding via 
complex formation of anti-dsDNA antibodies to nucleosomes 14183'. Furthermore, Morioka 
et al provide evidence that antibodies from serum of SLE patients form soluble histone-
DNA/anti-dsDNA immune complexes that bind to the glomerular capillary wall in vivo 39 
In many of the mice inoculated with anti-nuclear hybridomas, nuclear localization of 
autoantibodies (in vivo ANA) was observed in the different tissue specimens Recently, we 
reported that this in vivo ANA is a feature of anti-nuclear antibodies complexed to 
nucleosomes *° Anti-nuclear antibodies are able to bind to the cell surface via nucleosomes 
and are transported into the cytoplasm *°41. This intracellular uptake of antibodies was only 
observed if the antibodies were complexed to nucleosomes and did not occur with purified 
non-complexed antibodies. The nuclear localization we observed using our monoclonal 
antibodies was a fixation artifact since with paraformaldehyde fixation, instead of acetone, 
this nuclear staining did not occur m Whether the nuclear localization observed by Madaio 
et al. 4243 is due to different mechanisms or different specificities of the antibodies is not 
known yet The possible pathophysiological consequences of the internalization is still 
unclear 
In contrast to the difference in the incidence of glomerular wall deposits between mice 
receiving anti-dsDNA/anti-nucleosome hybridomas or those receiving anti-histone 
hybridomas, there was no difference in the incidence of mesangial deposits. We recently 
found that treatment with heparin, which structurally strongly resembles HS, not only 
reduced albuminuria and the seventy of the glomerulonephritis in MRL/1 mice but also 
prevented the binding of nucleosome-complexed antibodies to the GBM. In direct 
immunofluorescence of kidney sections of heparin treated animals we found, compared to 
PBS treatment, that there was a decrease in the amount of glomerular wall deposits but not 
in the mesangium **. This suggests that the formation of GBM and mesangial deposits occurs 
via different mechanisms. 
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In the past, several studies have been published which suggest that anti-histone auto-
antibodies are less nephritogenic in lupus than anti-dsDNA or anti-nucleosome antibodies. 
Although some studies described a correlation between anti-histone reactivity and lupus 
nephritis 45, in most studies this was not found 4M7 or even a negative correlation was 
reported 4M9. This is in line with our observation that the amount of anti-histone antibodies 
deposited in glomeruli of MRL/1 lupus mice was similar in age-matched albuminuric and 
non-albuminunc mice *°. In these glomerular eluates anti-nucleosome and anti-dsDNA 
reactivies were increased in albuminuric animals compared to age matched non-albuminuric 
mice. Another argument for the importance of anti-dsDNA is that the onset of lupus nephritis 
is often preceded by a rise in anti-dsDNA titer 51. Furthermore, it has been reported that 
there is a correlation between anti-nucleosome antibodies and lupus nephritis 12,52. 
Recently, we were able to demonstrate for the first time the presence of nucleosomes in 
GBM deposits in lupus nephritis with the use of nucleosome specific mAb. In biopsies of 
patients with diffuse proliferative glomerulonephritis (WHO class IV) 45% showed 
nucleosome deposits in the GBM. In 100% of these biopsies histone deposits were found 
using a polyclonal rabbit antibody raised against N-terminal region of histone H3, while no 
DNA deposits could be detected. We assume that the higher prevalence of histone deposits 
over nucleosome or DNA is due to the fact that DNA/nucleosome specific epitopes are 
covered by pathogenic anti-dsDNA and anti-nucleosome antibodies, whereas histone epitopes 
are still accessible for antibody probes. 
In conclusion, this study shows that complexes formed between nucleosomes and anti-dsDNA 
or anti-nucleosome auto-antibodies more frequently localize in the GBM than those formed 
between nucleosomes and anti-histone antibodies. In our view this latter is due to the fact that 
these anti-histone antibodies bind to the positively charged N-terminal regions of the core 
histones. This reduces the capacity of these histone moieties to bind to HS associated anionic 
sites within the GBM. We cannot exclude that the differences in affinity between the various 
classes of anti-nuclear antibodies contribute to this different in vivo behaviour, although our 
dissociation experiments under high salt conditions did not reveal gross differences in this 
respect. 
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Heparin and hepannoids prevent the binding of immune complexes 
containing nucleosomal antigens to the GBM and delay nephritis in 
MRL/lpr mice. Monoclonal anli-nucleosomi. antibodies (mAbs) com 
plexed to nucleosomal antigens can bind lo DNA and lo heparan sulfate 
(HS) in ELISA and lo the GBM in \ivo in a rat renal perfusion system 
whereas non-com plexed mAbs do not bind []) Inthisstudv we analyzed 
whether heparin (HEP) or N-desulfated/acervlatcd heparins (DSA-HEP) 
structurally and functionally strongly related to HS are able to prevent the 
binding of these complcxed mAbs to DNA and to HS m vitro and lo rat 
GBM in vivo In ELISA the binding of nucleosome complexed anti 
nucleosome antibodies io DNA and HS was inhibited dose -depende η tl\ 
by HEP DSA HEP and low molecular weight (LMW) DSA HEP 
Intravenous injection of nucleosome/anti nucleosome immune complexes 
without hepann/hepannoids in BALB/c mice led lo GBM binding while 
simultaneous injection of hepann/hepannoids with complexed antibodies 
or pretreatment with heparin subcutaneousK prior to injection of com 
plexes prevented this binding Subsequently we tested the preventive 
effect of HEP DSA-HEP and LMW-DSA-HEP on progression of renal 
disease in MRL/lpr mice Treatment was started at an age of eight weeks 
in a dose of SO μ-g daily With all three drugs albuminuria was significantly 
delayed compared to PBS treated controls (cumulative incidence of 
proteinuria at 20 weeks in controls 609<-vs 139r 149c and 6% respectively 
for HEP DSA-HEP and LMW DSA HEP Ρ < 0 05) At week 21 the 
glomerulonephritis was histologically less severe in hepann/hepannoid 
treated animals (P = 0 02) In immunofluorescence the amount of 
immunoglobulin and C3 deposits in the glomerular capillary wall tended 
to be less in hepann/hepannoid treated mice compared to PBS treated 
controls (P = 0 07) Furthermore at 20 weeks anti HS levels in plasma of 
hepann/hepannoid treated mice were significantly lower (P < 0 05) We 
conclude that interaction of heparin or heparin analogs with HS reactive 
immune complexes containing nucleosomal antigens prevents the binding 
of these immune complexes to the GBM and delays nephritis in MRL/lpr 
mice 
Systemic lupus e ryt he matos is (SLE) is an autoimmune disease 
characterized by Ihe occurrence of numerous autoantibodies, 
primarily directed against nuclear antigens Previously we have 
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shown that these anti-nuclear antibodies complexed to nucleoso­
mal antigens are able to bind to the glomerular basement 
membrane (GBM) in vivo [1, 2] In these nucleosome containing 
immune complexes the positively charged histones interact with 
the negatively charged HS in the GBM [1] The presence of these 
nucleosomes in the complexes is also responsible for the binding 
to heparan sulfate (HS) and DNA in vitro since non-complexed 
antibodies do not bind [1,3] In the present study, we investigated 
whether heparin or heparin analogs, which have structurally and 
functionally strong similarities with HS, could interfere with the 
binding of these nucleosome complexed anti-nucleosome antibod­
ies to HS and DNA m vitro and to the GBM in vivo Heparin is a 
drug with many biological activities [4] and the therapeutic effects 
of heparin in various experimental models of kidney diseases have 
been investigated In the renal ablation model heparin reduced 
systemic blood pressure, proteinuria and the extent of glomerular 
sclerosis [5-6] Also in lupus mice heparin reduced the glomerular 
damage [9] In the puromycine aminonucleoside-induced ne 
p h rot ic syndrome, heparin treatment prevented glomerular scle­
rosis, mesangial proliferation and reduction of the glomerular 
nitration rate [10] The development of hypertension and fibrinoid 
vascular lesions was prevented by heparin treatment in spontane­
ously hypertensive rats [11 12] In most studies a similar protec 
live effect was also found for non-anticoagulant hepannoids [7 
10] These results indicate that the beneficial effects can be 
obtained without the risks of anti-coagulation Because of the 
renal protective properties and the functional and structural 
similarities with HS, we analyzed the effects of heparin (HEP) and 
the non-anticoagulant derivatives, 
N-desutfated/acetylated heparin (DSA-HEP) and low molecular 
weight N-desulfated/acetylated heparin (LMW-DSA-HEP) on 
manifestations of glomerulonephritis in a spontaneous model of 
SLE, the MRL/lpr mouse 
We assessed the effects of heparin and of hepannoids on 
autoantibody formation, proteinuria and glomerular Ig and com­
plement deposition in MRL/lpr mice both prophylactically as well 
as therapeutically In addition, we studied the effects of these 
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drugs on the binding of complexed anti-nucleosomal autoantibod 
íes in ELISA to DNA and HS and m \i\o to the GBM 
Methods 
Animals 
MRL Ipr/lpr mice were bred from stock ongmdllv obtained via 
the Scnpps Clinic and Research Foundation (La Jolla CA, USA) 
from the Jackson Laboratory (Bar Harbor ME. USA) All strains 
were maintained b\ brother/sister malings at our animal labora-
tory For the in mo inhibition studies, the in \i\o coagulation 
studies and the m ι ivo assessment of immune modulation by the 
drugs, BALB/c mice were used, also originating from the Jackson 
Laboratory 
Drags 
Heparin (HEP) was commercially obtained from Organon 
Technica BV (Boxtel The Netherlands) As non-coagulant hep­
arin derivatives DSA-HEP (KF-E4282) and LMW-DSA-HEP 
(KF -E4567) were used, which were both produced and generously 
provided by Diosynlh BV (Oss The Netherlands) The N-desul-
fation of heparin was carried out as described by Inoue and 
Nagdsawa [13] Briefly, heparin was dissolved in water and passed 
through a cation-column (DowexSOW x 12) in the Η ' rorm The 
hepannic acid in the eluale was neutralized with pyridine (approx­
imately 2 5 ml per gram of heparin) to pH 6 5 After freeze-drying 
the pyridine salt of heparin was dissolved in 95cc dimelhvlsul-
phoxide and 5c/c water and incubated for 30 minutes at 50°C The 
desulfated heparin was obtained by adsorption on an anion 
exchanger (Bayer MP500A) elution with a 20rr NaCI solution 
and precipitation with 75rr methanol Acetvlaiion was carried out 
as described by Hirano and Ohashi [14] The N-desulfated 
material was dissolved in a 10 I water-methanol mixture and 1/20 
of the total volume of acetic anhydride ( 1 ml per gram of heparin) 
was added The pH was kept constant by addition of a Dowex 1 x 
8 ion exchanger in the carbonate form DSA-HEP was obtained 
by adsorption on an anion exchanger elution desalting on a G-10 
column and freeze drying LMW-DSA HEP was obtained by 
enzymatic (heparin lyase 1 EC 4 2 2 7) digestion of HEP which 
then was desulfated and acetylated as described above The 
sulfate content was determined by conductometnc titration as 
described by Casu and Gennaro [15] The N-acetvl content was 
determined by proton-NMR as described by Casu [16] For 
control experiments a neutral polysaccharide Dextran (Pharma­
cia Upsalla, Sweden) was used in concentrations identical to 
those of hepann/hepannoids 
Anticoagulation studies 
The anticoagulant properties of DSA-HEP and LMW-DSA 
HEP were analyzed and compared with standard HEP in vitro and 
in vivo The assay for anti-factor Xa activitv was carried out as 
described by Teien et al [17. 18] with minor modifications for use 
in microliter plates In addition the effect of DSA HEP, LMW-
DSA-HEP or HEP on the activated partial thromboplastin lime 
(aPTT) was determined by addition of the drugs to normal mouse 
plasma in a concentration range of respectively 0 to 50 and 0 to 10 
Mg/ml For the in vivo effect groups of BALB/c and MRL/lpr mice 
were treated for three days with daily subcutaneous injections of 
0 1 ml saline or 50 μg of either HEP, DSA-HEP or LMW-DSA-
HEP Two hours after the last injection 0 9 ml blood was obtained 
by cardiac puncture in a I ml svringe containing 0 I ml of CTAD 
solution (containing 0 089 м tnsodium citrate 0 021 м cilic acid 
15 μ\ι theophvlhn 3 7 μΜ adenosine and 0 198 μ\ι dip\ndamol) 
The plasma was collected after cenlnfugation and aPTT and 
heparin levels were determined, according to Fischer [19] Bneflv, 
in this assav 10 μΙ CTAD plasma or standard sample were mixed 
with 50 μΙ normal pooled plasma as a source of antithrombin III 
and 150 μΐ Tns-imidazole buffer (30 m\i in 0 25 м NaCI pH 8 4) 
and incubated for five minutes at 37°C Thereafter 20 μΙ thrombin 
(6 U/ml) were added and the mixture was incubated for exact К 30 
seconds To measure the remaining free thrombin 20 μ] (2 т м ) of 
the chromogenic substrate S 2238 (KabiVitnum) was added and 
two minutes later the reaction was stopped with 50 μΐ 50rc acetic 
acid The extinction at 450 nm was measured in a EAR 400 
microplale reader (SLT, Groding Austria) The hepann/AT 
Ill-complex mediated anti-thrombin activirv (= heparin level) was 
calculated from a standard curve obtained with heparin Treat 
ment of BALB/c and MRL/lpr mice with HEP resulted in heparin 
levels of 6 0 zu 3 0 and 3 1 ± 1 5 mg/hter respechvel·, (controls 
0 3 ± 0 2 mg/hter) The aPTT was measured bv mixing MX) μΙ of 
cilrated plasma with 100 μΙ PTT reagent of Stago (Asnieres 
France) containing Kieselguractivator and серпа h η After incu 
bation for three minutes at 37°C 100 μΙ 25 т м CaCl was added 
and the clotting time was recorded with а КС 10 coagulometer 
(Amelung Germany) 
Preparation of nucleosome complexed and purified 
ami nucleosome mAb 
Anti-nucleosome antibodies are directed against nucleosome or 
subnucleosomal complexes consisting of the histone octamer and 
DNA Purified non-complexed anti-nucleosome antibodies do not 
bind to individual histones or DNA However, complexed to 
nucleosomal antigens these antibodies bind to DNA and HS in 
ELISA and to the GBM in \i\o [1] Complexed antibodies of an 
anti-nucleosomal antibody, mAb #34 were obtained by purifica­
tion of culture supernatant under physiological conditions as 
described [1] Noncomplexed mAb #34 was obtained by purifica­
tion under high salt conditions preceded by a DNase treatment as 
previously described [1] 
Antigen reactivir, of purified and complexed anti-nucleosome mAb 
and of plasma samples 
Anti-DNA and anti-HS reactivities were determined in ELISA 
as described previousK [1 20] All ELISAs were titrated and the 
reciprocal of the dilution giving an absorption of 1 0 at 450 nm was 
used as titer 
Interaction of heparin or hepannoids with complexid 
anti-nucleosome mAb 
The in vitro effects of hepann/hepannoids were analyzed in an 
inhibition ELISA to HS or DNA using a concentration range of 
heparin hepannoids or dextran Fifty microliters of the different 
inhibitors were added to the complexed anti-nucleosome mAb 
#34 After incubation for 45 minutes at room temperature the 
reactivity of the mAb to HS or DNA was measured in ELISA as 
described before In these inhibition experiments the mAb was 
used in a concentration that gave 5()ci of the maximal absorption 
in the respective direct ELISAs 
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The in vi\o effects of hepann/hepannoids on GBM binding of 
complexed mAb #34 were evaluated in two different wavs (1) b> 
renal perfusion studies in the rat of complexed mAb #34 with or 
without heparin (2)bviv injection in BALB/c mice of complexed 
mAb #34 with or without pretreatment of the mice with heparin 
For the renal perfusion studies male Wistar rats (150 g) were 
anesthetized bv intraperitoneal administration of 0 15 ml (9 mg) 
sodium pentobarbital (Narcovel, Appharma Arnhem the Neth­
erlands) The control renal perfusion was performed as described 
before 11] For inhibition experiments 150 μg of complexed mAb 
#34 was mixed with 150 μg of hepann/hepannoids for 30 minutes 
at room temperature before renal perfusion After perfusion the 
perfused kidnev was taken out and immediately snap frozen in 
liquid N-, for evaluation of IgG binding bv immunofluorescence 
(IF) 
The glomerular binding after ι ν injection of complexed mAb 
was evaluated in BALB с mice injected with 150 μg complexed 
mAb #34 after pretreatment for three davs with either dailv 
subcutaneous injections of 0 1 ml PBS or 50 μg HEP Two hours 
after the last injection the complexed mAb #34 was injected ι ν 
After five minutes the kidnevs were taken out for IF 
Treatment protocols in MRL Ipr mice 
For the first set of experiments to test the preventive effect 
eight-week old MRUlpr mice were treated once daily with a 
subcutaneous (s с ) injection of 50 μg of either HEP DSA-HEP 
or LMW-DSA HEP in 0 1 ml PBS Control animals received 0 1 
ml PBS s с ddiK Each group consisted of 15 animals (8 males and 
7 females) Mice were treated from week 8 until week 21 At the 
start and after 12 weeks of treatment blood was drawn for the 
determination of the anti DNA and anti-HS titer in plasma 
Albuminuria was screened every week b\ urine collection in 
metabolic cages for 18 hours After 13 weeks of treatment (at the 
age of 21 weeks) the animals were sacrificed and the kidneys were 
removed for immunofluorescence 
In a second set of experiments, the therapeutic effect on 
established albuminuria (albuminuria period before treatment < 
7 days) was assessed MRUlpr mice between the ages of 20 to 30 
weeks with an albuminuria of at least 1000 ^g/18 hr were 
randomized for magnitude of albuminuria age and sex to treat 
ment with either 50
 Mg HEP 50 pg LMW DSA HEP or 0 1 ml 
PBS once daily subculaneously (each group N = 12) After the 
start of the treatment the albuminuria was analyzed every two 
weeks and the effect on survival was evaluated At several time 
points during treatment plasma was collected for determination of 
anti-DNA and anti-HS titers 
To investigate whether treatment with hepannoids could form 
a useful addition to immunosuppressive treatment, we performed 
d pilot experiment in which we tested whether the combination of 
LMW-DSA-HEP and cyclophosphamide (CY) was more effective 
than CY treatment alone MRL/lpr mice between the age of 20 to 
25 weeks with an albuminuria of at least 300 μ&'ΊΗ hr and a 
duration of albuminuria of less than seven days, were randomized 
for magnitude of albuminuria, age and sex Mice were treated 
once dailv s с with either PBS (group A and group B) or with 50 
μg LMW-DSA-HEP (group C) In addition mice in groups В and 
С received a weekly ι ρ injection of CY (EndoxanR-Asta, Dagra 
Pharma В V , Diemen The Netherlands) in a dose of 20 mg/kg 
body wt while control mice in group A received an equivalent 
volume of PBS Each group consisted of 5 animals The effect of 
this treatment regimen was evaluated for albuminuria and sur 
vivai 
Disease actt\tt\ assessment 
Ann DNA and anti-HS reactivities were determined in ELISA 
as described above The HS ELISA was used to detect nucleo-
some complexed autoantibodies in the circulation [3] After 
collection of urine for 18 hours in metabolic cages albuminuria 
was analyzed with radial immunodiffusion with rabbit anti-mouse 
albumin antibodies (Cappel West Chester PA USA) as de 
scribed before [21 22] Mouse albumin 5 mg/ml (Sigma Chemical 
Company, St Louis MO USA) was used as a standard To study 
the glomerular deposition of mouse lg and C3 and staining of 
GBM HS indirect immunofluorescence was performed on 2 μΐπ 
cryostat sections of kidney tissue, according to techniques de­
scribed previously [22] The coded sections of the kidnevs were 
analyzed by 3 different observers and scored semiquantitative^ on 
a scale trom 0 to 4-t- (in at least 20 glomeruli per mouse kidnev) 
For staining of Ig and C3 both the amount and intensity of 
staining was scored No staining was scored 0 mild staining was 
scored I moderate staining was scored 3 and severe staining was 
scored 4 For HS staining in the capillary loops no staining at all 
was scored 0 staining of 25c/c off all capillary loops and/or 759f 
decrease of staining intensity (as compared with a normal BALB/c 
glomerulus) was scored 1 staining of 50% off all capillary loops 
and/or 50<v decrease of staining intensity was scored 2 staining of 
15c/( of all capillary loops and/or 25*7 decrease of staining 
intensity was scored 3 and normal staining of all capillary loops 
was scored 4 For light microscopy tissue fragments fixed in 
Boum s solution were dehydrated and embedded in Paraplast 
(Amstelstad В V , Amsterdam The Netherlands) Four microme 
ter sections were stained with periodic acid-Schiff and silver 
methenamine [21 ] Coded sections were analyzed and scored on a 
scale 0 to 3+ The 0 to 3+ scale was defined as follows no 
glomerulonephritis was scored 0 mild/moderate glomerulone 
phritis was scored 1+ to 2+ and severe glomerulonephritis was 
scored 2+ to 3 + 
In vivo assessment of immune modulating properties of 
hepann/hepannoids 
The immunosuppressive properties of HEP DSA-HEP and 
LMW DSA HEP were studied in normal BALB/c mice bv mea­
suring their influence on delayed type hypersensitivity (DTH) and 
primary antibody response towards bovine serum albumin (BSA) 
according to methods described previously [23] In brief DTH 
reactivitv was determined in 4 groups of 10 BALB/c mice which 
were treated daily with 0 1 ml PBS se or 50 μg of either HEP 
DSA-HEP or LMW-DSA-HEP Treatment was started at day - 2 
At day 0 all mice received 0 1 mg BSA in 0 1 ml complete 
Freund s adjuvant s с At day 13 a rechallenge was given of 5 μΐ 
BSA s с (2 mg/ml) into the pinna of the right ear As control 5 μΙ 
PBS was injected in the pinna of the left ear At 4 24 and 48 hours 
after the rechallenge duplicate measurements of the ear thickness 
(x 10 Ί) were made with an engineers micrometer The DTH 
reactivity is expressed as the ratio between the swelling of the 
antigen injected site (R) and the saline injected site (L) as 
measured after 48 hours At day 15 blood was collected from the 
same animals for the determination of the anti-BSA response 
Anti-BSA titers were measured in ELISA [23] During the whole 
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Tabic 1 Biochemical characteristics and ami coagulant properties of hepannoids and dextran used as d control non charged polysaccharide 
Drug 
Hepdnn 
N desulfaled acetylated hepdnn 
Low molecular weight 
N desulfaled/acervldted heparin 
Dcxlran 
Abhreviation 
H E P 
DSA H E P 
L M W DSA H E P 
Dextran 
Number of 
sulfate groups 
per disacchande 
3 0 
2 3 
2 3 
0 
Ч О glucosamine 
residues containing 
a N acetyl group 
25 
IMI 
100 
N D 
Molecular 
wt 
l S k D a 
M k D a 
7 k D d 
l 4 k D d 
Anti Xd 
activirv 
Umg 
2(Ю 
< 2 4 
< 2 4 
<2A 
aPTT 
in \ι\υ 
secJ 
19 ± 12 
2H » Й 
25 " 5 
N D 
Values arc given as means •+• SD The aPTT in PBS treated animals was 30 i 6 sec The valuer were statistically not different between drug and PBS 
treated animals 
The aPTT in mice treated once daily with a subcutaneous injection of 50 ßg of either HEP DSA HEP or LMW DSA HEP compared lo miu. 
treated with PBS (/V = 5 per group) 
400 
300 
Я 200 
100 
Concentration \ig/ml 
Fig I Effect of heparin (HEP G) \ dcsulfaud acenlaied heparin (DSA 
HEP Φι or km molecular wight \ dt su (fand acenlaied heparin (LMW 
DSA HEP ZÀ) on aPTT in vitro 
Inhibition of the binding of complexée ami nucleosome mAb to 
HS or DNA by heparin or hepannoids m ELISA 
In pure non complexée! form mAb 14 reacted only with nucleo 
somes and had no reactivity with DNA or HS Complexed with 
nucleosomes however this mAb bound not only to nucleosomcs 
but also to DNA and HS as described before [1] The binding of 
complexed mAb #14 to HS and DNA could be inhibited bv HEP 
DSA HEP and LMW DSA HEP in a dose dependent manner as 
shown in Figure 2 More DSA HEP and LMW DSA HEP were 
required to achieve a similar degree of inhibition as with heparin 
which in all probability is due to the partial desulfalion of the 
former reagents In contrast to heparin and the hepannoids 
dextran was not able to inhibit the binding of complexed mAb #14 
in these competitive inhibition ELISAs This inhibition was not 
unique for mAb #34 since HEP DSA HEP and LMW DSA HEP 
could also inhibit to a similar degree the binding of other 
previously described [1| complexed anti nucleosome mAbs (#2 
and #32) to HS and DNA (data not shown) 
experimental period the dailv administration of the drugs was 
continued 
Statistical analysis 
Statistical analysis was performed using the Mann Whitney 
U test A rwo sided Ρ < 0 05 was considered to be statistically 
signifiant Spearman s correlation coefficient was used for linear 
regression analysis 
Results 
Characteristics and anti coagulant properties 
The biochemical characteristics of HEP DSA HEP LMW 
DSA HEP and dextran are listed in Table 1 As can be seen only 
HEP had an anti factor Xa activity in vitro while the other 
preparations were devoided of any anti factor Xa activity A 
similar pattern was observed analyzing the effect on the activated 
partial thromboplastin lime (aPTT) m vitro Even addition of 
large amounts of DSA HEP and LMW DSA HEP gave hardly 
anv prolongation of the aPTT (Fig 1) To prolong the aPTT to 
1(H) seconds 2S times more DSA HEP than HEP was needed 
while addition of LMW DSA HEP had no effect The effect on 
coagulation in vivo using 50 μg of the various drugs ts also shown 
in Table 1 In all drug treated animals the a PTT was not 
significantly different from control animals receiving PBS 
Inhibition of glomerular binding of complexed ami nucleosome 
mAb by heparin and hepannoids 
Previously we have shown that after renal perfusion of com 
plexed anti nucleosome mAb #34 glomerular binding occurs 
while in purified form the mAb does not show any binding [1] In 
this study we tested the effect of heparin/heparmoids on this 
GBM binding by renal perfusion (in Wistar rats) of complexed 
mAb #34 with or without heparin/heparmoids (N = 3 per group) 
When prior to perfusion complexed mAb #34 was mixed with 
PBS clear binding of the complex to the glomerulus was seen 
After perfusion of complexed anti nucleosome mAb #34 mixed 
with dextran a comparable binding was observed (Fig ЗА) 
However the addition of heparin DSA HEP or LMW DSA HEP 
to the complexed mAb #34 could completely prevent the glomer 
ular binding (Fig 3B) Similar results were obtained after pre 
treatment of BALB/c mice with either PBS or HEP BALB/c mict 
were pretreated for three days with either daily sc injections ol 
PBS or HEP (JV = 4 per group) Two hours after the last injection 
the complexed mAb #34 was injected ι ν Pretreatmenl of the 
mice with HEP resulted in detectable heparin levels (6 0 - 3 0 
mg/liter controls 0 3 ± 0 2 mg/liter) in the plasma at the time of 
injection of the compexed and nucleosome mAb #34 When 
complexed mAb #14 was injected ι ν after pretreatment with a 
daily subcutaneous injection of PBS glomerular binding was 
observed identical to that shown in Figure 1A In contrast to this 
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Fig 2 Inhibition of іЫ Ыпіііпц ol ihi сотркміі aun nitcleotorm niAb 
#UtoH4 i\) and D\A (B) in ihi inhibition ELISA Binding of complexed 
#14 »as inhibited dose uependinlli bv HFP ( j) DSA HEP O and 
LMW DSA HEP ( · ) Dcxlran (•) eould nol inhibit the binding For 
abbreviations see legend Figure I 
ι s injection of complexed mAh #14 in heparin pretreated mice 
did not lead to any GBM binding 
Effects on glomerular disease in MRL/Ιρτ mice 
In the preventive study a dailv dose 51) /ig of HEP DSA-HEP 
or LMW DSA HEP signifìcanlly delayed the onset of albuminuria 
in MRUtpr mice compared to PBS treated controls (P < 0 05 Fig 
4) At 20 weeks the cumulative incidence ot albuminuria in PBS 
treated animals was 609r while in the drug treated groups this was 
respectively 13Cr 14% and bci for HEP DSA HEP and LMW 
DSA-HEP Furthermore the administration of HEP or hepan 
noids prevented the development of the histological hallmarks of 
glomerulonephritis At week 21 10 out of 15 PBS treated control 
MRUlpr mice had glomerulonephritis In contrast mice treated 
with HEP, DSA-HEP and LMW-DSA-HEP respectively showed 
a significant lower prevalence of glomerulonephritis (3/15 3/14 
and 2/15 of the mice, respectively Ρ = 0 03, Ρ = 0 03, Ρ = 0 008, 
Fisher Exact test. Fig 5) In direct immunofluorescence of kidnev 
sections of drug-treated animals we found compared with PBS 
treated controls that there was a decrease ш the amount of 
immunoglobulin deposits in the glomerular capillari, wall {P = 
0117) but not in the mesangium (/· = 0 90 Figs 6 and 7 A B) 
The pattern of C3 deposition along the glomerular capillary wall 
was identical to that of the Ig deposits Less C3 deposits were 
observed in hepann/heparinoid treated groups (Fig 7 С D) 
Previously, we have shown that the staining of HS in the GBM of 
MRL/lpr mice is significantly decreased and correlated with the 
extent of lgG deposits [22] In the present studv we observed the 
same phenomenon since HS staining was markedly decreased in 
the GBM of PBS treated mice compared with PBS treated 
controls However in hepann/heparinoid treated mice this de 
crease in HS staining was much less as compared to PBS treated 
controls (Fig 7F) As we have described before [22] and also 
found in this study there was an inverse correlation between HS 
staining and albuminuria (r, = - 0 65, Ρ < 0 0001) and GBM Ig 
deposits (r, = - 0 54 Ρ < 0 0001) At the start of the treatment 
the anti-DNA and anti-HS reactivities in plasma were similar in 
all groups and rose with age (data not shown) After 12 weeks of 
treatment the anti-HS levels were significant» lower in HEP 
DSA-HEP or LMW DSA-HEP treated groups (P < 0 05 0 01 
and 0 05, respectively) compared to PBS treated controls (Fig 8) 
At that time there were no differences in anti-DNA antibods 
levels between the groups To establish whether HEP DSA-HEP 
and LMW DSA-HEP could also exert an antiprotcinuni effect in 
MRLIpr mice with an established albuminuria (range 1000 to 
9(HX) μg/l8 hr) animals were treated dailv with 50 μg HEP or 
LMW-DSA-HEP In the PBS treated group there was an increase 
of albuminuria in 90rr of the mice HEP and LMW-DSA-HEP 
treated groups showed an increase of albuminuria in 55rr and 
600- of the mice respectively This difference was not slatisticalK 
significant Both drugs also had no effect on survival anil DNA or 
anti-HS liters (data not shown) 
In the pilot experiment in which the additive effect of heparin 
to immunosuppressive treatment was tested MRUlpr mice with 
an established albuminuria were treated with PBS/CY or LMW 
DSA-HEP'CY Control mice were treated with PBS only This 
experiment revealed that there was a significant beneficial effect 
on survival for the LMW-DSA-HEP/CY treated mice as com­
pared to PBSCY treated mice (P < 0 05) and that the LMW 
DSA-HEP/CY treatment halted the progression of the protein 
una 
Effects on immune reactixm 
Treatment with 50 μg of either HEP DSA HEP or LMW 
DSA-HEP had no effect on DTH reactivity or on the primary 
antibody response towards BSA (Table 2) 
Discussion 
This studv shows that heparin and non-anticoagulant heparin 
derivatives are able to inhibit the binding of nucleosome com 
plexed antibodies to DNA and HS Also the in mo GBM binding 
of these complexes after renal perfusion was prevented Further 
more these drugs prevented the development of glomerular 
lesions in MRUlpr mice In addition we found that heparin 
hepannoid treatment can retard the onset of albuminuria and 
significantly reduces anti-HS reactivity in plasma Because hepa 
nn has many biological actions in inflammation and tissue repair 
this beneficial effect could be due to number of actions It has 
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Fig. 3. Direct immunofluorescence of glomerulus after perfusion ofcomptexed anti-nucleosome m-ih #.*V mixed utili dejaran l\l or DSA-HEP (Bi. After 
perfusion of complexed mAh #34 mixed with dcxlran clear binding of the complex to the glomerulus was observed (A). However, the addition of 
DSA-HEP to the complexed mAh #34 eould completely prevent this binding (B). 
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Fig. 4. Cumulativi' incidence of albuminuria in lite various groups of 
MRL Ipr mice Starting at the age ot eight weeks MRL/pr mice were 
treated once daily with either 50 Mg HEP. DSA-HEP or LMW-DSA-HEP 
and compared with PBS treated controls Each group consisted of 15 
animals. Albuminuria was considered to he present if the urinary albumin 
excretion exceeded 3(H) μ£ 18 hr (upper limit of albuminuria (mean + 2 x 
SD) in non-SLE normal control mice: KM ug. IX hr). PBS ( · ) . HEP (•). 
DSA-HEP (ZJ) and LMW-DSA-HEP (Ο). Ρ < 0.05. 
been shown that heparin inhibits mesangial cell proliferation 
[24-26]. modulates proteoglycan synthesis in vitro (13. 26. 27] as 
well as in vivo [10. 28. 29]. exerts an anti-mitogenic effect on 
glomerular epithelial cells [30] and inhibits the binding of immune 
complexes to mesangial cells at least in vitro [31. 32]. From our 
PBS HEP DSA-HEP LMW-DSA-
HEP 
Fig. 5. Sevenn of glomerular lesions m MRL Ipr mice treated null PBS 
HEP. DSA-HEP or LMW-DSA-HEP No glomerulonephritis (score (1. • ) . 
mild glomerulonephritis (score < 2 - . H ) . severe glomerulonephritis (score 
data we cannot draw conclusions whether these properties con­
tributed to the anli-proteinuric observed effect, but there were no 
differences between the control and drug treated mice in the 
extent of mesangial matrix expansion and mesangial immunoglob­
ulin deposition. The beneficial effect of heparin could also be due 
to its immunosuppressive properties [.13-36]. However, it is 
unlikely that this immunosuppressive effect is responsible for the 
diminution of the glomerulonephritis, since no effect on primary 
immune reactions like D T H and antibodv response was evident. 
Also, the fact that the levels of anti-DNA antibodies were 
94 
Chapter 7 
о \ L¿J ι [¿J , Le ι L-Jiü 
PBS HEP DSA-HEP LMW-DSA-
HEP 
Fig 6 The amount of Ιχ deposition m glonunilar captilan loops (Щ and 
mebangtum (Zìi in glomeruli of mm maud nuit PBS HI I' DSA HEP or 
LM4 DSA HEP Deposition of Ig in the mLsangium is similar in all 
groups A smaller amount οΓ Ig deposition in the CiBM was obseded in 
heparin hcpannoid treated mice compared to PDS treated controls 
unaltered does not provide support for an immunosuppressive 
effect Therefore an alternative explanation for the renoprotec-
tive effect seems more hkclv Several vcars ago we found that 
anli-DNA antibodies could cross react with HS [3] Later n 
became apparent that this binding was not a direct antibody 
binding but due to nucleosomes complexed to the antibody [2] 
The histone part of the nucleosome was responsible for the 
binding to HS Based on these in Miro results we could show that 
anti-nuclear antibodies complexed to nucleosomal antigens are 
potential nephntogemc immune complexes via their interaction 
with HS and other anionic sites in the G B M [1] These complexes 
can be identified in the circulation by using an anli-HS-ELISA [3] 
This anti-HS reactivity correlates with the onset and exacerbation 
of renal manifestations of SLE [37-39] In this study we show that 
heparin and hepannoids are able to prevent the binding of these 
complexed antt-nucleosome antibodies lo D N A and HS in 
ELISA In our view this inhibition is due to the binding of 
hepann/hepannoids to canonic charged nucleosomal antigens 
within the complex This explanation is different from that offered 
bv others showing inhibition of binding of SLE auto-antibodies to 
HS or D N A in ELISA by heparin [9, 40] In these latter studies 
inhibition of "direct" binding was suggested That inhibition of 
binding of nucleosome complexed anti-nuclear antibodies takes 
place also in vivo is suggested by our finding that the plasma 
anti-HS reactivity in the hepann/hepannoid treated mice was 
significantly reduced The inhibitory effect of hepann/hepannoids 
is not restricted to serum-derived complexed autoantibodies but 
also to antibodies eluted from glomeruli in SLE nephritis In 
glomerular eluates from albuminuric MRL/lpr mice, besides 
strong anti-DNA reactivity, we also found anti-HS reactivity Both 
reactivities could be inhibited by heparin and hepannoids (van 
Bruggen et al. unpublished observations) Similar results have 
been published not only for MRL/lpr mice but also for human 
SLE nephritis [9] These data support the suggestion that the 
protective effect of heparin and hepannoids can be explained by 
their ability to prevent the binding of nucleosome containing 
immune complexes to HS in the G B M 
In line with the m vitro findings, we found in the acute G B M 
binding studies that hepann/hepannoids were able to prevent 
G B M binding both after renal perfusion and after ι ν injection of 
nucleosome complexed antibodies More importantly, a similar 
mechanism seems to occur in the chronic model of lupus nephritis 
in MRL/lpr mice The onset of albuminuria was signiñcantlv 
postponed bv heparin and the used hepannoids This was also 
reflected bv the decrease in histological severity of the glomeru 
loncphntis in the drug treated animals Furthermore the amount 
of immunoglobulin deposits in the glomerular capillarv wall 
tended to be less in hepann/hepannoid treated MRL/lpr mice 
compared to PBS treated controls This decrease in IgG deposits 
is relevant for the degree of proteinuria since we found a strong 
correlation between GBM-Ig deposits and albuminuria Comple-
ment activation is an important contribution to tissue damage in 
diseases mediated by immune complexes like lupus nephritis The 
pattern of C3 deposition along the capillary wall was identical to 
the lg deposition This suggests that the reduced deposition of О 
in drug treated animals is secondarv to the decrease of IgG 
deposition However, we cannot exclude that heparin and the 
hepannoids had a direct effect on complement, since inhibition of 
complement activation in \ttro and m mo has been described [41. 
42] 
In this studv we could confirm in the control group our earlier 
observation that in MRL/lpr mice the staining of GBM-HS is 
strongly reduced and related to proteinuria and GBM-Ig deposi­
tion [22] Hepann/hepannoids were able to prevent this decrease 
of HS staining significantly As outlined above, this seems to be 
due to the reduction of deposition of nucleosome complexed 
autoantibodies in the G B M A similar mechanism has been 
demonstrated for other canonic molecules like human platelet-
derived cationic molecules (43] and platelet factor 4 [44], which 
binding to the glomerular poly a η ion was inhibited by heparin 
However, in recent years data has emerged that points to addi­
tional mechanisms which could explain the observed beneficial 
effect of heparin It was found that glycosaminoglycans (GAGs) 
like heparin could prevent the progressive loss of HS-associated 
anionic charges in the G B M in adriamycin nephropathy [45] and 
in streptozotocin-induced diabetic nephropathy [46, 47] The 
significance of these observations is supported by our findings that 
GBM-HS expression in adriamycin nephropathy [4H] and diabetic 
nephropathy [49] is significantly correlated to proteinuria Indeed 
in patients with insulin-dependent diabetes microalbuminuria was 
substantially reduced by heparin treatment [50] These protective 
effects were not related to the anticoagulant properties of the 
agents It is therefore conceivable that exogenous administration 
of GAGs can interfere with the functional decrease of the 
glomerular polyanion, that is, HS A similar mechanism might 
have contnbuted to the attenuation of the decreased expression of 
HS in the G B M by hepann/hepannoids as observed in this study 
However, once albuminuria was established, heparin or hepann-
oid treatment did not reduce it, suggesting that the loss of HS was 
not corrected anymore We therefore assume that immune com­
plexes, once they are bound to the G B M , are not resolved by 
hepann/hepannoids 
Our preliminary data on the combination treatment of LMW-
DSA-HEP and CY suggest that addition of non-anticoagulant 
hepannoids to immunosuppressive drugs in the initial phases of 
treatment of lupus nephritis could be of clinical importance After 
initiation of the immunosuppressive treatment for disease fiares 
the reduction of the autoantibody production is not immediate 
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Fig. 7. Representative examples of the immunofluorescence findings of glomeruli of MRL Ipr mice showing déposition of/g after PBS treatment I A) or HEP 
treatment (B)i staining for C3 in PBS treated mice (C) and HEP treated mice ID): staining for HS in PBS treated mice IE) and HEP ireated mice IF) The 
few animals that developed albuminuria in the treated hepann'hepannoid treated groups showed a staining pattern similar to that of albuminuric: PBS 
treated controls 
96 
Chapter 7 
юоо 
PBS HEP DSA-HEP LMW-DSA-
HEP 
Fig 8 The ami HS геаспмп al the age of 21 weeks in plasma samples of 
MRZ-Лрг mice Mated wilh PBS HEP DSA HEP or LMU DSA HEP 
Individual titers are given plus the median value for each group 'P < 0 05 
Table 2 Influence of 50 μg daily of either HEP DSA HEP or LMW 
DSA HEP on delaved tvpe hypersensitivity (DTH) and primary 
antibodv response after immunization with BSA 
Treatment DTH R l . ratio Primary antibodv response 
PBS 
HEP 
DSA HEP 
LMW DSA HEP 
1 5 * 0 2 
14 z 0 2 
1 3 ζ 0 1 
11 = о : 
100(20-4H0) 
«0 (40-320) 
280(10-640) 
320(10-1900) 
Control animals were treated daily with PBS Results arc expressed as 
means ΐ SD or medians (range) 
" ratio between the antigen (R) and PBS (L) injected site 
ь
 titer 
During this period temporary treatment with hepannoids could 
pi event further glomerular damage by reducing the deposition of 
nephntogenic complexes Further studies are needed to see 
whether this promising option is realistic 
In conclusion our study indicates that heparin and more 
importantly non coagulant heparin derivatives are able to bind to 
nephntogenic complexes consisting of nucleosomes and anti 
nuclear antibodies This binding of hepann/hepannoids prevents 
the subsequent deposition of these nephntogenic immune com 
plexes in the GBM By this diminution of lgG deposition the 
ensuing glomerular inflammation and albuminuria is reduced 
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Introduction 
Systemic lupus erythemathosus (SLE) is an auto­
immune disease characterized by the formation of 
antinuclear autoantibodies especially against double-
stranded (ds) DNA [1.2] Although initially it was 
thought that the formation of these autoantibodies 
was due to polyclonal В cell activation, it is now clear 
that the disease anses as a result of an (auto-) antigen 
driven response, since somatic mutations, clonal expan­
sion and IgG class switches occur There is fair evidence 
that anli-dsDNA antibodies are important in the initi­
ation of tissue lesions especially lupus glomerulo­
nephritis. Because of this pathogenic role, numerous 
attempts have been made to induce these anli-dsDNA 
antibodies by immunization of dsDNA from various 
sources, either alone or complexed to proteins These 
experiments have revealed that DNA is poorly 
immunogenic. But if the formation of autoantibodies 
in SLE is antigen driven and DNA is not the driving 
antigen, are there other candidates'1 
In recent years the nucleosome has been put forward 
as a major candidate for the auioanligen thai drives 
the autoimmune response in SLE [3.4] In this editorial 
comment we will review these data and also discuss 
the role of nucleosomes in the pathogenesis of lupus 
nephritis 
Immunogeniciry of nucleosomes 
Nucleosomes consists of a 146 bp segment of DNA 
wrapped, in two superhelical turns, around an octam-
enc core complex containing four pairs of the hislone 
proteins H2A. H2B, H3. and H4 DNA within the 
nucleosome is responsible for clustered negative 
charges. On the other hand, the amino-lerannal 20-30 
amino acids of H2A. H2B. H3 and H4. which are 
exposed on the surface, are strongly positively charged 
Nucleosomes can act as polyclonal В cell activators, 
which might be relevant in the initiation of disease 
But more importantly, since lupus is an antigen-driven 
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9101. 6500 HB Nijmegen. The Netherlands 
disease, nucleosomes are epitopes for pathogenic Τ 
helper cells Mohan el al showed that about 50% of 
pathogenic CD4' Τ helper cell clones isolated from 
lupus mice had a specificity for nucleosomes These 
nucleosome-specific Τ helper cells induced the forma­
tion not only of nucleosome-specific autoantibodies, 
but also of anti-DNA and anti-histone antibodies In 
murine and human SLE nucleosome-specific autoanti­
bodies are reported with increasing frequency These 
nucleosome-specific antibodies react with the intact 
nucleosome but not with its individual components 
dsDNA and histones Interestingly, the formation of 
these nucleosome-specific antibodies precedes the 
formation of anti-DNA and anti-histone antibodies 
in lupus [5.6] This suggests that the autoimmune 
response was initiated by a loss of tolerance for 
nucleosomes 
Nucleosome-specific autoantibodies 
In spontaneous SLE nucleosome-specific reactivity was 
first described for monoclonal autoantibodies derived 
from lupus mice Later, these nucleosome-specific anti­
bodies were also detected in serum/plasma of SLE 
patients and SLE mice In fact these nucleosome-
specific antibodies are present in about 80% of both 
lupus mice and SLE patients [6.7] Retrospectively, 
antibodies to nucleosomes are probably the first 
autoantibodies described in association with SLE, in 
the so-called 'LE-cell phenomenon' which is due to the 
phagocytosis of'LE cell factors' These 'LE cell factors' 
were subsequently identified as autoantibodies and it 
was shown that nucleosomes. in contrast to free 
dsDNA or histones. were able to inhibit the formation 
of the 'LE cell phenomenon'. This suggests that the 
autoantibodies which are responsible for the "LE cell 
phenomenon' are nucleosome-specific antibodies 
When analysing polyclonal serum plasma for anti-
nucleosome reactivity one should realize that anti-
dsDNA and anti-histone antibodies will also give a 
positive result These antibodies have to be removed 
by absorption on a DNA-cellulose and a histone-
Sepharose column [6.8.9] From such absorption 
studies it appeared that in the presence of anti-
DNA antibodies. 25-65% of the anti-nucleosome react-
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iviiv in non-absorbed plasma was due to anti-dsDNA 
antibodies while this was much lower for anti-histone 
antibodies ( 10-20 4) Most data on epitope spécifiât) 
of nucleosome-specific antibodies have been obtained 
with monoclonal antibodies Most of these monoclon-
al antibodies recognize epitopes within the H2A-
H2B DNA and to a lesser extent within the 
( ЬП H4), DNA complex but for some monoclonal 
antibodies the reactivity with the intact nucleosomes 
is higher than with these subnucleosomal structures 
suggesting that additional epitopes are involved 
Interestingly the VH regions of these nucleosome-
specific mAbs contained within the CDR1 region an 
increased amount of canonic charged residues ( like 
anti-DNA antibodies) and an increase in anionic res­
idues m CDR2 region (as in anti-histone antibodies! 
[10] Therefore, these antibodies seem to harbour 
antigen-binding characteristics for both anionic DNA 
and canonic histone epitopes 
Systemic release of nucleosomes and apoptosis 
There is now increasing evidence that apoptosis (a 
process of programmed cell death leading to the ïnter-
nucleosomal cleavage of chromatin) is disturbed in 
both murine and human lupus In several (MRL Ipr 
and gld) but not all (NZBWFI ) lupus mouse strains 
it was demonstrated that this disturbance in apoptosis 
was due lo a deficient expression of either the Fas 
receptor (APO-1, CD95) or its ligand Activation of 
this Fas-receptor leads to apoptosis In human SLE 
the expression of the Fas system is normal but 
increased concentrations of soluble Fas, increased 
expression of the apoptosis inhibitor bcl-2 and an 
increased rate of spontaneous apoptosis m vitro of 
lymphocytes from SLE patients point to abnormalities 
in apoptosis also in human SLE These disturbances 
in apoptosis lead not only to persistence of auto-
reactive Τ cells but also to quantitative and qualitative 
changes in the release and composition of nucleosomes 
This process might be enhanced by a decreased phago­
cytosis of apoptotic cells This concept is in line with 
the observation that nuclear material in the circulation 
of SLE patients is present in the form of (ohgo-) 
nucleosomes suggesting that it originates from apop­
totic cells [11] Recently, in an experimental set-up 
Casciola-Rosen et al [12] elegantly demonstrated the 
relationship between apoptosis, nucleosomes and 
nucleosome-specific auto­
antibodies They found that these lupus-derived 
nucleosome-specific antibodies bound to nucleosomes 
localized in apoptotic bodies (blebs) at the surface of 
keratinocytes undergoing apoptosis induced by UV 
light Similar evidence is provided by the observation 
that nucleosome-specific autoantibodies bind to 
nucleosomes released from apoptotic mononuclear 
cells The apoptotic 'blebs in which the nucleosomes 
appear are topologically restricted to selected sites 
(nuclear membranes mitochondria and endoplasmatic 
reticulum) where free radical-induced protein modi­
fications (e g fragmentation amino-acid modification. 
novel proteolytic cleavages) may generate novel (more 
immunogenic) nucleosome epitopes that may then 
trigger non-tolerant Τ helper cells 
Role of nucleosomes in the binding of 
autoantibodies to the GBM 
An alternative explanation other than deposition of 
DNA anti-DNA complexes for the pathogenicity of 
anlinuclear antibodies is that these antibodies cross-
react with epitopes present within the glomerulus 
Many direct interactions ofanti-DNA and other lupus 
autoantibodies with glomerular antigens (endothelial 
and epithelial cell surlace antigens individual basement 
membrane components and matrix constituents) have 
been described [Π 14] Several years ago we found 
that both monoclonal and polyclonal anti-DNA anti­
bodies could bind to heparan sulphate (HS) an 
intrinsic constituent of the GBM (HS has a strong 
negative charge and is responsible for the net negative 
charge of the GBM and for its charge-dependent 
permeability ) Later we found that this HS cross-
reactivity was due to nucleosomal material complexed 
to the antibodies Subsequent experiments showed that 
monoclonal antinuclear autoantibodies (mAbs) which 
are complexed to nucleosomes arc able to bind to the 
GBM in IMO whereas purified antibodies are not [8] 
The positively charged histone part in the nucleosome 
is responsible for the binding to negatively charged 
determinants in the GBM The pathophysiological 
significance of this binding is underlined by the fact 
that complement activation occurs after binding 
Besides HS collagen IV has been put forward as a 
ligand in the GBM [15] The importance of HS as 
ligand for this binding was illustrated bv the fact that 
after renal perfusion of heparmnase which removes 
HS from the GBM the binding of the complexed mAbs 
decreased considerably [8] The involvement of HS in 
the pathogenesis of SLE nephritis was further substan­
tiated by the finding that the staining of HS in the 
GBM was almost completely absent both in human 
and murine (MRL 1 and NZBWFI mice) SLE This 
decrease was due to the binding of nucleosome-
conlaining immune complexes to HS in the GBM The 
pathophysiological significance of this binding was 
illustrated by the inverse correlation between GBM 
HS staining and proteinuria [16] 
Several other observations point also to the in \no 
relevance of this nucleosome-mediated binding of 
autoantibodies to the GBM in SLE nephritis First 
elution of antibodies from glomeruli disclosed specifi­
cities towards all components of the nucleosome ι e 
DNA histones and nucleosomes [17 18] Furthermore 
deposition of anti-nucleosome antibodies preceded the 
deposition of anti-DNA antibodies Second histones 
and nucleosomes are present in glomerular deposits in 
human SLE With a panel of histone and nucleosome-
specific monoclonal antibodies we found respectively 
100'VI and 45% of human kidney biopsies with difTuse 
proliferative lupus nephritis deposits along the GBM 
This observation confirms and extends the detection 
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of histones in glomerular deposits reported earlier by 
Schmiedeke and Stockl [19.20] The clinical relevance 
of nucleosome-complexed autoantibodies was substan-
 ю 
Hated by the finding that anti-HS reactivity (as a 
method to identify nucleosome-complexed autoanti­
bodies in the circulation) was elevated at the onset or " 
exacerbation of SLE nephritis [21.22] ρ 
Finally, indirect evidence for nucleosome involve­
ment in lupus nephritis comes from our studies in 
which we used different heparins Heparin and non-
coagulant heparin derivatives are able to inhibit the 
binding of nucleosome-complexed autoantibodies to 14 
HS in ¡uro (ELISA), but more importantly also, after 
renal perfusion to the GBM in ¡no In the MRL 1 
lupus mouse model we found that heparin and non-
coagulant hepannoids prevented the deposition of 
nucleosome complexed autoantibodies in the GBM 
and delaved the onset of nephritis 
16 
Concluding remarks 
17 
These data suggest that nucleosomes may be the prim-
ary and major autoantigen in SLE Besides serving as 
an immunogen for pathogenic Τ helper cells, nucleo- 18 
somes contribute to the development of lupus nephritis 
by mediating the binding of antinuclear antibodies to 
the glomerular basement membrane 
19 
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SUMMARY 
Anti-nuclear auto-antibodies are a key feature of the systemic auto-immune disease systemic 
lupus erythematosus (SLE). The auto-immune response in this disease is antigen driven. 
Recent research has suggested that the auto-antigen that drives this auto-antibody formation 
is the nucleosome. This is in line with the fact that the presence of nucleosome-specific 
antibodies in SLE is reported with increasing frequency. Nucleosome-specific antibodies are 
defined as antibodies which are directed exclusively or predominantly against nucleosomes 
or subnucleosomal structures consisting of core histones and DNA. Not only in the induction 
phase of the disease nucleosomes seem to be important, since research from our group has 
revealed that nucleosomes play also an important role in the initiation of tissue lesions by 
targetting auto-antibodies to the glomerular basement membrane (GBM). Elucidation of the 
mechanism behind this auto-antibody binding to the GBM was the major aim of this thesis. 
In chapter 2 we evaluated in lupus the relation between nephritis and auto-antibody 
formation and deposition in the glomerulus. To this end, we studied MRL/lpr mice at the age 
of 18-24 weeks with either no albuminuria, with albuminuria of short duration ( <7days) or 
with prolonged albuminuria. From these animals we isolated the glomeruli and eluted 
antibodies. In eluates of albuminuric mice higher amounts of immunoglobulins were found 
compared to non-albuminunc mice. Anti-extracellular matrix, anti-dsDNA and anti-
nucleosome reactivities were higher in eluates of albuminuric mice than in eluates of non-
albuminuric mice. There were no differences between albuminuric and non-albuminunc mice 
with regard to deposition of anti-histone antibodies. Anti-nucleosome antibodies were 
deposited to a greater extent in the early phase of the disease (short duration of albuminuria) 
than anti-DNA antibodies, which accumulated later. Furthermore, in a longitudinal 
prospective study on plasma samples we found in the same lupus mouse model that at the 
onset of albuminuria anti-dsDNA reactivity was higher, while anti-nucleosome reactivity was 
lower compared to age matched non-albuminuric mice. This suggest that there is a 
preferential deposition of anti-nucleosome antibodies. In this study we provide evidence that 
deposition of auto-antibodies directed against nucleosomes, dsDNA and extracellular matrix 
proteins is correlated with the development of albuminuria in lupus nephritis. 
In chapter 3 we describe studies analysing the nucleosome reactivity of monoclonal 
antibodies which displayed, in purified non-complexed form, a high binding activity in the 
Farr-assay. This defines these antibodies as high avidity anti-DNA antibodies. The 
equilibrium affinity constants (Ka) of these monoclonal antibodies towards both dsDNA and 
nucleosomes were measured in a biosensor system. On mononucleosomes 15 to 25 times 
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higher Ka values were found as compared to dsDNA. In addition, we found that these anti-
dsDNA antibodies bound to a determinant formed by DNA and the region 83-100 of histone 
H3 on the surface of the nucleosome. This data indicate that auto-antibodies defined as high 
avidity anti-dsDNA antibodies according to the "golden standard" the Farr assay bind better 
to nucleosomal antigens than to epitopes on dsDNA and thus are in fact anti-nucleosome 
antibodies. This findings stress the importance of the nucleosome as the major autoantigen 
in SLE. 
An important argument for the involvement of nucleosomes in the evolution of tissue lesions 
in lupus is the identification of nucleosomes in GBM deposits as described in chapter 4. 
Using monoclonal nucleosome specific antibodies, nucleosomes were identified in the GBM 
in 45% of human kidney biopsies with diffuse proliferative lupus glomerulonephritis (WHO 
class IV). With a polyclonal anti-histone antiserum, histones were identified in all patients 
with diffuse proliferative glomerulonephritis. The higher frequency of histone deposits over 
that of nucleosomes might be due to masking in vivo of nucleosomal epitopes by anti-
nucleosome and anti-DNA antibodies, in contrast to histone epitopes which are relatively 
spared. This is in line with the observations described in chapter 2 showing a relation 
between nephritis and deposition of anti-nucleosome and anti-dsDNA antibodies, in contrast 
to the deposition of anti-histone antibodies. Furthermore, we found that the presence of 
histones in the GBM was significantly associated with a decrease of GBM-HS staining. 
The disappearance of GBM-HS staining in lupus nephritis was studied in more detail in the 
MRL/lpr mouse model (chapter 5). We studied MRL/lpr mice with albuminuria of short 
duration or prolonged duration and compared these with mice of different ages without 
albuminuria. We found that GBM-HS staining disappeared in albuminuric mice. There was 
a significant inverse correlation between GBM-HS staining and albuminuria as well as 
between GBM-HS staining and GBM-Ig deposits. This decrease in GBM-HS staining was not 
secondary to a decrease in HS content in the GBM. Furthermore, in vitro studies revealed 
that anti-nuclear antibodies complexed to nucleosomes can inhibit the binding of the anti-HS 
antibody to HS, whereas non-complexed anti-nuclear antibodies do not interfere. Taken 
together, our data suggest that the absence of GBM-HS staining in lupus nephritis is not due 
to a decreased HS content of the GBM but to the binding of nucleosome complexed anti-
nuclear antibodies which results in a masking of HS. 
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In chapter 6 studies are described anlysing whether the specificity of the auto-antibody 
complexed to the nucleosome influences the glomerular binding of the nucleosome/auto-
antibody complex. We induced the formation of nucleosome/Ig complexes in vivo by 
intraperitoneal inoculation of hybridomas producing monoclonal anti-nuclear antibodies 
(either anti-histone, anti-dsDNA or anti-nucleosome) into nude BALB/c mice. Although the 
amount of nucleosome/antibody complexes was the same in all mice, differences were 
observed in glomerular Ig deposits. About 60% of the mice inoculated with anti-DNA or 
anti-nucleosome hybridomas had Ig deposits in the GBM whereas only 15% of the mice 
inoculated with anti-histone hybridomas showed GBM-Ig deposits. Thus, nucleosome/Ig 
complexes comprising anti-nucleosome or anti-DNA antibodies did bind more frequently to 
the GBM in vivo than nucleosome/Ig complexes containing anti-histone antibodies. We 
suggest that by binding to the histone moiety of the nucleosome, anti-histone antibodies 
decrease the ability of the complex to interact with the GBM, whereas anti-dsDNA and anti-
nucleosome antibodies can increase the affinity of the complex for the GBM by binding to 
anionic DNA or nucleosome specific determinants. 
In chapter 4, 5 and 6 we described that the nephritogenicity of nucleosome/antibody 
complexes is determined by the interaction of canonie histone moieties within the complex 
with the HS associated anionic sites in the GBM. Therefore, we tried to interfere with this 
interaction using heparin and heparinoids, which functionally and structurally strongly 
resemble HS (chapter 7). We found that heparin and heparinoids are able to prevent the 
binding of nucleosome complexed autoantibodies to HS in vitro and to the GBM in vivo in 
renal perfusion studies. In addition, we tested the preventive effect of heparin and 
heparinoids on the development of renal disease manifestations in MRL/lpr mice. In heparin 
and heparinoid treated mice the albuminuria was significantly delayed and the 
glomerulonephritis was less severe compared to PBS treated controls. Furthermore, the 
amount of immunoglobulin and complement C3 deposits in the glomerular capillary wall 
tended to be less in heparin and heparinoid treated mice. From these findings we conclude 
that heparin and heparinoids are able to postpone nephritis in MRL/lpr mice by preventing 
the binding of nucleosome/auto-antibody complexes to anionic sites (HS) in the GBM. 
In this thesis we provide several lines of evidence to support the involvement of nucleosomes 
and anti-nuclear antibodies complexed to nucleosomes in the pathogenesis of SLE nephritis. 
In chapter 8 the results described in chapter 2-7 are discussed and put into perspective. 
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FUTURE DIRECTIONS OF RESEARCH 
Future research needs to be directed at the analysis of the structure and composition of the 
nucleosome bound to auto-antibodies in the circulation or deposited in tissue lesions This 
may tell us whether the nucleosome participating in this auto-immune process is altered or 
not. A different approach for this could be to evaluate whether apoptosis in SLE leads to the 
release of structurally changed nucleosomes, secondary to disturbances in the apoptotic 
process This could provide insight in the auto-antigen that drives the auto-immune respons 
in SLE, both at the Τ cell and at the В cell level. Furthermore, the possibility should be 
studied that different epitopes within the nucleosome dictate the production of anti-histone, 
anti-dsDNA and anti-nucleosome auto-antibodies. Finally, the interaction between the 
(altered) nucleosome and the GBM should be analysed further with regard to affinity, ligand 
interaction and prevention. All together these new insights could lead to new treatment 
strategies for SLE since the last 30 years not much progress has been made in this respect. 
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Anti-nucleaire auto-antistoffen zijn kenmerkend voor de auto-immuun ziekte systemische 
lupus erythematoses (SLE). De auto-immuun reactie bij deze ziekte is antigeen afhankelijk. 
Uit onderzoek van de laatste jaren is gebleken dat het nucleosoom wellicht het auto-antigeen 
is dat verantwoordelijk is voor de inductie van deze auto-antistoffen. In toenemende mate 
verschijnen er publikaties waarin de aanwezigheid van anti-nucleosoom antistoffen bij SLE 
wordt beschreven. Anti-nucleosoom antistoffen zijn gericht tegen determinanten op het intacte 
nucleosoom of subnucleosomale structuren die zowel histonen als DNA bevatten. 
Nucleosomen spelen niet alleen een belangrijke rol bij de inductie van SLE, maar ook bij de 
initiatie van weefselschade. Onze groep heeft namelijk gevonden dat nucleosomen een 
belangrijke rol spelen in de binding van auto-antistoffen aan de glomerulaire basaalmembraan 
(GBM) Het mechanisme van deze auto-antistof binding aan de GBM is het belangrijkste 
onderwerp van dit proefschrift en is nader bestudeerd. 
In hoofdstuk 2 wordt de studie beschreven naar het verband tussen nefritis en de vorming 
van auto-antistoffen. Tevens werd nagegaan welke auto-antistoffen aanwezig waren in 
glomerulaire immuun-deposities MRL/lpr muizen (een spontaan diermodel voor SLE) van 
18-24 weken oud werden verdeeld in 3 groepen: muizen zonder albuminurie, muizen met 
kortdurende albuminurie (< 7 dagen) en muizen met langdurige albuminurie. Uit de 
glomeruli van deze dieren werden antistoffen geelueerd. Zowel de hoeveelheid 
Immunoglobulinen als ook de reactiviteiten tegen extracellulaire matrix, dsDNA en 
nucleosoom waren hoger in de eluaten van muizen met albuminurie dan in eluaten van 
muizen zonder albuminurie. Depositie van anti-histon antistoffen was gelijk bij muizen met 
of zonder albuminurie. In een vroeg stadium van de ziekte (kortdurende albuminurie) waren 
er meer anti-nucleosoom dan anti-dsDNA antistoffen aanwezig in de deposities. Bovendien 
werd met een prospectieve analyse met plasmamonsters aangetoond dat op het moment van 
het ontstaan van de albuminurie de anti-dsDNA reactiviteit was verhoogd terwijl de anti-
nucleosoom reactiviteit was verlaagd ten opzichte van even oude muizen zonder albuminurie. 
Dit suggereert een preferentiële depositie van anti-nucleosoom antistoffen. Dus in deze studie 
tonen we een correlatie aan tussen het ontstaan van albuminurie en de depositie van anti-
nucleosoom, anti-dsDNA en anti-extracellulaire matrix antistoffen in de glomerulus. 
In hoofdstuk 3 worden studies beschreven waarin de reactiviteit met nucleosomen wordt 
geanalyseerd van monoclonale antistoffen die, in zuivere met-gecomplexeerde vorm, een 
hoge reactiviteit in de Farr assay vertonen. Deze reactiviteit bestempelt deze antistoffen als 
hoog-avide anti-dsDNA antistoffen Met behulp van het BIAcore systeem werd van elk van 
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deze monoclonale antistoffen de affiniteitscontante (KJ bepaald ten opzichte van nucleosomen 
en dsDNA. De binding van de geteste antistoffen aan het mononucleosoom bleek veel sterker 
te zijn dan de binding aan dsDNA (15-25x hogere Ka waarden). Bovendien vonden we dat 
deze anti-dsDNA antistoffen gericht zijn tegen een epitoop dat gevormd wordt door DNA en 
het 83-100 peptide van histon H3 Uit deze bevindingen blijkt dat de geteste antistoffen, die 
gedefinieerd zijn als hoog-avide anti-dsDNA antistoffen, in feite sterker binden aan 
nucleosomale epitopen dan aan epitopen op dsDNA en dus in feite anti-nucleosoom 
antistoffen zijn 
In de experimenten beschreven in hoofdstuk 4 werden nucleosomen aangetoond in 
glomerulaire immuun-deposities bij patiënten met lupus nefritis. Deze bevindingen vormen 
een belangrijk bewijs voor de betrokkenheid van nucleosomen bij het ontstaan van 
weetselschade. Met behulp van monoclonale nucleosoom-specifieke antistoffen werden 
nucleosomen aangetoond in de GBM in 45% van de merbiopsieen van patiënten met diffuus 
proliferative SLE glomerulonefntis (WHO klasse IV). Met een polyclonaal anti-histon 
antiserum werden histonen aangetoond in alle biopsieen. Het feit dat aankleuring met anti-
histone antistoffen vaker werd gezien dan met anti-nucleosoom antistoffen kan verklaard 
worden door het feit dat in vivo nucleosomale epitopen zijn afgedekt door anti-nucleosoom 
en anti-DNA antistoffen (aangezien deze zijn verrijkt in glomerulaire eluaten, hoofdstuk 2) 
in tegenstelling tot epitopen die herkend worden door de anti-histon antistoffen. Daarnaast 
correleerde de aanwezigheid van histonen in de GBM significant met de afname van heparan 
sulfaat (HS) aankleuring in de GBM. 
De afname van HS aankleuring in de GBM bij lupus nefritis werd nader bestudeerd in 
MRL/lpr muizen (hoofdstuk 5) MRl/lpr muizen met kortdurende of langdurige albuminurie 
werden vergeleken met MRL/lpr muizen zonder albuminurie. Bij muizen met albuminurie 
vonden we een sterke afname van de HS aankleuring in de GBM De afname van GBM-HS 
aankleuring correleerde significant met de albuminurie en met de Ig deposities in de GBM 
Isolatie van het HS uit de glomeruli van de verschillende muizen toonde geen verschillen in 
de hoeveelheid HS aan. De afname van de HS aankleuring is dan ook geen gevolg van een 
vermindering van HS in de glomerulus Anti-nucleaire antistoffen die gecomplexeerd zijn aan 
nucleosomen remden in vitro de binding van anti-HS antistoffen aan HS terwijl zuivere, niet 
gecomplexeerde. antistoffen geen effect hadden op deze binding. Samengevat suggereren deze 
proeven dat bij lupus nefritis de afname van HS aankleuring in de GBM niet wordt 
veroorzaakt door een afname van de HS hoeveelheid in de GBM, maar door afdekking van 
HS door nucleosoom/anti-nucleaire antistofcomplexen 
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In hoofdstuk 6 worden studies beschreven of de specificiteit van de auto-antistof die 
gebonden is aan het nucleosoom, bepalend is voor de glomerulaire binding van het 
nucleosoom/auto-antistof complex. Naakte BALB/c muizen werden intraperitoneaal 
geïnjecteerd met hybridoma cellen die monoclonale anti-nucleaire (anti-histon, anti-dsDNA 
of anti-nucleosoom) antistoffen produceren. In het ascites en in het plasma van deze muizen 
waren nucleosoom/anti-histon, nucleosoom/anti-dsDNA of nucleosoom/anti-nucleosoom 
complexen aantoonbaar. Hoewel de hoeveelheid van de gevormde nucleosoom/antistof 
complexen vergelijkbaar was in alle muizen, waren er verschillen in de mate van 
glomerulaire Ig deposities. Ongeveer 60% van de muizen die geïnjecteerd waren met de anti-
dsDNA of de anti-nucleosoom producerende hybridoma's hadden Ig deposities in de GBM, 
terwijl dit slechts bij 15% van de muizen werd gevonden die waren geïnjecteerd met anti-
histon hybridomas. Bij de nucleosoom/Ig complexen die anti-dsDNA of anti-nucleosoom 
antistoffen bevatten, zagen we dus significant meer glomerulaire binding dan bij 
nucleosoom/Ig complexen die anti-histon antistoffen bevatten. Wij denken dat anti-histon 
antistoffen de affiniteit van het nucleosoom/antistofcomplex voor de GBM vermindert door 
te binden aan het histon-deel van het nucleosoom, terwijl anti-dsDNA en anti-nucleosoom 
antistoffen de affiniteit van het complex voor de GBM verhogen door te binden aan het 
negatief geladen DNA of aan nucleosoom specifieke determinanten. 
In de hoofdstukken 4, 5 en 6 hebben we aangetoond dat de nefritogeniciteit van 
nucleosoom/antistofcomplexen wordt bepaald door de interactie tussen het positief geladen 
histon-deel in het complex en de HS-geassocieerde negatieve ladingen in de GBM. Daarom 
hebben we geprobeerd deze binding te voorkomen met héparine en heparine-derivaten die 
zowel structureel als functioneel zeer sterk op HS lijken (hoofdstuk 7). Heparine en de 
heparine-derivaten waren in staat om de binding van nucleosoom/auto-antistofcomplexen aan 
HS (in vitro) en aan de GBM (in vivo) te remmen. Daarnaast vonden we dat héparine en de 
heparine-derivaten de ontwikkeling van nefritis verschijnselen in MRL/lpr muizen konden 
afremmen. In vergelijking met de PBS behandelde controle muizen was in de muizen die 
behandeld waren met héparine of heparine-derivaten het ontstaan van de albuminurie 
significant vertraagd en was de glomerulonefritis minder ernstig. Bovendien hadden de 
muizen die met héparine of de héparine derivaten behandeld waren minder Ig- en 
complementfactor C3 deposities in de GBM. Uit deze proeven concluderen we dat héparine 
en heparine-derivaten de ontwikkeling van nefritis in MRL/lpr muizen kan vertragen doordat 
ze de binding van nucleosoom/auto-antistofcomplexen aan de negatieve ladingen (HS) in de 
GBM remmen. 
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In dit proefschrift hebben we op verschillende manieren aangetoond dat nucleosomen en 
nucleosoom/anti-nucleaire antistofcomplexen betrokken zijn bij de Pathogenese van SLE 
nefritis. De resultaten, beschreven in de hoofdstukken 2-7, worden bediscussieerd in 
hoofdstuk 8. 
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Stellingen 
1 Binding van auto-antistoffen aan de glomerulaire basaalmembraan is een complex 
gebeuren (dit proefschrift) 
2 Hoog-avide anti dsDNA antistoffen die sterker binden aan nucleosomale epitopen 
dan aan epitopen op dsDNA, zijn in feite anti-nucleosoom antistoffen 
3 Bij onderzoek naar het verband tussen nefritis en antistof reactiviteit in het bloed, 
moet men zich realiseren dat de nefritogene antistoffen zich in de glomerulus 
bevinden. 
4 BIJ lupus nefritis wordt de afname van heparan sulfaat aankleuring in de 
glomerulaire basaalmembraan veroorzaakt door maskering van epitopen op heparan 
sulfaat. 
5 In MRL/lpr muizen is preventie van lupus nefritis makkelijker dan behandeling 
6 Manuscripten met vooruitstrevende data worden vaak vertraagd gepubliceerd 
7 Gedachten zijn één van de drijfveren voor lichamelijke gezondheid 
8. De besluitvorming m b.t. de "Betuwelijn" is in vele opzichten eenzijdig De 
geluidsoverlast voor 'geluidsgevoelige objecten', zoals woningen, is aan regels 
gebonden Met de geluidsbelasting voor bewoners wordt helaas geen rekening 
gehouden. 
9 Raad vragen betekent vrijwel altijd een medeplichtige zoeken. 
10 Door een baan krijgen weekends en vakanties extra waarde 
11 Als op de werkvloer de man/vrouw verhouding kleiner is dan 1, zou bij 
gelijkwaardige sollicitanten de voorkeur moeten uitgaan naar een man 
12 God gunt elke vogel zijn worm. maar hij legt hem niet in het nest 
(Zweeds spreekwoord) 
13 De grootheid van een ideaal ligt niet in het bereiken ervan maar in het streven ernaar 
14 De lengte van het dankwoord is omgekeerd evenredig met de dankbaarheid aan alle 
betrokkenen, (dit proefschrift) 
Mieke van Bruggen 
11 maart 1997 
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